- 抑制劑
- 化合物庫
- 抗體
- 生物試劑
- 新產(chǎn)品
- 聯(lián)系我們
別名: NSC 125973,PTX 中文名稱:紫杉醇
Paclitaxel是一種microtubule聚合物穩(wěn)定劑,在人內(nèi)皮細胞中IC50為0.1 pM。Paclitaxel可引起有絲分裂停滯和細胞凋亡。 Paclitaxel還會誘導自噬。
Paclitaxel Chemical Structure
CAS: 33069-62-4
規(guī)格 | 價格 | 庫存 | 購買數(shù)量 |
---|---|---|---|
10mM (1mL in DMSO) | 749.07 | 現(xiàn)貨 | |
10mg | 571.49 | 現(xiàn)貨 | |
50mg | 1711.71 | 現(xiàn)貨 | |
100mg | 2694.51 | 現(xiàn)貨 | |
1g | 7944.3 | 現(xiàn)貨 | |
更大包裝 有超大折扣 | |||
細胞系 | 實驗類型 | 給藥濃度 | 孵育時間 | 活性描述 | 文獻信息 |
---|---|---|---|---|---|
MCF7 | Antiproliferative activity assay | 72 h | IC50 = 0.002 μM | 11325226 | |
SW626 | Cytotoxicity assay | 72 h | IC50 = 0.00001 μM | 12088425 | |
Lu1 | Cytotoxicity assay | 72 h | IC50 = 0.01 μM | 12088425 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.02 μM | 12088425 | |
P388 | Cytotoxicity assay | 72 h | IC50 = 0.02 μM | 12088425 | |
LNCAP | Cytotoxicity assay | 72 h | IC50 = 0.02 μM | 12088425 | |
KB | Cytotoxicity assay | 72 h | IC50 = 0.02 μM | 12088425 | |
Col2 | Cytotoxicity assay | 72 h | IC50 = 0.02 μM | 12088425 | |
BC1 | Cytotoxicity assay | 72 h | IC50 = 0.02 μM | 12088425 | |
SK-MEL-2 | Cytotoxicity assay | 72 h | IC50 = 0.07 μM | 12088425 | |
NCI-H460 | Cytotoxicity assay | 48 h | IC50 = 0.0095 μM | 14695798 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.0112 μM | 14695798 | |
SF268 | Cytotoxicity assay | 48 h | IC50 = 0.0217 μM | 14695798 | |
MDA-MB-231 | Cytotoxicity assay | 48 h | IC50 = 0.0045 μM | 14987051 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.0049 μM | 14987051 | |
A2780 | Cytotoxicity assay | 48 h | IC50 = 0.025 μM | 14987051 | |
PC3 | Cytotoxicity assay | 48 h | IC50 = 0.077 μM | 14987051 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.0014 μM | 14987056 | |
multidrug-resistant MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.354 μM | 14987056 | |
PC3 | Cytotoxicity assay | 48 h | IC50 = 0.016 μM | 15043402 | |
Hep3B | Cytotoxicity assay | 48 h | IC50 = 0.031 μM | 15043402 | |
NCI-H460 | Cytotoxicity assay | 48 h | IC50 = 0.0095 μM | 15043404 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.0112 μM | 15043404 | |
SF268 | Cytotoxicity assay | 48 h | IC50 = 0.0217 μM | 15043404 | |
T47D | Apoptosis assay | 24 h | EC50 = 0.03 μM | 15566300 | |
DLD1 | Apoptosis assay | 24 h | EC50 = 0.075 μM | 15566300 | |
H1299 | Apoptosis assay | 24 h | EC50 = 0.163 μM | 15566300 | |
VA13 | Cytotoxicity assay | 48 h | IC50 = 0.005 μM | 15730243 | |
WI 38 | Cytotoxicity assay | 48 h | IC50 = 0.04 μM | 15730243 | |
Hep G2 | Cytotoxicity assay | 48 h | IC50 = 8.1 μM | 15730243 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 1.25 μM | 15787460 | |
SKOV3 | Cytotoxicity assay | 48 h | IC50 = 1.35 μM | 15787460 | |
KB | Cytotoxicity assay | 3 days | IC50 = 0.001 μM | 16038545 | |
1A9 | Cytotoxicity assay | 3 days | IC50 = 0.002 μM | 16038545 | |
HCT8 | Cytotoxicity assay | 3 days | IC50 = 0.013 μM | 16038545 | |
VA13 | Growth inhibition assay | 48 h | IC50 = 0.0043 μM | 16499322 | |
WI38 | Growth inhibition assay | 48 h | IC50 = 0.034 μM | 16499322 | |
HepG2 | Growth inhibition assay | 48 h | IC50 = 6.9 μM | 16499322 | |
U937 GTB | Cytotoxicity assay | 72 h | IC50 = 0.0059 μM | 16562840 | |
RPMI 8226/s | Cytotoxicity assay | 72 h | IC50 = 0.007 μM | 16562840 | |
CEM/s | Cytotoxicity assay | 72 h | IC50 = 0.007 μM | 16562840 | |
LT12 | Antiproliferative activity assay | 48 h | IC50 = 0.006 μM | 17181164 | |
SKOV3 | Antiproliferative activity assay | 48 h | IC50 = 0.01 μM | 17181164 | |
NCI-H460 | Antiproliferative activity assay | 48 h | IC50 = 0.01 μM | 17181164 | |
SF268 | Antiproliferative activity assay | 48 h | IC50 = 0.01 μM | 17181164 | |
RKO | Antiproliferative activity assay | 48 h | IC50 = 0.01 μM | 17181164 | |
KB/HeLa | Antiproliferative activity assay | 48 h | IC50 = 0.01 μM | 17181164 | |
P388 | Antiproliferative activity assay | 48 h | IC50 = 0.04 μM | 17181164 | |
L1210 | Antiproliferative activity assay | 48 h | IC50 = 0.06 μM | 17181164 | |
LT12 MDR | Antiproliferative activity assay | 48 h | IC50 = 0.4 μM | 17181164 | |
NCI-H1299 | Cytotoxicity assay | 96 h | IC50 = 0.015 μM | 17419065 | |
HT29 | Growth inhibition assay | 48 h | GI50 = 0.015 μM | 17498960 | |
M21 | Growth inhibition assay | 48 h | GI50 = 0.037 μM | 17498960 | |
MCF7 | Growth inhibition assay | 48 h | GI50 = 0.054 μM | 17498960 | |
1A9 | Growth inhibition assay | 72 h | GI50 = 0.00071 μM | 17542572 | |
1A9/Ptx22 | Growth inhibition assay | 72 h | GI50 = 0.051 μM | 17542572 | |
1A9/Ptx10 | Growth inhibition assay | 72 h | GI50 = 0.064 μM | 17542572 | |
HL60 | Cytotoxicity assay | 72 h | IC50 = 0.93 μM | 17896816 | |
P388 | Cytotoxicity assay | 72 h | IC50 = 0.93 μM | 17896816 | |
BEL-7402 | Cytotoxicity assay | 24 h | IC50 = 0.93 μM | 17896816 | |
A459 | Cytotoxicity assay | 24 h | IC50 = 0.93 μM | 17896816 | |
Aro | Cytotoxicity assay | 72 h | IC50 = 0.0002 μM | 17915851 | |
PT45 | Cytotoxicity assay | 72 h | IC50 = 0.005 μM | 17915851 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.006 μM | 17915851 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.007 μM | 17915851 | |
HeLa | Cytotoxicity assay | 72 h | IC50 = 0.008 μM | 17915851 | |
Ovcar3 | Cytotoxicity assay | 72 h | IC50 = 0.01 μM | 17915851 | |
HT29 | Cytotoxicity assay | 72 h | IC50 = 0.05 μM | 17915851 | |
A549T12 | Cytotoxicity assay | 72 h | IC50 = 0.06 μM | 17915851 | |
H295R | Cytotoxicity assay | 72 h | IC50 = 0.08 μM | 17915851 | |
A549T24 | Cytotoxicity assay | 72 h | IC50 = 0.102 μM | 17915851 | |
OE33 | Cytotoxicity assay | 72 h | IC50 = 0.2 μM | 17915851 | |
HepG2 | Cytotoxicity assay | 72 h | IC50 = 0.3 μM | 17915851 | |
OE19 | Cytotoxicity assay | 72 h | IC50 = 0.4 μM | 17915851 | |
L12 | Antiproliferative activity assay | 48 h | IC50 = 0.006 μM | 17973361 | |
NCI-H460 | Cytotoxicity assay | 48 h | IC50 = 0.01 μM | 17973361 | |
SKOV3 | Cytotoxicity assay | 48 h | IC50 = 0.01 μM | 17973361 | |
SF268 | Cytotoxicity assay | 48 h | IC50 = 0.01 μM | 17973361 | |
RKO | Cytotoxicity assay | 48 h | IC50 = 0.01 μM | 17973361 | |
KB/HeLa | Cytotoxicity assay | 48 h | IC50 = 0.01 μM | 17973361 | |
P388 | Antiproliferative activity assay | 48 h | IC50 = 0.04 μM | 17973361 | |
L1210 | Antiproliferative activity assay | 48 h | IC50 = 0.06 μM | 17973361 | |
PANC1 | Cytotoxicity assay | 72 h | IC50 = 0.007 μM | 18081257 | |
DLD1 | Cytotoxicity assay | 72 h | IC50 = 0.011 μM | 18081257 | |
AsPC1 | Cytotoxicity assay | 72 h | IC50 = 0.02 μM | 18081257 | |
NCI/ADR | Cytotoxicity assay | 72 h | IC50 = 1 μM | 18081257 | |
SK-BR3 | Antiproliferative activity assay | 96 h | GI50 = 6.1 μM | 18164205 | |
A2780 | Antiproliferative activity assay | 96 h | IC50 = 0.0234 μM | 18177014 | |
SNU398 | Apoptosis assay | 24 h | EC50 = 0.011 μM | 18197614 | |
HCT116 | Apoptosis assay | 24 h | EC50 = 0.024 μM | 18197614 | |
T47D | Apoptosis assay | 24 h | EC50 = 0.036 μM | 18197614 | |
SJSA1 | Cytotoxicity assay | 6 h | IC50 = 0.0032 μM | 18243696 | |
P388 | Cytotoxicity assay | 72 h | IC50 = 0.93 μM | 18281952 | |
HL60 | Cytotoxicity assay | 72 h | IC50 = 0.93 μM | 18281952 | |
Bel7402 | Cytotoxicity assay | 24 h | IC50 = 0.93 μM | 18281952 | |
A549 | Cytotoxicity assay | 24 h | IC50 = 0.93 μM | 18281952 | |
KB | Cytotoxicity assay | 48 h | IC50 = 0.0042 μM | 18295490 | |
KBV20C | Cytotoxicity assay | 48 h | IC50 = 1.44 μM | 18295490 | |
DU145 | Cytotoxicity assay | 72 h | IC50 = 0.005 μM | 18308566 | |
HL60 | Cytotoxicity assay | 72 h | IC50 = 0.005 μM | 18308566 | |
MDA435 | Cytotoxicity assay | 72 h | IC50 = 0.005 μM | 18308566 | |
MESSA | Cytotoxicity assay | 72 h | IC50 = 0.005 μM | 18308566 | |
P388 | Cytotoxicity assay | 72 h | IC50 = 0.01 μM | 18308566 | |
HL60/TX1000 | Cytotoxicity assay | 72 h | IC50 = 5 μM | 18308566 | |
MESSA/DX5 | Cytotoxicity assay | 72 h | IC50 = 5 μM | 18308566 | |
K562 | Growth inhibition assay | 72 h | IC50 = 0.0006 μM | 18313307 | |
KB3-1 | Growth inhibition assay | 72 h | IC50 = 0.002 μM | 18313307 | |
HepG2 | Growth inhibition assay | 72 h | IC50 = 0.007 μM | 18313307 | |
KB V1 | Growth inhibition assay | 72 h | IC50 = 8 μM | 18313307 | |
A549 | Cytotoxicity assay | 3 days | IC50 = 0.007 μM | 18419154 | |
MCF7 | Cytotoxicity assay | 3 days | IC50 = 0.0117 μM | 18419154 | |
HepG2 | Cytotoxicity assay | 3 days | IC50 = 0.0468 μM | 18419154 | |
MDA-MB-231 | Cytotoxicity assay | 3 days | IC50 = 0.0703 μM | 18419154 | |
Hep3B | Cytotoxicity assay | 3 days | IC50 = 0.13 μM | 18419154 | |
CCRF-CEM | Cytotoxicity assay | 72 h | IC50 = 0.001274 μM | 18450456 | |
HCT116 | Cytotoxicity assay | 72 h | IC50 = 0.0013 μM | 18450456 | |
MX1 | Cytotoxicity assay | 72 h | IC50 = 0.035 μM | 18450456 | |
HeLa | Antiproliferative activity assay | 48 h | IC50 = 0.0015 μM | 18461997 | |
HT29 | Antiproliferative activity assay | 48 h | IC50 = 0.0019 μM | 18461997 | |
U2OS | Antiproliferative activity assay | 48 h | IC50 = 0.024 μM | 18461997 | |
A2780 | Cytotoxicity assay | 72 h | IC50 = 0.00138 μM | 18465846 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.0017 μM | 18465846 | |
LCC6 | Cytotoxicity assay | 72 h | IC50 = 0.0031 μM | 18465846 | |
1A9PTX22 | Cytotoxicity assay | 72 h | IC50 = 0.1607 μM | 18465846 | |
NCI/ADR | Cytotoxicity assay | 72 h | IC50 = 0.3 μM | 18465846 | |
1A9PTX10 | Cytotoxicity assay | 72 h | IC50 = 0.53295 μM | 18465846 | |
HepG2 | Growth inhibition assay | 72 h | IC50 = 0.0059 μM | 18512984 | |
HepG2/Dox | Growth inhibition assay | 72 h | IC50 = 1.4 μM | 18512984 | |
HT29 | Growth inhibition assay | 48 h | GI50 = 0.015 μM | 18579387 | |
M21 | Growth inhibition assay | 48 h | GI50 = 0.037 μM | 18579387 | |
MCF7 | Growth inhibition assay | 48 h | GI50 = 0.054 μM | 18579387 | |
KB403 | Cytotoxicity assay | 24 h | IC50 = 0.001 μM | 18586491 | |
WRL68 | Cytotoxicity assay | 24 h | IC50 = 0.004 μM | 18586491 | |
MCF7 | Cytotoxicity assay | 24 h | IC50 = 0.006 μM | 18586491 | |
CaCO2 | Cytotoxicity assay | 24 h | IC50 = 0.008 μM | 18586491 | |
HEPG2 | Cytotoxicity assay | 24 h | IC50 = 0.009 μM | 18586491 | |
MDA-MB-435 | Antiproliferative activity assay | 72 h | GI50 = 0.004 μM | 18610995 | |
HT29 | Antiproliferative activity assay | 48 h | GI50 = 0.015 μM | 18617414 | |
M21 | Antiproliferative activity assay | 48 h | GI50 = 0.037 μM | 18617414 | |
MCF7 | Antiproliferative activity assay | 48 h | GI50 = 0.054 μM | 18617414 | |
HepG2 | Antiproliferative activity assay | 48 h | IC50 = 0.62 μM | 18701301 | |
PC3 | Antiproliferative activity assay | 48 h | IC50 = 2.73 μM | 18701301 | |
HCT116 | Antiproliferative activity assay | 48 h | IC50 = 6.18 μM | 18701301 | |
CCRF-CEM | Cytotoxicity assay | 72 h | IC50 = 0.0011 μM | 18752869 | |
SKOV3 | Anticancer assay | 72 h | IC50 = 0.00134 μM | 18762358 | |
PANC1 | Cytotoxicity assay | 72 h | IC50 = 0.0099 μM | 18951787 | |
DLD1 | Cytotoxicity assay | 72 h | IC50 = 0.022 μM | 18951787 | |
AsPC1 | Cytotoxicity assay | 72 h | IC50 = 0.089 μM | 18951787 | |
NCI/ADR-RES | Cytotoxicity assay | 72 h | IC50 = 1.3 μM | 18951787 | |
A431 | Cytotoxicity assay | 72 h | IC50 = 0.0251 μM | 18990574 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.039 μM | 18990574 | |
MDA-MB-231 | Cytotoxicity assay | 72 h | IC50 = 0.0471 μM | 18990574 | |
SKOV3 | Cytotoxicity assay | 72 h | IC50 = 0.0658 μM | 18990574 | |
PANC1 | Growth inhibition assay | 72 h | IC50 = 0.0099 μM | 19022679 | |
DLD1 | Growth inhibition assay | 72 h | IC50 = 0.022 μM | 19022679 | |
AsPC1 | Growth inhibition assay | 72 h | IC50 = 0.089 μM | 19022679 | |
NCI/ADR | Growth inhibition assay | 72 h | IC50 = 1.3 μM | 19022679 | |
A2780 | Antiproliferative activity assay | 2 days | IC50 = 0.0234 μM | 19028102 | |
KB | Antiproliferative activity assay | 3 days | IC50 = 0.0025 μM | 19041247 | |
COLO205 | Antiproliferative activity assay | 24 h | IC50 = 0.0033 μM | 19041247 | |
KB 8.5 | Antiproliferative activity assay | 3 days | IC50 = 0.026 μM | 19041247 | |
KBV1 | Antiproliferative activity assay | 3 days | IC50 = 2.013 μM | 19041247 | |
KB | Growth inhibition assay | 72 h | IC50 = 0.0033 μM | 19053773 | |
KB-7D | Growth inhibition assay | 72 h | IC50 = 0.0079 μM | 19053773 | |
Pgp170 overexpressing multidrug resistant-KB-TAX50 | Growth inhibition assay | 72 h | IC50 = 0.273 μM | 19053773 | |
NPC-TW01 | Cytotoxicity assay | 72 h | IC50 = 0.006 μM | 19053781 | |
MES-SA | Cytotoxicity assay | 72 h | IC50 = 0.008 μM | 19053781 | |
NCI-H838 | Cytotoxicity assay | 72 h | IC50 = 0.026 μM | 19053781 | |
HCT116 | Cytotoxicity assay | 72 h | IC50 = 0.061 μM | 19053781 | |
Hep3B | Cytotoxicity assay | 72 h | IC50 = 7.26 μM | 19053781 | |
A498 | Cytotoxicity assay | 72 h | IC50 = 8.81 μM | 19053781 | |
NB4 | Cytotoxicity assay | 48 h | IC50 = 0.1 μM | 19072209 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.1 μM | 19072209 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.1 μM | 19072209 | |
SH-SY5Y | Cytotoxicity assay | 48 h | IC50 = 0.2 μM | 19072209 | |
PC3 | Cytotoxicity assay | 48 h | IC50 = 0.2 μM | 19072209 | |
DLD1 | Cytotoxicity assay | 72 h | GI50 = 0.01 μM | 19081249 | |
B16 | Cytotoxicity assay | 72 h | GI50 = 0.01 μM | 19081249 | |
A172 | Cytotoxicity assay | 72 h | GI50 = 0.01 μM | 19081249 | |
HeLa | Cytotoxicity assay | 72 h | GI50 = 0.02 μM | 19081249 | |
U87 | Cytotoxicity assay | 72 h | GI50 = 0.02 μM | 19081249 | |
SiHa | Cytotoxicity assay | 72 h | GI50 = 0.03 μM | 19081249 | |
HeLa | Antiproliferative activity assay | 96 h | IC50 = 0.001 μM | 19091579 | |
SKOV3 | Antiproliferative activity assay | 96 h | IC50 = 0.016 μM | 19091579 | |
BGC823 | Antiproliferative activity assay | 96 h | IC50 = 0.0189 μM | 19091579 | |
HCT116 | Cytotoxicity assay | 72 h | IC50 = 0.0011 μM | 19124250 | |
CCRF-CEM | Cytotoxicity assay | 72 h | IC50 = 0.0031 μM | 19124250 | |
MX1 | Cytotoxicity assay | 72 h | IC50 = 0.046 μM | 19124250 | |
HCT116 | Cytotoxicity assay | 4 days | IC50 = 0.0011 μM | 19128156 | |
HT-29 | Cytotoxicity assay | 4 days | IC50 = 0.0036 μM | 19128156 | |
A2780 | Cytotoxicity assay | 48 h | IC50 = 0.0013 μM | 19128972 | |
P388 | Antiproliferative activity assay | 48 h | IC50 = 0.05 μM | 19220018 | |
cells ectopic expression of human | Antiproliferative activity assay | 48 h | IC50 = 0.05 μM | 19220018 | |
L1210 | Antiproliferative activity assay | 48 h | IC50 = 0.06 μM | 19220018 | |
Antiproliferative activity assay | 48 h | IC50 = 0.3 μM | 19220018 | ||
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.0012 μM | 19239240 | |
A2780 | Cytotoxicity assay | 72 h | IC50 = 0.00138 μM | 19239240 | |
wild type A2780 | Cytotoxicity assay | 72 h | IC50 = 0.0017 μM | 19239240 | |
cisplatin-resistant A2780 | Cytotoxicity assay | 72 h | IC50 = 0.0022 μM | 19239240 | |
LCC-6 | Cytotoxicity assay | 72 h | IC50 = 0.00245 μM | 19239240 | |
HT-29 | Cytotoxicity assay | 72 h | IC50 = 0.0036 μM | 19239240 | |
H460 | Cytotoxicity assay | 72 h | IC50 = 0.0049 μM | 19239240 | |
topotecan-resistant A2780 | Cytotoxicity assay | 72 h | IC50 = 0.0072 μM | 19239240 | |
PANC1 | Cytotoxicity assay | 72 h | IC50 = 0.0257 μM | 19239240 | |
1A9PTX22 | Cytotoxicity assay | 72 h | IC50 = 0.1607 μM | 19239240 | |
NCI/ADR | Cytotoxicity assay | 72 h | IC50 = 0.3 μM | 19239240 | |
1A9PTX10 | Cytotoxicity assay | 72 h | IC50 = 0.53295 μM | 19239240 | |
A2780/ADR | Cytotoxicity assay | 72 h | IC50 = 1.239 μM | 19239240 | |
A549 | Cytotoxicity assay | 24 h | IC50 = 0.0052 μM | 19245261 | |
PC3M | Cytotoxicity assay | 24 h | IC50 = 0.027 μM | 19245261 | |
HCT8 | Cytotoxicity assay | 24 h | IC50 = 0.037 μM | 19245261 | |
Bel7402 | Cytotoxicity assay | 24 h | IC50 = 0.095 μM | 19245261 | |
SNU398 | Apoptosis assay | 48 h | GI50 = 0.01 μM | 19282188 | |
HCT116 | Apoptosis assay | 48 h | EC50 = 0.023 μM | 19282188 | |
T47D | Apoptosis assay | 48 h | EC50 = 0.035 μM | 19282188 | |
PC3 | Cytotoxicity assay | 4 days | IC50 = 0.0014 μM | 19359169 | |
A2780 | Cytotoxicity assay | 4 days | IC50 = 0.0149 μM | 19359169 | |
K562 | Cytotoxicity assay | 48 h | IC50 = 1.16 μM | 19359185 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 2.11 μM | 19359185 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 2.46 μM | 19359185 | |
SGC | Cytotoxicity assay | 48 h | IC50 = 3.34 μM | 19359185 | |
HCT116 | Cytotoxicity assay | 48 h | IC50 = 4.37 μM | 19359185 | |
wild type A2780 | Growth inhibition assay | 72 h | IC50 = 0.0017 μM | 19423340 | |
cisplatin-resistant A2780 | Growth inhibition assay | 72 h | IC50 = 0.0022 μM | 19423340 | |
topotecan-resistant A2780 | Growth inhibition assay | 72 h | IC50 = 0.0072 μM | 19423340 | |
adriamycin and doxorubicin-resistant A2780 | Growth inhibition assay | 72 h | IC50 = 1.239 μM | 19423340 | |
NB4 | Cytotoxicity assay | 48 h | IC50 = 0.1 μM | 19425589 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.1 μM | 19425589 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.1 μM | 19425589 | |
SH-SY5Y | Cytotoxicity assay | 48 h | IC50 = 0.2 μM | 19425589 | |
PC3 | Cytotoxicity assay | 48 h | IC50 = 0.2 μM | 19425589 | |
SNU398 | Apoptosis assay | 48 h | EC50 = 0.009 μM | 19467598 | |
HCT116 | Apoptosis assay | 48 h | EC50 = 0.018 μM | 19467598 | |
T47D | Growth inhibition assay | 48 h | GI50 = 0.026 μM | 19467598 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.08 μM | 19467877 | |
H1299 | Growth inhibition assay | 48 h | GI50 = 0.023 μM | 19500976 | |
T47D | Growth inhibition assay | 48 h | GI50 = 0.026 μM | 19500976 | |
DLD1 | Apoptosis assay | 48 h | EC50 = 0.054 μM | 19500976 | |
HCT116 | Cytotoxicity assay | 72 h | IC50 = 0.0011 μM | 19576785 | |
CCRF-CEM | Cytotoxicity assay | 72 h | IC50 = 0.0012 μM | 19576785 | |
MX1 | Cytotoxicity assay | 72 h | IC50 = 0.046 μM | 19576785 | |
vinblastine-resistant CCRF-CEM | Cytotoxicity assay | 72 h | IC50 = 0.4 μM | 19576785 | |
taxol-resistant CCRF-CEM | Cytotoxicity assay | 72 h | IC50 = 1.2 μM | 19576785 | |
MCF7 | Growth inhibition assay | 48 h | IC50 = 0.003 μM | 19601594 | |
HCT116 | Antiproliferative activity assay | 72 h | IC50 = 0.0008 μM | 19665384 | |
PC3 | Antiproliferative activity assay | 72 h | IC50 = 0.0008 μM | 19665384 | |
NCI/ADR | Antiproliferative activity assay | 72 h | IC50 = 0.004 μM | 19665384 | |
HuH7 | Antiproliferative activity assay | 72 h | IC50 = 0.008 μM | 19665384 | |
Caco-2 | Antiproliferative activity assay | 72 h | IC50 = 0.02 μM | 19665384 | |
DG75 | Antiproliferative activity assay | 24 to 72 h | IC50 = 0.01 μM | 19717215 | |
MUTU-I | Antiproliferative activity assay | 24 h | IC50 = 0.01 μM | 19717215 | |
HCT116 | Antiproliferative activity assay | 72 h | IC50 = 0.001 μM | 19743863 | |
SW48 | Antiproliferative activity assay | 72 h | IC50 = 0.001 μM | 19743863 | |
MES-SA | Antiproliferative activity assay | 72 h | IC50 = 0.001 μM | 19743863 | |
CEM | Antiproliferative activity assay | 72 h | IC50 = 0.002 μM | 19743863 | |
SW480 | Antiproliferative activity assay | 72 h | IC50 = 0.002 μM | 19743863 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.003 μM | 19743863 | |
RL | Antiproliferative activity assay | 72 h | IC50 = 0.003 μM | 19743863 | |
T47D | Antiproliferative activity assay | 72 h | IC50 = 0.004 μM | 19743863 | |
UACC-812 | Antiproliferative activity assay | 72 h | IC50 = 0.7 μM | 19743863 | |
DU145 | Cytotoxicity assay | 72 h | IC50 = 4.84 μM | 19754130 | |
LNCAP | Cytotoxicity assay | 72 h | IC50 = 6.32 μM | 19754130 | |
HT-29 | Cytotoxicity assay | 1 h | IC50 = 0.0034 μM | 19778067 | |
HCT116 | Cytotoxicity assay | 1 h | IC50 = 0.0035 μM | 19778067 | |
K562 | Antiproliferative activity assay | 48 h | IC50 = 1.16 μM | 19815316 | |
A549 | Antiproliferative activity assay | 48 h | IC50 = 2.28 μM | 19815316 | |
SGC7901 | Antiproliferative activity assay | 48 h | IC50 = 3.34 μM | 19815316 | |
HCT116 | Antiproliferative activity assay | 48 h | IC50 = 4.37 μM | 19815316 | |
IGROV1 | Antiproliferative activity assay | 72 h | IC50 = 0.06 μM | 19833515 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.002 μM | 19860383 | |
KB | Cytotoxicity assay | 48 h | IC50 = 0.02 μM | 19879765 | |
BT549 | Cytotoxicity assay | 48 h | IC50 = 0.02 μM | 19879765 | |
SKOV3 | Cytotoxicity assay | 48 h | IC50 = 0.53 μM | 19879765 | |
african green monkey Vero | Toxicity assay | 48 h | TC50 = 0.53 μM | 19879765 | |
SK-MEL | Cytotoxicity assay | 48 h | IC50 = 4.1 μM | 19879765 | |
pig LLC-PK11 | Toxicity assay | 48 h | TC50 = 4.39 μM | 19879765 | |
OVCAR-3 | Growth inhibition assay | 48 h | IC50 = 2.7 μM | 19939522 | |
A549 | Growth inhibition assay | 48 h | IC50 = 2.7 μM | 19939522 | |
SNU398 | Apoptosis assay | 48 h | EC50 = 0.009 μM | 20034792 | |
HCT116 | Apoptosis assay | 48 h | EC50 = 0.018 μM | 20034792 | |
T47D | Growth inhibition assay | 48 h | GI50 = 0.026 μM | 20034792 | |
HCT116 | Cytotoxicity assay | 72 h | IC50 = 0.002399 μM | 20116905 | |
MCF7 | Antiproliferative activity assay | 20 h | IC50 = 0.021 μM | 20149494 | |
HeLa | Cytotoxicity assay | 48 h | IC50 = 0.03 μM | 20180542 | |
HCT116 | Cytotoxicity assay | 72 h | IC50 = 0.0013 μM | 20181487 | |
CCRF-CEM | Cytotoxicity assay | 72 h | IC50 = 0.0031 μM | 20181487 | |
MX1 | Cytotoxicity assay | 72 h | IC50 = 0.035 μM | 20181487 | |
KB3-1 | Cytotoxicity assay | 72 h | IC50 = 0.0012 μM | 20302303 | |
HT-29 | Cytotoxicity assay | 3 days | ED50 = 0.0001 μM | 20384315 | |
HL60 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 20521771 | |
SMMC7721 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 20521771 | |
PANC1 | Growth inhibition assay | 48 h | IC50 = 0.008 μM | 20521771 | |
SK-BR-3 | Cytotoxicity assay | 48 h | IC50 = 0.11 μM | 20521771 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 1.4 μM | 20521771 | |
LT12 | Antiproliferative activity assay | 48 h | IC50 = 0.006 μM | 20537765 | |
SKOV3 | Antiproliferative activity assay | 48 h | IC50 = 0.01 μM | 20537765 | |
SF268 | Antiproliferative activity assay | 48 h | IC50 = 0.01 μM | 20537765 | |
NCI-H460 | Antiproliferative activity assay | 48 h | IC50 = 0.01 μM | 20537765 | |
RKO | Antiproliferative activity assay | 48 h | IC50 = 0.01 μM | 20537765 | |
KB/HeLa | Antiproliferative activity assay | 48 h | IC50 = 0.01 μM | 20537765 | |
P388 | Antiproliferative activity assay | 48 h | IC50 = 0.04 μM | 20537765 | |
L1210 | Antiproliferative activity assay | 48 h | IC50 = 0.06 μM | 20537765 | |
DLD1 | Cytotoxicity assay | 72 h | GI50 = 0.01 μM | 20538462 | |
B16 | Cytotoxicity assay | 72 h | GI50 = 0.01 μM | 20538462 | |
A172 | Cytotoxicity assay | 72 h | GI50 = 0.01 μM | 20538462 | |
HeLa | Cytotoxicity assay | 72 h | GI50 = 0.02 μM | 20538462 | |
U87 | Cytotoxicity assay | 72 h | GI50 = 0.02 μM | 20538462 | |
SiHa | Cytotoxicity assay | 72 h | GI50 = 0.03 μM | 20538462 | |
A549 | Cytotoxicity assay | 96 h | IC50 = 0.001 μM | 20560647 | |
BGC823 | Cytotoxicity assay | 96 h | IC50 = 0.04 μM | 20560647 | |
A2780 | Cytotoxicity assay | 96 h | IC50 = 0.9 μM | 20560647 | |
HCT8 | Cytotoxicity assay | 96 h | IC50 = 3.6 μM | 20560647 | |
Bel7402 | Cytotoxicity assay | 96 h | IC50 = 6.3 μM | 20560647 | |
A2780 | Cytotoxicity assay | 3 days | IC50 = 0.65 μM | 20593839 | |
HCT8 | Cytotoxicity assay | 3 days | IC50 = 0.67 μM | 20593839 | |
Bel7402 | Cytotoxicity assay | 3 days | IC50 = 1.8 μM | 20593839 | |
BGC823 | Cytotoxicity assay | 72 h | IC50 = 0.001 μM | 20719510 | |
A2780 | Cytotoxicity assay | 72 h | IC50 = 0.001 μM | 20719510 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.016 μM | 20719510 | |
HCT8 | Cytotoxicity assay | 72 h | IC50 = 0.051 μM | 20719510 | |
Bel7402 | Cytotoxicity assay | 72 h | IC50 = 0.06 μM | 20719510 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.0038 μM | 20732809 | |
HEK | Cytotoxicity assay | 72 h | IC50 = 0.0039 μM | 20732809 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.0044 μM | 20732809 | |
HeLa | Cytotoxicity assay | 72 h | IC50 = 0.0089 μM | 20732809 | |
Hep3B | Anticancer assay | 3 days | GI50 = 0.0004 μM | 20735140 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.002 μM | 20800500 | |
wild type LCC-6 | Cytotoxicity assay | 72 h | IC50 = 0.003 μM | 20800500 | |
A2780 | Cytotoxicity assay | 72 h | IC50 = 0.02 μM | 20800500 | |
CFPAC-1 | Cytotoxicity assay | 72 h | IC50 = 0.047 μM | 20800500 | |
multidrug-resistant LCC-6 | Cytotoxicity assay | 72 h | IC50 = 0.379 μM | 20800500 | |
NCI/ADR | Cytotoxicity assay | 72 h | IC50 = 0.41 μM | 20800500 | |
multidrug-resistant MDA-MB-435/LCCMDR1 | Cytotoxicity assay | 48 h | IC50 = 0.004 μM | 20919720 | |
MDA-MB-435 | Cytotoxicity assay | 48 h | IC50 = 0.277 μM | 20919720 | |
HT-29 | Cytotoxicity assay | 3 days | ED50 = 0.0006 μM | 20939540 | |
HCT116 | Growth inhibition assay | 96 h | IC50 = 0.002 μM | 20943401 | |
HCT15 | Growth inhibition assay | 96 h | IC50 = 0.14 μM | 20943401 | |
A549 | Antiproliferative activity assay | 96 h | IC50 = 0.0049 μM | 20974505 | |
MCF7 | Antiproliferative activity assay | 96 h | IC50 = 0.021 μM | 20974505 | |
K562 | Cytotoxicity assay | 48 h | IC50 = 1.16 μM | 21067933 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 2.11 μM | 21067933 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 2.46 μM | 21067933 | |
SGC | Cytotoxicity assay | 48 h | IC50 = 3.34 μM | 21067933 | |
HCT116 | Cytotoxicity assay | 48 h | IC50 = 4.37 μM | 21067933 | |
CCRF-CEM | Cytotoxicity assay | 72 h | IC50 = 0.003 μM | 21106377 | |
MCF7 | Cytotoxicity assay | 72 h | GI50 = 0.003 μM | 21115210 | |
HT-29 | Cytotoxicity assay | 72 h | GI50 = 0.003 μM | 21115210 | |
K562 | Cytotoxicity assay | 72 h | GI50 = 0.004 μM | 21115210 | |
PC3 | Cytotoxicity assay | 72 h | GI50 = 0.004 μM | 21115210 | |
MCF7 | Cytotoxicity assay | 24 h | IC50 = 0.63 μM | 21115212 | |
SMMC7721 | Cytotoxicity assay | 24 h | IC50 = 1.42 μM | 21115212 | |
A2780 | Cytotoxicity assay | 48 to 72 h | IC50 = 0.01 μM | 21126027 | |
Jurkat | Cell cycle arrest assay | 24 h | IC50 = 0.01 μM | 21126027 | |
HeLa | Cytotoxicity assay | 48 to 72 h | IC50 = 0.02 μM | 21126027 | |
SW620 | Cytotoxicity assay | 48 to 72 h | IC50 = 0.03 μM | 21126027 | |
HCT116 | Cytotoxicity assay | 72 h | IC50 = 0.0013 μM | 21144756 | |
CCRF-CEM | Cytotoxicity assay | 72 h | IC50 = 0.003 μM | 21144756 | |
MX1 | Cytotoxicity assay | 72 h | IC50 = 0.035 μM | 21144756 | |
chemoresistant DG75 | Cytotoxicity assay | 72 h | IC50 = 0.01 μM | 21227702 | |
chemosensitive MUTU-I | Cytotoxicity assay | 24 h | IC50 = 0.01 μM | 21227702 | |
HT1080 | Antiproliferative activity assay | 96 h | IC50 = 0.0012 μM | 21296467 | |
A549 | Antiproliferative activity assay | 96 h | IC50 = 0.0044 μM | 21296467 | |
A375 | Antiproliferative activity assay | 96 h | IC50 = 0.0046 μM | 21296467 | |
NCI-N87 | Antiproliferative activity assay | 96 h | IC50 = 0.0059 μM | 21296467 | |
MCF7 | Antiproliferative activity assay | 96 h | IC50 = 0.0205 μM | 21296467 | |
HeLa | Antiproliferative activity assay | 96 h | IC50 = 0.1 μM | 21296467 | |
PANC1 | Antiproliferative activity assay | 96 h | IC50 = 0.3841 μM | 21296467 | |
Bel7402 | Antiproliferative activity assay | 96 h | IC50 = 0.5782 μM | 21296467 | |
1A9 | Antiproliferative activity assay | 3 days | ED50 = 0.00209 μM | 21296579 | |
A549 | Antiproliferative activity assay | 3 days | ED50 = 0.00256 μM | 21296579 | |
KB | Antiproliferative activity assay | 3 days | ED50 = 0.00287 μM | 21296579 | |
PC3 | Antiproliferative activity assay | 3 days | ED50 = 0.00887 μM | 21296579 | |
KB | Cytotoxicity assay | 72 h | GI50 = 0.00487 μM | 21316977 | |
DU145 | Cytotoxicity assay | 72 h | GI50 = 0.00555 μM | 21316977 | |
A549 | Cytotoxicity assay | 72 h | GI50 = 0.00558 μM | 21316977 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.006 μM | 21341718 | |
HT-29 | Cytotoxicity assay | 48 h | IC50 = 0.007 μM | 21341718 | |
K562 | Cytotoxicity assay | 48 h | IC50 = 1.16 μM | 21342735 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 2.11 μM | 21342735 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 2.46 μM | 21342735 | |
SGC | Cytotoxicity assay | 48 h | IC50 = 3.34 μM | 21342735 | |
HCT116 | Cytotoxicity assay | 48 h | IC50 = 4.37 μM | 21342735 | |
multidrug-resistant K562 | Cytotoxicity assay | 48 h | IC50 = 5.63 μM | 21342735 | |
CCRF-CEM | Cytotoxicity assay | 72 h | IC50 = 0.003 μM | 21356592 | |
taxol-resistant CCRF-CEM | Cytotoxicity assay | 72 h | IC50 = 0.43 μM | 21356592 | |
vinblastine-resistant CCRF-CEM | Cytotoxicity assay | 72 h | IC50 = 1.27 μM | 21356592 | |
KB | Cytotoxicity assay | 3 days | GI50 = 0.00516 μM | 21377368 | |
DU145 | Cytotoxicity assay | 3 days | GI50 = 0.00523 μM | 21377368 | |
A549 | Cytotoxicity assay | 3 days | GI50 = 0.0076 μM | 21377368 | |
A2780 | Cytotoxicity assay | 24 h | IC50 = 0.00082 μM | 21396747 | |
A2780AD | Cytotoxicity assay | 24 h | IC50 = 0.949 μM | 21396747 | |
HT-29 | Cytotoxicity assay | 3 days | ED50 = 0.0001 μM | 21428375 | |
MCF7 | Antiproliferative activity assay | 72 h | IC50 = 0.002 μM | 21440449 | |
HeLa | Cytotoxicity assay | 48 h | IC50 = 0.0026 μM | 21446699 | |
HT-29 | Cytotoxicity assay | 48 h | IC50 = 0.003 μM | 21446699 | |
A549 | Antiproliferative activity assay | 72 h | IC50 = 0.0023 μM | 21480626 | |
HT-29 | Antiproliferative activity assay | 72 h | IC50 = 0.0061 μM | 21480626 | |
A431 | Antiproliferative activity assay | 72 h | IC50 = 0.0092 μM | 21480626 | |
SKOV3 | Antiproliferative activity assay | 72 h | IC50 = 0.0145 μM | 21480626 | |
NCI-H460 | Antiproliferative activity assay | 72 h | IC50 = 0.0146 μM | 21480626 | |
MCF7 | Cytotoxicity assay | 48 h | GI50 = 0.012 μM | 21513294 | |
HT-29 | Cytotoxicity assay | 48 h | GI50 = 0.012 μM | 21513294 | |
SF268 | Cytotoxicity assay | 48 h | GI50 = 0.012 μM | 21513294 | |
H460 | Cytotoxicity assay | 48 h | GI50 = 0.024 μM | 21513294 | |
CHOK1 | Cytotoxicity assay | 48 h | GI50 = 5.9 μM | 21513294 | |
HeLa | Cytotoxicity assay | 24 h | IC50 = 6.62 μM | 21514015 | |
HELF | Cytotoxicity assay | 24 h | IC50 = 7.17 μM | 21514015 | |
SH-SY5Y | Cytotoxicity assay | 24 h | IC50 = 8.56 μM | 21514015 | |
BGC823 | Cytotoxicity assay | 24 h | IC50 = 9.24 μM | 21514015 | |
A2780 | Cytotoxicity assay | 72 h | IC50 = 0.001 μM | 21530251 | |
BGC823 | Cytotoxicity assay | 72 h | IC50 = 0.001 μM | 21530251 | |
Bel7402 | Cytotoxicity assay | 72 h | IC50 = 0.006 μM | 21530251 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.016 μM | 21530251 | |
HCT8 | Cytotoxicity assay | 72 h | IC50 = 0.051 μM | 21530251 | |
SW480 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 21534539 | |
SMMC7721 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 21534539 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 21534539 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 21534539 | |
HL60 | Cytotoxicity assay | 48 h | IC50 = 0.01 μM | 21534539 | |
OVCAR8 | Anticancer assay | 96 h | IC50 = 0.0047 μM | 21557538 | |
NCI/ADR-RES | Anticancer assay | 96 h | IC50 = 6.263 μM | 21557538 | |
NCI-H460 | Antiproliferative activity assay | 48 h | IC50 = 0.004 μM | 21563750 | |
COLO205 | Antiproliferative activity assay | 48 h | IC50 = 0.005 μM | 21563750 | |
SKOV3 | Antiproliferative activity assay | 48 h | IC50 = 0.006 μM | 21563750 | |
BT549 | Antiproliferative activity assay | 48 h | IC50 = 0.006 μM | 21563750 | |
451LU | Antiproliferative activity assay | 48 h | IC50 = 0.006 μM | 21563750 | |
SW480 | Antiproliferative activity assay | 48 h | IC50 = 0.011 μM | 21563750 | |
DLD1 | Antiproliferative activity assay | 48 h | IC50 = 0.05 μM | 21563750 | |
HT1080 | Antiproliferative activity assay | 48 h | IC50 = 0.00015 μM | 21604746 | |
CEM | Antiproliferative activity assay | 48 h | IC50 = 0.00027 μM | 21604746 | |
L1210 | Antiproliferative activity assay | 48 h | IC50 = 0.0004 μM | 21604746 | |
K562 | Antiproliferative activity assay | 48 h | IC50 = 0.00071 μM | 21604746 | |
DU145 | Antiproliferative activity assay | 48 h | IC50 = 0.0013 μM | 21604746 | |
SKOV3 | Antiproliferative activity assay | 48 h | IC50 = 0.0026 μM | 21604746 | |
MDA-MB-231 | Antiproliferative activity assay | 48 h | IC50 = 0.0091 μM | 21604746 | |
B16F0 | Antiproliferative activity assay | 48 h | IC50 = 0.028 μM | 21604746 | |
P388D1 | Antiproliferative activity assay | 48 h | IC50 = 0.035 μM | 21604746 | |
CHO-VV 3-2 | Antiproliferative activity assay | 48 h | IC50 = 0.14 μM | 21604746 | |
CHO | Antiproliferative activity assay | 48 h | IC50 = 0.17 μM | 21604746 | |
CHO-TAX 5-6 | Antiproliferative activity assay | 48 h | IC50 = 0.52 μM | 21604746 | |
CEM/VLB | Antiproliferative activity assay | 48 h | IC50 = 3.34 μM | 21604746 | |
A549 | Antiproliferative activity assay | 72 h | IC50 = 0.0072 μM | 21663319 | |
taxol-resistant A549-T12 | Antiproliferative activity assay | 72 h | IC50 = 0.0752 μM | 21663319 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.0025 μM | 21680190 | |
MCF7/VP | Cytotoxicity assay | 48 h | IC50 = 0.0028 μM | 21680190 | |
NCI/ADR | Cytotoxicity assay | 48 h | IC50 = 2.7 μM | 21680190 | |
LT12 | Antiproliferative activity assay | 48 h | IC50 = 0.006 μM | 21705223 | |
NCI-H460 | Cytotoxicity assay | 48 h | IC50 = 0.01 μM | 21705223 | |
SF268 | Cytotoxicity assay | 48 h | IC50 = 0.01 μM | 21705223 | |
KB/HeLa | Cytotoxicity assay | 48 h | IC50 = 0.01 μM | 21705223 | |
SKOV3 | Cytotoxicity assay | 48 h | IC50 = 0.01 μM | 21705223 | |
RKOp27 | Cytotoxicity assay | 48 h | IC50 = 0.01 μM | 21705223 | |
P388 | Antiproliferative activity assay | 48 h | IC50 = 0.04 μM | 21705223 | |
L1210 | Antiproliferative activity assay | 48 h | IC50 = 0.06 μM | 21705223 | |
NCI-H460 | Anticancer assay | 72 h | IC30 = 3.6 μM | 21707046 | |
A2780 | Cytotoxicity assay | 48 h | IC50 = 0.00062 μM | 21764308 | |
A2780AD | Cytotoxicity assay | 48 h | IC50 = 1.9 μM | 21764308 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.00162 μM | 21779519 | |
COLO205 | Cytotoxicity assay | 48 h | IC50 = 0.00331 μM | 21779519 | |
HeLa | Antiproliferative activity assay | 48 h | IC50 = 0.0012 μM | 21800839 | |
A2780 | Cytotoxicity assay | 2 days | IC50 = 0.014 μM | 21802957 | |
Hep3B2 | Cytotoxicity assay | 72 h | IC50 = 0.000016 μM | 21812410 | |
PANC1 | Cytotoxicity assay | 72 h | IC50 = 0.0011 μM | 21812410 | |
CNE1-LMP1 | Cytotoxicity assay | 72 h | IC50 = 0.0042 μM | 21812410 | |
MGC | Cytotoxicity assay | 72 h | IC50 = 0.0064 μM | 21812410 | |
A375 | Cytotoxicity assay | 72 h | IC50 = 0.0089 μM | 21812410 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.014 μM | 21812410 | |
HaCaT | Cytotoxicity assay | 72 h | IC50 = 0.024 μM | 21812410 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.03 μM | 21812410 | |
EC109 | Cytotoxicity assay | 72 h | IC50 = 0.14 μM | 21812410 | |
MES-SA | Cytotoxicity assay | 96 h | IC50 = 0.004 μM | 21812421 | |
MES-SA/Dx5 | Cytotoxicity assay | 96 h | IC50 = 0.75 μM | 21812421 | |
HL60 | Cytotoxicity assay | 72 h | IC50 = 0.0034 μM | 21848268 | |
MCF7 | Antiproliferative activity assay | 96 h | IC50 = 0.00091 μM | 21870795 | |
A549 | Antiproliferative activity assay | 72 h | IC50 = 0.00314 μM | 21870795 | |
A549 | Cytotoxicity assay | 24 h | EC50 = 0.0046 μM | 21873068 | |
MCF7 | Cytotoxicity assay | 3 days | GI50 = 1.07 μM | 21889341 | |
PC3 | Cytotoxicity assay | 3 days | GI50 = 1.46 μM | 21889341 | |
SK-N-SH | Cytotoxicity assay | 3 days | GI50 = 2.19 μM | 21889341 | |
HeLa | Cytotoxicity assay | 3 days | GI50 = 2.82 μM | 21889341 | |
CHO-VV 3-2 | Antiproliferative activity assay | 48 h | IC50 = 0.14 μM | 21920638 | |
CHO-TAX 5-6 | Antiproliferative activity assay | 48 h | IC50 = 0.52 μM | 21920638 | |
multidrug-resistant CEM/VLB | Antiproliferative activity assay | 48 h | IC50 = 3.34 μM | 21920638 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.01 μM | 21973054 | |
HeLa | Cytotoxicity assay | 48 h | IC50 = 0.6 μM | 21973054 | |
HT-29 | Cytotoxicity assay | 3 days | ED50 = 0.006 μM | 21973101 | |
A549 | Antiproliferative activity assay | 72 h | IC50 = 0.0072 μM | 22027100 | |
taxol-resistant A549-T12 | Antiproliferative activity assay | 72 h | IC50 = 0.075 μM | 22027100 | |
OVCAR8 | Growth inhibition assay | 96 h | IC50 = 0.002 μM | 22044164 | |
NCI-ADR-RES | Growth inhibition assay | 96 h | IC50 = 1.5 μM | 22044164 | |
KB | Growth inhibition assay | 72 h | IC50 = 0.0033 μM | 22060033 | |
KB-7d | Growth inhibition assay | 72 h | IC50 = 0.0079 μM | 22060033 | |
KB-S15 | Growth inhibition assay | 72 h | IC50 = 0.273 μM | 22060033 | |
A2780 | Antiproliferative activity assay | 2 days | IC50 = 0.015 μM | 22071526 | |
KB | Cytotoxicity assay | 48 h | IC50 = 0.0045 μM | 22074257 | |
L1210 | Cytotoxicity assay | 48 h | IC50 = 0.12 μM | 22074257 | |
A2780 | Antiproliferative activity assay | 2 days | IC50 = 0.02 μM | 22136523 | |
QGY7701 | Cytotoxicity assay | 72 h | IC50 = 0.04 μM | 22153338 | |
HepG2 | Cytotoxicity assay | 72 h | IC50 = 0.05 μM | 22153338 | |
Bel7404 | Cytotoxicity assay | 72 h | IC50 = 0.82 μM | 22153338 | |
SMMC7721 | Cytotoxicity assay | 72 h | IC50 = 0.88 μM | 22153338 | |
Bel7402 | Cytotoxicity assay | 72 h | IC50 = 1.25 μM | 22153338 | |
MCF7 | Cytotoxicity assay | 24 to 48 h | IC50 = 0.003 μM | 22222040 | |
SH-SY5Y | Cytotoxicity assay | 24 to 48 h | IC50 = 0.004 μM | 22222040 | |
HepG2 | Cytotoxicity assay | 24 to 48 h | IC50 = 0.007 μM | 22222040 | |
H460 | Cytotoxicity assay | 24 to 48 h | IC50 = 0.008 μM | 22222040 | |
HT-29 | Cytotoxicity assay | 3 days | IC50 = 0.006 μM | 22239601 | |
DU145 | Antiproliferative activity assay | 72 h | GI50 = 0.00386 μM | 22265685 | |
KB | Antiproliferative activity assay | 72 h | GI50 = 0.00412 μM | 22265685 | |
A549 | Antiproliferative activity assay | 72 h | GI50 = 0.00546 μM | 22265685 | |
MCF7 | Cytotoxicity assay | 96 h | IC50 = 0.1 μM | 22360613 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.19 μM | 22472043 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.006 μM | 22472045 | |
K562 | Cytotoxicity assay | 72 h | IC50 = 0.41 μM | 22483090 | |
CaEs17 | Cytotoxicity assay | 72 h | IC50 = 0.43 μM | 22483090 | |
MGC803 | Cytotoxicity assay | 72 h | IC50 = 0.85 μM | 22483090 | |
HeLa | Cytotoxicity assay | 72 h | IC50 = 0.89 μM | 22483090 | |
Bel7402 | Cytotoxicity assay | 72 h | IC50 = 1.89 μM | 22483090 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 3.46 μM | 22483090 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 4.77 μM | 22483090 | |
CCRF-CEM | Cytotoxicity assay | 72 h | IC50 = 0.0012 μM | 22507893 | |
taxol-resistant CCRF-CEM | Cytotoxicity assay | 72 h | IC50 = 0.43 μM | 22507893 | |
vinblastine-resistant CCRF-CEM | Cytotoxicity assay | 72 h | IC50 = 1.27 μM | 22507893 | |
BGC823 | Cytotoxicity assay | 72 h | IC50 = 0.001 μM | 22583079 | |
A2780 | Cytotoxicity assay | 72 h | IC50 = 0.001 μM | 22583079 | |
Bel7402 | Cytotoxicity assay | 72 h | IC50 = 0.006 μM | 22583079 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.016 μM | 22583079 | |
HCT8 | Cytotoxicity assay | 72 h | IC50 = 0.051 μM | 22583079 | |
MES-SA | Cytotoxicity assay | 96 h | IC50 = 0.004 μM | 22587519 | |
MESSA/DX5 | Cytotoxicity assay | 96 h | IC50 = 0.75 μM | 22587519 | |
PC3 | Antiproliferative activity assay | 48 h | IC50 = 0.0004 μM | 22783954 | |
paclitaxel-resistant PC3-TxR | Antiproliferative activity assay | 48 h | IC50 = 0.188 μM | 22783954 | |
MCF7 | Cytotoxicity assay | 24 h | IC50 = 0.015 μM | 22818081 | |
SKBR3 | Growth inhibition assay | 48 h | IC50 = 0.0019 μM | 22850214 | |
HepG2 | Cytotoxicity assay | 72 h | IC50 = 0.00044 μM | 22871217 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.003 μM | 22871217 | |
A375 | Cytotoxicity assay | 72 h | IC50 = 0.0092 μM | 22871217 | |
BxPC3 | Cytotoxicity assay | 72 h | IC50 = 0.09 μM | 22871217 | |
SMMC7721 | Cytotoxicity assay | 72 h | IC50 = 0.15 μM | 22871217 | |
PANC1 | Cytotoxicity assay | 72 h | IC50 = 0.26 μM | 22871217 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.72 μM | 22871217 | |
AGS | Cytotoxicity assay | 72 h | IC50 = 1.6 μM | 22871217 | |
NCI-H2126 | Cytotoxicity assay | 72 h | IC50 = 2.5 μM | 22871217 | |
MDA-MB-231 | Cytotoxicity assay | 72 h | IC50 = 5 μM | 22871217 | |
U87 | Cytotoxicity assay | 72 h | IC50 = 8.1 μM | 22871217 | |
HELF | Cytotoxicity assay | 24 h | IC50 = 7.14 μM | 22901410 | |
BGC | Cytotoxicity assay | 24 h | IC50 = 9.26 μM | 22901410 | |
HELF | Cytotoxicity assay | 24 h | IC50 = 7.14 μM | 22921966 | |
BGC | Cytotoxicity assay | 24 h | IC50 = 9.26 μM | 22921966 | |
DU145 | Cytotoxicity assay | 72 h | GI50 = 0.00255 μM | 22932313 | |
KB | Cytotoxicity assay | 72 h | GI50 = 0.00265 μM | 22932313 | |
A549 | Cytotoxicity assay | 72 h | GI50 = 0.00489 μM | 22932313 | |
KBVIN | Cytotoxicity assay | 72 h | GI50 = 0.948 μM | 22932313 | |
HL60 | Cytotoxicity assay | 72 h | IC50 = 0.00282 μM | 22959518 | |
HeLa | Cytotoxicity assay | 72 h | IC50 = 0.00293 μM | 22959518 | |
U937 | Cytotoxicity assay | 72 h | IC50 = 0.00337 μM | 22959518 | |
A549 | Antiproliferative activity assay | 72 h | IC50 = 0.0072 μM | 23117171 | |
taxol-resistant A549-T12 | Antiproliferative activity assay | 72 h | IC50 = 0.0752 μM | 23117171 | |
IGROV1/Pt1 | Cytotoxicity assay | 72 h | IC50 = 0.0022 μM | 23140358 | |
SKOV3 | Cytotoxicity assay | 72 h | IC50 = 0.0027 μM | 23140358 | |
U2OS | Cytotoxicity assay | 72 h | IC50 = 0.0034 μM | 23140358 | |
PANC1 | Cytotoxicity assay | 72 h | IC50 = 0.0052 μM | 23140358 | |
MIAPaCa2 | Cytotoxicity assay | 72 h | IC50 = 0.0072 μM | 23140358 | |
IGROV1 | Cytotoxicity assay | 72 h | IC50 = 0.023 μM | 23140358 | |
A2780 | Antiproliferative activity assay | 2 days | IC50 = 0.028 μM | 23149304 | |
MDA-MB-231 | Cytotoxicity assay | 72 h | IC50 = 0.052 μM | 23153397 | |
HepG2 | Cytotoxicity assay | 72 h | IC50 = 0.054 μM | 23153397 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.056 μM | 23153397 | |
HeLa | Cytotoxicity assay | 96 h | IC50 = 0.001 μM | 23176628 | |
SW780 | Cytotoxicity assay | 96 h | IC50 = 0.0011 μM | 23176628 | |
MESSA | Cytotoxicity assay | 72 h | IC50 = 0.004 μM | 23214452 | |
HeLa | Cytotoxicity assay | 48 h | IC50 = 0.005 μM | 23214452 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.007 μM | 23214452 | |
HT-29 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 23214452 | |
HCT15 | Cytotoxicity assay | 72 h | IC50 = 0.09 μM | 23214452 | |
MESSA/DX5 | Cytotoxicity assay | 72 h | IC50 = 1.764 μM | 23214452 | |
U937 | Cytotoxicity assay | 72 h | IC50 = 0.0023 μM | 23301703 | |
MOLT4 | Cytotoxicity assay | 72 h | IC50 = 0.0027 μM | 23301703 | |
K562 | Cytotoxicity assay | 72 h | IC50 = 0.0051 μM | 23301703 | |
KU812 | Cytotoxicity assay | 72 h | IC50 = 0.0053 μM | 23301703 | |
HL60 | Cytotoxicity assay | 72 h | IC50 = 0.0058 μM | 23301703 | |
SUP-B15 | Cytotoxicity assay | 72 h | IC50 = 0.008 μM | 23301703 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 23327668 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 23327668 | |
HL60 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 23327668 | |
SMMC7721 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 23327668 | |
SW480 | Cytotoxicity assay | 48 h | IC50 = 0.15 μM | 23327668 | |
HT-29 | Cytotoxicity assay | 3 days | IC50 = 0.001 μM | 23327794 | |
HeLa | Cytotoxicity assay | 48 h | IC50 = 0.0016 μM | 23332369 | |
SKOV3 | Cytotoxicity assay | 48 h | IC50 = 0.0044 μM | 23332369 | |
JC | Cytotoxicity assay | 48 h | IC50 = 0.15 μM | 23352482 | |
HeLa | Cytotoxicity assay | 48 h | IC50 = 0.0063 μM | 23356786 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.0082 μM | 23356786 | |
QGY | Cytotoxicity assay | 48 h | IC50 = 0.0113 μM | 23356786 | |
SW480 | Cytotoxicity assay | 48 h | IC50 = 0.0121 μM | 23356786 | |
K562 | Cytotoxicity assay | 48 h | IC50 = 0.0157 μM | 23356786 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.0035 μM | 23445496 | |
A549-T12 | Cytotoxicity assay | 72 h | IC50 = 0.0923 μM | 23445496 | |
MDA-MB-435 | Cytotoxicity assay | 48 h | IC50 = 0.004 μM | 23547728 | |
MDA-MB-435/LCC6MDR1 | Cytotoxicity assay | 48 h | IC50 = 0.277 μM | 23547728 | |
KB403 | Cytotoxicity assay | 6 h | IC50 = 0.001 μM | 23584542 | |
WRL68 | Cytotoxicity assay | 6 h | IC50 = 0.004 μM | 23584542 | |
MCF7 | Cytotoxicity assay | 6 h | IC50 = 0.005 μM | 23584542 | |
Caco2 | Cytotoxicity assay | 6 h | IC50 = 0.008 μM | 23584542 | |
PA1 | Cytotoxicity assay | 6 h | IC50 = 0.008 μM | 23584542 | |
HL60 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 23586920 | |
A2058 | Cytotoxicity assay | 96 h | IC50 = 0.0047 μM | 23623678 | |
H522-T1 | Cytotoxicity assay | 96 h | IC50 = 0.0081 μM | 23623678 | |
A2780 | Cytotoxicity assay | 2 days | IC50 = 0.012 μM | 23623678 | |
K562 | Cytotoxicity assay | 72 h | IC50 = 0.41 μM | 23644204 | |
CaEs17 | Cytotoxicity assay | 72 h | IC50 = 0.43 μM | 23644204 | |
MGC803 | Cytotoxicity assay | 72 h | IC50 = 0.85 μM | 23644204 | |
Bel7402 | Cytotoxicity assay | 72 h | IC50 = 1.89 μM | 23644204 | |
HT1080 | Cytotoxicity assay | 24 h | IC50 = 6 μM | 23647462 | |
SNU387 | Cytotoxicity assay | 48 h | IC50 = 0.27 μM | 23701597 | |
HepG2 | Cytotoxicity assay | 72 h | IC50 = 0.006 μM | 23708235 | |
SKOV3 | Cytotoxicity assay | 72 h | IC50 = 0.012 μM | 23708235 | |
A549 | Cytotoxicity assay | 3 days | IC50 = 0.02 μM | 23738539 | |
NB4 | Cytotoxicity assay | 3 days | IC50 = 0.03 μM | 23738539 | |
MCF7 | Cytotoxicity assay | 3 days | IC50 = 0.1 μM | 23738539 | |
PC3 | Cytotoxicity assay | 3 days | IC50 = 0.2 μM | 23738539 | |
SH-SY5Y | Cytotoxicity assay | 3 days | IC50 = 0.2 μM | 23738539 | |
HT-29 | Cytotoxicity assay | 96 h | IC50 = 0.00198 μM | 23746477 | |
HCT116 | Cytotoxicity assay | 96 h | IC50 = 0.00613 μM | 23746477 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 23819871 | |
SMMC7721 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 23819871 | |
HL60 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 23819871 | |
SW480 | Cytotoxicity assay | 48 h | IC50 = 0.04 μM | 23819871 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 1.4 μM | 23819871 | |
MCF7 | Cytotoxicity assay | 72 h | GI50 = 0.003 μM | 23831811 | |
HT-29 | Cytotoxicity assay | 72 h | GI50 = 0.003 μM | 23831811 | |
MDA-MB-231 | Cytotoxicity assay | 72 h | IC50 = 1 μM | 23848163 | |
PANC1 | Cytotoxicity assay | 72 h | IC50 = 1 μM | 23848163 | |
HeLa | Antiproliferative activity assay | 48 h | IC50 = 0.0017 μM | 23855338 | |
rat lymphatic endothelial | Antiproliferative activity assay | 48 h | IC50 = 0.018 μM | 23855338 | |
HeLa | Antiproliferative activity assay | 48 h | IC50 = 0.0012 μM | 23855953 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.014 μM | 23886686 | |
HT-29 | Cytotoxicity assay | 72 h | IC50 = 0.0006 μM | 23895019 | |
HeLa | Antiproliferative activity assay | 48 h | IC50 = 0.0016 μM | 23895532 | |
SKOV3 | Antiproliferative activity assay | 48 h | IC50 = 0.003 μM | 23895532 | |
SKOV3/M6-6 isogenic | Function assay | 48 h | IC50 = 2.6 μM | 23895532 | |
MES-SA | Growth inhibition assay | 48 h | GI50 = 0.007 μM | 23927793 | |
MES-SA/Dx5 | Growth inhibition assay | 48 h | GI50 = 9.8 μM | 23927793 | |
HL60 | Antimicrobial assay | 48 h | IC50 = 0.008 μM | 23957453 | |
SMMC7721 | Antimicrobial assay | 48 h | IC50 = 0.008 μM | 23957453 | |
MCF7 | Antimicrobial assay | 48 h | IC50 = 0.008 μM | 23957453 | |
SW480 | Antimicrobial assay | 48 h | IC50 = 0.04 μM | 23957453 | |
A549 | Antimicrobial assay | 48 h | IC50 = 0.1 μM | 23957453 | |
MCF7 | Antiproliferative activity assay | 72 h | IC50 = 0.003 μM | 24012378 | |
PC3 | Cytotoxicity assay | 72 h | IC50 = 0.02 μM | 24033131 | |
DU145 | Cytotoxicity assay | 72 h | IC50 = 0.04 μM | 24033131 | |
WI38 | Cytotoxicity assay | 72 h | IC50 = 0.05 μM | 24033131 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.5 μM | 24056146 | |
PC3 | Cytotoxicity assay | 48 h | IC50 = 1.5 μM | 24056146 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.02 μM | 24063567 | |
NB4 | Cytotoxicity assay | 72 h | IC50 = 0.03 μM | 24063567 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.1 μM | 24063567 | |
SH-SY5Y | Cytotoxicity assay | 72 h | IC50 = 0.2 μM | 24063567 | |
PC3 | Cytotoxicity assay | 72 h | IC50 = 0.2 μM | 24063567 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.02 μM | 24063582 | |
NB4 | Cytotoxicity assay | 48 h | IC50 = 0.03 μM | 24063582 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.1 μM | 24063582 | |
PC3 | Cytotoxicity assay | 48 h | IC50 = 0.2 μM | 24063582 | |
SH-SY5Y | Cytotoxicity assay | 48 h | IC50 = 0.2 μM | 24063582 | |
HeLa | Cytotoxicity assay | 72 h | IC50 = 0.0014 μM | 24087857 | |
SKOV3 | Cytotoxicity assay | 72 h | IC50 = 0.003 μM | 24087857 | |
KB | Cytotoxicity assay | 72 h | IC50 = 0.0041 μM | 24106982 | |
KB-7d | Cytotoxicity assay | 72 h | IC50 = 0.0079 μM | 24106982 | |
KB-S15 | Cytotoxicity assay | 72 h | IC50 = 0.273 μM | 24106982 | |
A549 | Antiproliferative activity assay | 96 h | IC50 = 0.0044 μM | 24211639 | |
MCF7 | Antiproliferative activity assay | 96 h | IC50 = 0.0205 μM | 24211639 | |
HL60 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24219809 | |
SW480 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24219809 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24219809 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24219809 | |
SMMC7721 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24219809 | |
A2780 | Antiproliferative activity assay | 2 days | IC50 = 0.024 μM | 24239390 | |
SMMC7721 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24256484 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24256484 | |
SW480 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24256484 | |
HL60 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24256484 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24256484 | |
BEAS2B | Cytotoxicity assay | 48 h | IC50 = 0.58 μM | 24256484 | |
SKOV3 | Cytotoxicity assay | 48 h | IC50 = 0.035 μM | 24269481 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.93 μM | 24269481 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.00705 μM | 24332858 | |
SW480 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24417634 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24417634 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24417634 | |
SMMC7721 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24417634 | |
HL60 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24417634 | |
Bel7402 | Cytotoxicity assay | 96 h | IC50 = 0.011 μM | 24467317 | |
HCT8 | Cytotoxicity assay | 96 h | IC50 = 0.02 μM | 24467317 | |
BGC823 | Cytotoxicity assay | 96 h | IC50 = 0.026 μM | 24467317 | |
A549 | Cytotoxicity assay | 96 h | IC50 = 0.032 μM | 24467317 | |
A2780 | Cytotoxicity assay | 96 h | IC50 = 0.59 μM | 24467317 | |
ViBo | Antiproliferative activity assay | 24 h | IC50 = 1.6 μM | 24487193 | |
CaSki | Antiproliferative activity assay | 24 h | IC50 = 2.9 μM | 24487193 | |
MDA-MB-231 | Cytotoxicity assay | 72 h | IC50 = 0.0056 μM | 24564494 | |
KB | Cytotoxicity assay | 72 h | IC50 = 0.0051 μM | 24657567 | |
KB-7d | Cytotoxicity assay | 72 h | IC50 = 0.0084 μM | 24657567 | |
KB-S15 | Cytotoxicity assay | 72 h | IC50 = 0.135 μM | 24657567 | |
HL60 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24697496 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24697496 | |
SW480 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24697496 | |
SMMC7721 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24697496 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 24697496 | |
HT-29 | Growth inhibition assay | 48 h | GI50 = 0.001 μM | 24727464 | |
U251 | Growth inhibition assay | 48 h | GI50 = 0.003 μM | 24727464 | |
MCF7 | Growth inhibition assay | 48 h | GI50 = 0.005 μM | 24727464 | |
UACC62 | Growth inhibition assay | 48 h | GI50 = 0.01 μM | 24727464 | |
786-0 | Growth inhibition assay | 48 h | GI50 = 0.02 μM | 24727464 | |
African green monkey Vero | Growth inhibition assay | 48 h | GI50 = 0.03 μM | 24727464 | |
NCI-ADR-RES | Growth inhibition assay | 48 h | GI50 = 0.04 μM | 24727464 | |
NCI-H460 | Growth inhibition assay | 48 h | GI50 = 0.1 μM | 24727464 | |
PC3 | Growth inhibition assay | 48 h | GI50 = 0.1 μM | 24727464 | |
K562 | Growth inhibition assay | 48 h | GI50 = 0.1 μM | 24727464 | |
OVCAR3 | Growth inhibition assay | 48 h | GI50 = 0.2 μM | 24727464 | |
HepG2 | Cytotoxicity assay | 3 days | IC50 = 0.00019 μM | 24745968 | |
KB | Cytotoxicity assay | 3 days | IC50 = 0.0039 μM | 24745968 | |
NALM6 | Antiproliferative activity assay | 48 to 72 h | IC50 = 0.0041 μM | 24852281 | |
Jurkat | Antiproliferative activity assay | 48 to 72 h | IC50 = 0.0045 μM | 24852281 | |
K562 | Antiproliferative activity assay | 48 to 72 h | IC50 = 0.0055 μM | 24852281 | |
PC3 | Cytotoxicity assay | 96 h | IC50 = 0.0025 μM | 24900437 | |
HeLa | Growth inhibition assay | 96 h | IC50 = 0.0053 μM | 24900865 | |
OVCAR8 | Growth inhibition assay | 96 h | IC50 = 0.01 μM | 24900865 | |
NCI/ADR-RES | Growth inhibition assay | 96 h | IC50 = 5 μM | 24900865 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.045 μM | 24929344 | |
HCT116 | Cytotoxicity assay | 72 h | IC50 = 0.069 μM | 24929344 | |
HepG2 | Cytotoxicity assay | 72 h | IC50 = 0.084 μM | 24929344 | |
HeLa | Cytotoxicity assay | 72 h | IC50 = 0.096 μM | 24929344 | |
U251 | Cytotoxicity assay | 72 h | IC50 = 0.128 μM | 24929344 | |
HT-29 | Antiproliferative activity assay | 24 and 72 h | IC50 = 0.29 μM | 24941130 | |
HeLa | Antiproliferative activity assay | 24 and 72 h | IC50 = 0.29 μM | 24941130 | |
Caco2 | Antiproliferative activity assay | 24 and 72 h | IC50 = 0.31 μM | 24941130 | |
HL60 | Antiproliferative activity assay | 24 and 72 h | IC50 = 0.32 μM | 24941130 | |
MCF7 | Antiproliferative activity assay | 24 and 72 h | IC50 = 0.33 μM | 24941130 | |
Saos2 | Antiproliferative activity assay | 24 and 72 h | IC50 = 0.35 μM | 24941130 | |
SKOV3-MDR1-M6/6 | Anticancer assay | 48 h | IC50 = 0.97 μM | 24946145 | |
SKOV3 | Anticancer assay | 48 h | IC50 = 1 μM | 24946145 | |
MDA435/LCC6 | Cytotoxicity assay | 5 days | IC50 = 0.0026 μM | 24952376 | |
MDA435/LCC6MDR | Cytotoxicity assay | 5 days | IC50 = 0.1493 μM | 24952376 | |
MCF7 | Antiproliferative activity assay | 48 h | IC50 = 0.02581 μM | 24996136 | |
HepG2 | Antiproliferative activity assay | 48 h | IC50 = 0.06727 μM | 24996136 | |
A549 | Antiproliferative activity assay | 48 h | IC50 = 1.525 μM | 24996136 | |
KB | Cytotoxicity assay | 72 h | IC50 = 0.0039 μM | 25008456 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.0057 μM | 25008456 | |
MDA-MB-231 | Cytotoxicity assay | 72 h | IC50 = 0.0066 μM | 25008456 | |
KBVIN | Cytotoxicity assay | 72 h | IC50 = 1.44 μM | 25008456 | |
MESSA | Cytotoxicity assay | 72 h | IC50 = 0.004 μM | 25025991 | |
OVCAR8 | Cytotoxicity assay | 96 h | IC50 = 0.005 μM | 25025991 | |
MESSA/DX5 | Cytotoxicity assay | 72 h | IC50 = 1.764 μM | 25025991 | |
HepG2 | Cytotoxicity assay | 48 h | IC50 = 2.037 μM | 25025991 | |
NCI/ADR-RES | Cytotoxicity assay | 96 h | IC50 = 3.3 μM | 25025991 | |
PC3 | Cytotoxicity assay | 48 h | IC50 = 3.99 μM | 25025991 | |
TCT1 | Cytotoxicity assay | 48 h | IC50 = 2.5 μM | 25046128 | |
CNE2 | Antiproliferative activity assay | 48 h | IC50 = 0.003 μM | 25061803 | |
A549 | Antiproliferative activity assay | 48 h | IC50 = 0.005 μM | 25061803 | |
SW480 | Antiproliferative activity assay | 48 h | IC50 = 0.007 μM | 25061803 | |
A2780 | Antiproliferative activity assay | 48 h | IC50 = 0.015 μM | 25061803 | |
HCT8 | Antiproliferative activity assay | 48 h | IC50 = 0.021 μM | 25061803 | |
MCF7 | Antiproliferative activity assay | 48 h | IC50 = 0.023 μM | 25061803 | |
HepG2 | Antiproliferative activity assay | 48 h | IC50 = 0.028 μM | 25061803 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.004 μM | 25084144 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.082 μM | 25084144 | |
K562 | Cytotoxicity assay | 72 h | IC50 = 0.004 μM | 25091926 | |
A431 | Cytotoxicity assay | 72 h | IC50 = 0.007 μM | 25091926 | |
MDA-MB-435S | Cytotoxicity assay | 72 h | IC50 = 0.009 μM | 25091926 | |
HeLa | Cytotoxicity assay | 72 h | IC50 = 0.41 μM | 25091926 | |
HepG2 | Cytotoxicity assay | 72 h | IC50 = 0.99 μM | 25091926 | |
MDA-MB-DYT2 | Cytotoxicity assay | 4 days | IC50 = 0.00608 μM | 25098528 | |
MDA-MB-468 | Cytotoxicity assay | 4 days | IC50 = 0.00717 μM | 25098528 | |
NCI-N87 | Cytotoxicity assay | 4 days | IC50 = 0.00753 μM | 25098528 | |
NCI-H1975 | Cytotoxicity assay | 4 days | IC50 = 0.00794 μM | 25098528 | |
BT474 | Cytotoxicity assay | 4 days | IC50 = 0.00836 μM | 25098528 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.2 μM | 25176329 | |
NCI-H358 | Antiproliferative activity assay | 48 h | IC50 = 0.002 μM | 25208345 | |
A2780S | Antiproliferative activity assay | 48 h | IC50 = 0.004 μM | 25208345 | |
HCT8 | Antiproliferative activity assay | 48 h | IC50 = 0.005 μM | 25208345 | |
AGS | Antiproliferative activity assay | 48 h | IC50 = 0.008 μM | 25208345 | |
DLD1 | Antiproliferative activity assay | 48 h | IC50 = 0.016 μM | 25208345 | |
HCT116 | Antiproliferative activity assay | 48 h | IC50 = 0.018 μM | 25208345 | |
ES2 | Antiproliferative activity assay | 48 h | IC50 = 0.02 μM | 25208345 | |
U251 | Antiproliferative activity assay | 48 h | IC50 = 0.023 μM | 25208345 | |
HCT15 | Antiproliferative activity assay | 48 h | IC50 = 0.024 μM | 25208345 | |
HepG2 | Antiproliferative activity assay | 48 h | IC50 = 0.038 μM | 25208345 | |
MCF7 | Antiproliferative activity assay | 48 h | IC50 = 0.132 μM | 25208345 | |
C26 | Antiproliferative activity assay | 48 h | IC50 = 0.21 μM | 25208345 | |
HL60 | Cytotoxicity assay | 48 h | IC50 = 1.5 μM | 25211032 | |
K562 | Cytotoxicity assay | 48 h | IC50 = 2.4 μM | 25211032 | |
HepG2 | Cytotoxicity assay | 48 h | IC50 = 2.7 μM | 25211032 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 3.2 μM | 25211032 | |
HT-29 | Cytotoxicity assay | 48 h | IC50 = 3.5 μM | 25211032 | |
KB | Cytotoxicity assay | 48 h | IC50 = 3.8 μM | 25211032 | |
NCI-H1688 | Cytotoxicity assay | 24 h | IC50 = 0.85 μM | 25226363 | |
PC3 | Cytotoxicity assay | 24 h | IC50 = 0.94 μM | 25226363 | |
A549 | Cytotoxicity assay | 24 h | IC50 = 1.04 μM | 25226363 | |
DU145 | Cytotoxicity assay | 24 h | IC50 = 1.79 μM | 25226363 | |
A549 | Antiproliferative activity assay | 3 days | IC50 = 0.0024 μM | 25241925 | |
KB | Antiproliferative activity assay | 3 days | IC50 = 0.0037 μM | 25241925 | |
DU145 | Antiproliferative activity assay | 3 days | IC50 = 0.00488 μM | 25241925 | |
KBVIN | Antiproliferative activity assay | 3 days | IC50 = 1.58 μM | 25241925 | |
HeLa | Growth inhibition assay | 48 h | GI50 = 0.025 μM | 25264072 | |
MiaPaCa | Growth inhibition assay | 48 h | GI50 = 0.056 μM | 25264072 | |
IMR32 | Growth inhibition assay | 48 h | GI50 = 0.075 μM | 25264072 | |
MDA-MB-231 | Growth inhibition assay | 48 h | GI50 = 0.091 μM | 25264072 | |
SMMC7721 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 25375202 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 25375202 | |
HL60 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 25375202 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 25375202 | |
SW480 | Cytotoxicity assay | 48 h | IC50 = 0.15 μM | 25375202 | |
HepG2 | Cytotoxicity assay | 3 days | IC50 = 0.00019 μM | 25442315 | |
KB | Cytotoxicity assay | 3 days | IC50 = 0.0039 μM | 25442315 | |
MDA-MB-231 | Antiproliferative activity assay | 4 h | IC50 = 6.2 μM | 25453798 | |
MDA435 | Cytotoxicity assay | 24 h | IC50 = 0.005 μM | 25462222 | |
HL60 | Cytotoxicity assay | 24 h | IC50 = 0.007 μM | 25462222 | |
MES-SA | Cytotoxicity assay | 24 h | IC50 = 0.008 μM | 25462222 | |
MDA-MB-231 | Cytotoxicity assay | 24 h | IC50 = 0.457 μM | 25462222 | |
MES-SA/Dx5 | Cytotoxicity assay | 24 h | IC50 = 5.1 μM | 25462222 | |
HeLa | Antiproliferative activity assay | 48 h | GI50 = 0.025 μM | 25462234 | |
MiaPaCa | Antiproliferative activity assay | 48 h | GI50 = 0.056 μM | 25462234 | |
IMR32 | Antiproliferative activity assay | 48 h | GI50 = 0.075 μM | 25462234 | |
MDA-MB-231 | Antiproliferative activity assay | 48 h | GI50 = 0.091 μM | 25462234 | |
HCT116 | Cytotoxicity assay | 72 h | IC50 = 0.004 μM | 25462279 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.006 μM | 25462279 | |
HeLa | Cytotoxicity assay | 72 h | IC50 = 0.008 μM | 25462279 | |
SKOV3 | Cytotoxicity assay | 48 h | IC50 = 0.001 μM | 25462285 | |
HCT116 | Cytotoxicity assay | 72 h | IC50 = 0.0027 μM | 25499433 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 2.58 μM | 25563891 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 4.9 μM | 25563891 | |
A375 | Cytotoxicity assay | 48 h | IC50 = 8 μM | 25563891 | |
LC2/ad | Antiproliferative activity assay | 72 h | IC50 = 0.0025 μM | 25625617 | |
GSS | Antiproliferative activity assay | 72 h | IC50 = 0.0034 μM | 25625617 | |
MKN45 | Antiproliferative activity assay | 72 h | IC50 = 0.004 μM | 25625617 | |
PC14 | Antiproliferative activity assay | 72 h | IC50 = 0.0044 μM | 25625617 | |
Lu116 | Antiproliferative activity assay | 72 h | IC50 = 0.0051 μM | 25625617 | |
LU99A | Antiproliferative activity assay | 72 h | IC50 = 0.0052 μM | 25625617 | |
MIAPaCa2 | Antiproliferative activity assay | 72 h | IC50 = 0.0061 μM | 25625617 | |
HCT116 | Antiproliferative activity assay | 72 h | IC50 = 0.0061 μM | 25625617 | |
HT-29 | Antiproliferative activity assay | 72 h | IC50 = 0.007 μM | 25625617 | |
NCI-H358 | Antiproliferative activity assay | 72 h | IC50 = 0.0079 μM | 25625617 | |
HL60 | Antiproliferative activity assay | 72 h | IC50 = 0.0079 μM | 25625617 | |
NCI-H460 | Antiproliferative activity assay | 72 h | IC50 = 0.01 μM | 25625617 | |
MRC5 | Antiproliferative activity assay | 72 h | IC50 = 0.08 μM | 25625617 | |
HCT15 | Antiproliferative activity assay | 72 h | IC50 = 0.24 μM | 25625617 | |
HeLa | Cytotoxicity assay | 48 h | IC50 = 0.01 μM | 25647428 | |
PC3 | Cytotoxicity assay | 48 h | IC50 = 0.012 μM | 25647428 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.025 μM | 25647428 | |
MES-SA | Antiproliferative activity assay | 48 h | GI50 = 0.007 μM | 25671501 | |
MES-SA/Dx5 | Antiproliferative activity assay | 48 h | GI50 = 9.8 μM | 25671501 | |
A549 | Antiproliferative activity assay | 48 h | IC50 = 0.003 μM | 25682561 | |
MCF7 | Antiproliferative activity assay | 48 h | IC50 = 0.003 μM | 25682561 | |
A549/CDDP | Antiproliferative activity assay | 48 h | IC50 = 0.006 μM | 25682561 | |
A2780 | Antiproliferative activity assay | 48 h | IC50 = 0.006 μM | 25682561 | |
HepG2 | Antiproliferative activity assay | 48 h | IC50 = 0.009 μM | 25682561 | |
SW480 | Antiproliferative activity assay | 48 h | IC50 = 0.021 μM | 25682561 | |
HCT8 | Antiproliferative activity assay | 48 h | IC50 = 0.066 μM | 25682561 | |
NIH/3T3 | Antiproliferative activity assay | 48 h | IC50 = 0.58 μM | 25682561 | |
A2780/TAX | Antiproliferative activity assay | 48 h | IC50 = 4.4 μM | 25682561 | |
MCF7/DX | Antiproliferative activity assay | 48 h | IC50 = 6.2 μM | 25682561 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.032 μM | 25728023 | |
HepG2 | Cytotoxicity assay | 48 h | IC50 = 0.045 μM | 25728023 | |
HL60 | Antiproliferative activity assay | 72 h | IC50 = 0.0017 μM | 25771484 | |
HCT116 | Antiproliferative activity assay | 72 h | IC50 = 0.0049 μM | 25771484 | |
KB | Antiproliferative activity assay | 72 h | IC50 = 0.015 μM | 25771484 | |
A549 | Antiproliferative activity assay | 72 h | IC50 = 0.058 μM | 25771484 | |
SMMC7721 | Antiproliferative activity assay | 72 h | IC50 = 0.12 μM | 25771484 | |
SMMC7721 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 25798528 | |
HL60 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 25798528 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 25798528 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 25798528 | |
SW480 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 25798528 | |
HL60 | Cytotoxicity assay | 72 h | IC50 = 0.0018 μM | 25819096 | |
MOLT4 | Cytotoxicity assay | 72 h | IC50 = 0.0022 μM | 25819096 | |
U937 | Cytotoxicity assay | 72 h | IC50 = 0.0025 μM | 25819096 | |
HeLa | Cytotoxicity assay | 72 h | IC50 = 0.0032 μM | 25819096 | |
DU145 | Cytotoxicity assay | 72 h | IC50 = 0.0034 μM | 25819096 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.0044 μM | 25819096 | |
SGC7901 | Cytotoxicity assay | 72 h | IC50 = 0.0051 μM | 25819096 | |
K562 | Cytotoxicity assay | 72 h | IC50 = 0.0052 μM | 25819096 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.0062 μM | 25819096 | |
NCI-H1975 | Cytotoxicity assay | 72 h | IC50 = 0.0077 μM | 25819096 | |
MX1 | Cytotoxicity assay | 72 h | IC50 = 0.00559 μM | 25819334 | |
ID8 | Cytotoxicity assay | 72 h | IC50 = 0.0138 μM | 25819334 | |
L1210 | Cytotoxicity assay | 72 h | IC50 = 0.0276 μM | 25819334 | |
WI38 | Cytotoxicity assay | 72 h | IC50 = 0.0557 μM | 25819334 | |
MDA-MB-231 | Antiproliferative activity assay | 48 h | GI50 = 0.01 μM | 25827522 | |
A549 | Antiproliferative activity assay | 48 h | GI50 = 0.01 μM | 25827522 | |
PANC1 | Antiproliferative activity assay | 48 h | GI50 = 0.012 μM | 25827522 | |
HeLa | Antiproliferative activity assay | 48 h | GI50 = 0.02 μM | 25827522 | |
HEK293 | Cytotoxicity assay | 72 h | IC50 = 0.04 μM | 25842364 | |
SW480 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 25871261 | |
HL60 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 25871261 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 25871261 | |
SMMC7721 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 25871261 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 25871261 | |
SCC114 | Antiproliferative activity assay | 72 h | IC50 = 0.0003 μM | 25872984 | |
HeLa | Antiproliferative activity assay | 48 h | IC50 = 0.0019 μM | 25882519 | |
MDA-MB-435 | Antiproliferative activity assay | 48 h | IC50 = 0.0033 μM | 25882519 | |
SKOV3 | Antiproliferative activity assay | 48 h | IC50 = 0.0063 μM | 25882519 | |
SKOV3-MDR1-M6/6 | Antiproliferative activity assay | 48 h | IC50 = 1.1872 μM | 25882519 | |
A549 | Antiproliferative activity assay | 48 h | IC50 = 0.0023 μM | 25937236 | |
taxol-resistant A549 | Antiproliferative activity assay | 48 h | IC50 = 0.52 μM | 25937236 | |
EL4 | Cytotoxicity assay | 48 h | IC50 = 1.7 μM | 25951057 | |
HeLa | Antiproliferative activity assay | 48 h | IC50 = 0.38 μM | 25959813 | |
A549 | Antiproliferative activity assay | 48 h | IC50 = 2.82 μM | 25959813 | |
LCC-6 | Cytotoxicity assay | 3 days | IC50 = 0.0016 μM | 25985195 | |
MDA435/LCC6MDR | Cytotoxicity assay | 3 days | IC50 = 0.1446 μM | 25985195 | |
A2780 | Antiproliferative activity assay | 2 days | IC50 = 0.028 μM | 26042470 | |
SMMC7721 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 26068802 | |
HL60 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 26068802 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 26068802 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 26068802 | |
SW480 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 26068802 | |
BEAS2B | Cytotoxicity assay | 48 h | IC50 = 0.58 μM | 26068802 | |
NB4 | Cytotoxicity assay | 48 h | IC50 = 0.0023 μM | 26132075 | |
NCI-H1975 | Cytotoxicity assay | 72 h | IC50 = 0.0025 μM | 26132075 | |
OVCAR8 | Cytotoxicity assay | 48 h | IC50 = 0.0037 μM | 26132075 | |
MESSA | Cytotoxicity assay | 72 h | IC50 = 0.004 μM | 26132075 | |
MDA-MB-468 | Cytotoxicity assay | 72 h | IC50 = 0.005 μM | 26132075 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.007 μM | 26132075 | |
MDA-MB-231 | Cytotoxicity assay | 72 h | IC50 = 0.007 μM | 26132075 | |
MDA-MB-436 | Cytotoxicity assay | 72 h | IC50 = 0.008 μM | 26132075 | |
MESSA/DX5 | Cytotoxicity assay | 72 h | IC50 = 1.764 μM | 26132075 | |
HepG2 | Cytotoxicity assay | 48 h | IC50 = 2.6 μM | 26132075 | |
PC3 | Cytotoxicity assay | 48 h | IC50 = 4.9 μM | 26132075 | |
NCI-ADR-RES | Cytotoxicity assay | 48 h | IC50 = 6 μM | 26132075 | |
KB | Antiproliferative activity assay | 72 h | IC50 = 0.0051 μM | 26160020 | |
KB-7d | Antiproliferative activity assay | 72 h | IC50 = 0.0084 μM | 26160020 | |
KB-S15 | Antiproliferative activity assay | 72 h | IC50 = 0.135 μM | 26160020 | |
U937 | Cytotoxicity assay | 72 h | IC50 = 2.1 μM | 26316467 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 2.1 μM | 26316467 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 2.3 μM | 26316467 | |
MOLT4 | Cytotoxicity assay | 72 h | IC50 = 2.7 μM | 26316467 | |
NCI-H1975 | Cytotoxicity assay | 72 h | IC50 = 2.8 μM | 26316467 | |
HeLa | Cytotoxicity assay | 72 h | IC50 = 2.9 μM | 26316467 | |
DU145 | Cytotoxicity assay | 72 h | IC50 = 3.1 μM | 26316467 | |
K562 | Cytotoxicity assay | 72 h | IC50 = 3.8 μM | 26316467 | |
HL60 | Cytotoxicity assay | 72 h | IC50 = 3.8 μM | 26316467 | |
SGC7901 | Cytotoxicity assay | 72 h | IC50 = 9.8 μM | 26316467 | |
MES-SA | Cytotoxicity assay | 48 h | GI50 = 0.007 μM | 26360047 | |
Rhabdomyosarcoma | Antiproliferative activity assay | 96 h | IC50 = 0.0084 μM | 26386818 | |
HT-29 | Cytotoxicity assay | 3 days | IC50 = 0.0008 μM | 26422131 | |
MDA-MB-231 | Cytotoxicity assay | 72 h | IC50 = 0.001 μM | 26448037 | |
PC3 | Cytotoxicity assay | 72 h | IC50 = 0.001 μM | 26448037 | |
HCT116 | Cytotoxicity assay | 48 h | IC50 = 0.0028 μM | 26448037 | |
HepG2 | Cytotoxicity assay | 48 h | IC50 = 1.217 μM | 26448037 | |
H460 | Cytotoxicity assay | 48 h | IC50 = 4.287 μM | 26448037 | |
HeLa | Antiproliferative activity assay | 72 h | IC50 = 2.29 μM | 26602827 | |
184B5 | Antiproliferative activity assay | 72 h | IC50 = 2.32 μM | 26602827 | |
MDA-MB-231 | Antiproliferative activity assay | 72 h | IC50 = 2.56 μM | 26602827 | |
MDA-MB-468 | Antiproliferative activity assay | 72 h | IC50 = 3.87 μM | 26602827 | |
MCF7 | Antiproliferative activity assay | 72 h | IC50 = 3.99 μM | 26602827 | |
Jurkat | Cytotoxicity assay | 48 h | IC50 = 0.0005 μM | 26638041 | |
U937 | Cytotoxicity assay | 48 h | IC50 = 0.006 μM | 26638041 | |
HeLa | Cytotoxicity assay | 48 h | IC50 = 0.099 μM | 26638041 | |
MDA-MB-231 | Cytotoxicity assay | 72 h | IC50 = 0.0039 μM | 26690274 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.0074 μM | 26690274 | |
U937 | Cytotoxicity assay | 72 h | IC50 = 0.00166 μM | 26697718 | |
HL60 | Cytotoxicity assay | 72 h | IC50 = 0.00199 μM | 26697718 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.00212 μM | 26697718 | |
DU145 | Cytotoxicity assay | 72 h | IC50 = 0.0023 μM | 26697718 | |
HeLa | Cytotoxicity assay | 72 h | IC50 = 0.00301 μM | 26697718 | |
HT-29 | Cytotoxicity assay | 72 h | IC50 = 0.00304 μM | 26697718 | |
K562 | Cytotoxicity assay | 72 h | IC50 = 0.00717 μM | 26697718 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.00732 μM | 26697718 | |
NCI-H292 | Cytotoxicity assay | 72 h | IC50 = 0.006 μM | 26712098 | |
KB | Growth inhibition assay | 72 h | GI50 = 0.001 μM | 26778612 | |
DU145 | Antiproliferative activity assay | 48 h | IC50 = 0.0038 μM | 26785306 | |
PC3 | Antiproliferative activity assay | 48 h | IC50 = 0.02 μM | 26785306 | |
A549 | Antiproliferative activity assay | 3 days | IC50 = 0.00003 μM | 26865176 | |
KB | Antiproliferative activity assay | 3 days | IC50 = 0.00004 μM | 26865176 | |
MCF7 | Antiproliferative activity assay | 3 days | IC50 = 0.0039 μM | 26865176 | |
MDA-MB-231 | Antiproliferative activity assay | 3 days | IC50 = 0.018 μM | 26865176 | |
KBVIN | Antiproliferative activity assay | 3 days | IC50 = 2.6 μM | 26865176 | |
PC3 | Cytotoxicity assay | 72 h | IC50 = 0.002 μM | 26904921 | |
SKOV3 | Cytotoxicity assay | 72 h | IC50 = 0.0047 μM | 26974508 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.0132 μM | 26985296 | |
SKMES1 | Cytotoxicity assay | 48 h | IC50 = 0.0135 μM | 26985296 | |
HeLa | Cytotoxicity assay | 48 h | IC50 = 0.0189 μM | 26985296 | |
WPMY-1 | Cytotoxicity assay | 48 h | GI50 = 0.01 μM | 26994690 | |
A549 | Antiproliferative activity assay | 48 h | GI50 = 0.01 μM | 26994690 | |
MDA-MB-231 | Antiproliferative activity assay | 48 h | GI50 = 0.01 μM | 26994690 | |
HeLa | Antiproliferative activity assay | 48 h | GI50 = 0.023 μM | 26994690 | |
HepG2 | Antiproliferative activity assay | 48 h | IC50 = 0.02171 μM | 27017265 | |
MCF7 | Antiproliferative activity assay | 48 h | IC50 = 0.02581 μM | 27017265 | |
HCT116 | Antiproliferative activity assay | 48 h | IC50 = 0.06727 μM | 27017265 | |
A2780 | Cytotoxicity assay | 48 h | IC50 = 0.005 μM | 27149641 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.009 μM | 27149641 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.012 μM | 27149641 | |
HCT8 | Cytotoxicity assay | 48 h | IC50 = 0.019 μM | 27149641 | |
A549/CDDP | Cytotoxicity assay | 48 h | IC50 = 0.023 μM | 27149641 | |
HCT8/VCT | Cytotoxicity assay | 48 h | IC50 = 0.125 μM | 27149641 | |
MCF7/DX | Cytotoxicity assay | 48 h | IC50 = 0.135 μM | 27149641 | |
A2780/TAX | Cytotoxicity assay | 48 h | IC50 = 5.68 μM | 27149641 | |
HeLa | Antiproliferative activity assay | 48 h | GI50 = 0.025 μM | 27209232 | |
MiaPaCa | Antiproliferative activity assay | 48 h | GI50 = 0.056 μM | 27209232 | |
IMR32 | Antiproliferative activity assay | 48 h | GI50 = 0.075 μM | 27209232 | |
MDA-MB-231 | Antiproliferative activity assay | 48 h | GI50 = 0.091 μM | 27209232 | |
PC3 | Antiproliferative activity assay | 72 h | IC50 = 0.002 μM | 27214307 | |
NCI-H1993 | Antiproliferative activity assay | 48 to 96 h | GI50 = 0.004 μM | 27218860 | |
MES-SA | Antiproliferative activity assay | 48 to 96 h | GI50 = 0.007 μM | 27218860 | |
NCI-H2073 | Antiproliferative activity assay | 48 to 96 h | GI50 = 2.4 μM | 27218860 | |
KBVIN | Antiproliferative activity assay | 48 h | GI50 = 2.6 μM | 27238842 | |
A549 | Antiproliferative activity assay | 48 h | GI50 = 2.6 μM | 27238842 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.00125 μM | 27311893 | |
HeLa | Cytotoxicity assay | 72 h | IC50 = 0.01262 μM | 27311893 | |
MDA-MB-231 | Anticancer assay | 72 h | IC50 = 0.003388 μM | 27317645 | |
HeLa | Anticancer assay | 72 h | IC50 = 0.01987 μM | 27317645 | |
HT-29 | Cytotoxicity assay | 72 h | IC50 = 0.02 μM | 27329938 | |
PC3 | Cytotoxicity assay | 72 h | IC50 = 0.03 μM | 27329938 | |
HL-7702 | Cytotoxicity assay | 72 h | IC50 = 0.06 μM | 27329938 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.08 μM | 27329938 | |
HepG2 | Cytotoxicity assay | 72 h | IC50 = 0.2 μM | 27329938 | |
MCF7 | Cytotoxicity assay | 96 h | IC50 = 0.0002 μM | 27434426 | |
HeLa | Cytotoxicity assay | 96 h | IC50 = 0.0064 μM | 27434426 | |
NCI60 | Cytotoxicity assay | 48 h | GI50 = 0.0315 μM | 27448924 | |
HepG2 | Cytotoxicity assay | 48 h | IC50 = 0.006 μM | 27627130 | |
Hep3B | Cytotoxicity assay | 48 h | IC50 = 0.02 μM | 27627130 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.03 μM | 27627130 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.06 μM | 27627130 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 27704807 | |
SW480 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 27704807 | |
HL60 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 27704807 | |
SMMC7721 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 27704807 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 27704807 | |
HeLa | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 27704807 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.02 μM | 27704822 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.1 μM | 27704822 | |
HeLa | Cytotoxicity assay | 72 h | IC50 = 1.7 μM | 27748595 | |
K562 | Cytotoxicity assay | 72 h | IC50 = 2.7 μM | 27748595 | |
HCT116 | Cytotoxicity assay | 72 h | IC50 = 3.3 μM | 27748595 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 5.5 μM | 27748595 | |
HepG2 | Cytotoxicity assay | 72 h | IC50 = 6.7 μM | 27748595 | |
HELF | Cytotoxicity assay | 24 h | IC50 = 7.14 μM | 27769031 | |
BGC823 | Cytotoxicity assay | 24 h | IC50 = 9.26 μM | 27769031 | |
KB | Cytotoxicity assay | 48 h | IC50 = 0.0008 μM | 27797192 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.00099 μM | 27797192 | |
MDA-MB-231 | Cytotoxicity assay | 48 h | IC50 = 0.00305 μM | 27797192 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.02275 μM | 27797192 | |
KBVIN | Cytotoxicity assay | 48 h | IC50 = 1.896 μM | 27797192 | |
HCT116 | Cytotoxicity assay | 48 h | IC50 = 0.1 μM | 27887843 | |
Bel7402 | Cytotoxicity assay | 48 h | IC50 = 0.1 μM | 27887843 | |
OVCAR8 | Growth inhibition assay | 96 h | IC50 = 5 μM | 27894589 | |
HeLa | Growth inhibition assay | 96 h | IC50 = 5.3 μM | 27894589 | |
HeLa | Growth inhibition assay | 48 h | GI50 = 0.0389 μM | 27964883 | |
MiaPaCa | Growth inhibition assay | 48 h | GI50 = 0.06 μM | 27964883 | |
IMR32 | Growth inhibition assay | 48 h | GI50 = 0.086 μM | 27964883 | |
MDA-MB-231 | Growth inhibition assay | 48 h | GI50 = 0.092 μM | 27964883 | |
DU145 | Antiproliferative activity assay | 48 h | IC50 = 0.011 μM | 27979593 | |
HeLa | Antiproliferative activity assay | 48 h | IC50 = 0.036 μM | 27979593 | |
MCF7 | Antiproliferative activity assay | 48 h | IC50 = 0.63 μM | 27979593 | |
ECA109 | Antiproliferative activity assay | 48 h | IC50 = 0.94 μM | 27979593 | |
MDA-MB-435 | Cytotoxicity assay | 72 h | IC50 = 0.0002 μM | 27983842 | |
HT-29 | Cytotoxicity assay | 72 h | IC50 = 0.0008 μM | 27983842 | |
MDA-MB-231 | Cytotoxicity assay | 72 h | IC50 = 0.0027 μM | 27983842 | |
OVCAR3 | Cytotoxicity assay | 72 h | IC50 = 0.0033 μM | 27983842 | |
H1299 | Cytotoxicity assay | 24 h | IC50 = 1.5 μM | 27983842 | |
HEK-Blue | Function assay | 3 h | IC50 = 7.94328 μM | 28075581 | |
A549 | Antiproliferative activity assay | 72 h | IC50 = 0.0062 μM | 28099003 | |
KB | Antiproliferative activity assay | 72 h | IC50 = 0.00627 μM | 28099003 | |
MDA-MB-231 | Antiproliferative activity assay | 72 h | IC50 = 0.00882 μM | 28099003 | |
MCF7 | Antiproliferative activity assay | 72 h | IC50 = 0.0104 μM | 28099003 | |
KBVIN | Antiproliferative activity assay | 72 h | IC50 = 1.926 μM | 28099003 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 6.195 μM | 28237662 | |
KB | Cytotoxicity assay | 48 h | IC50 = 6.587 μM | 28237662 | |
MDA-MB-231 | Cytotoxicity assay | 48 h | IC50 = 9.384 μM | 28237662 | |
HeLa | Cytotoxicity assay | 72 h | IC50 = 0.0014 μM | 28240909 | |
MDA-MB-231 | Cytotoxicity assay | 72 h | IC50 = 0.0026 μM | 28252962 | |
MDA-MB-435 | Cytotoxicity assay | 72 h | IC50 = 0.0031 μM | 28252962 | |
OVCAR3 | Cytotoxicity assay | 72 h | IC50 = 0.0075 μM | 28252962 | |
MDA-MB-231 | Cytotoxicity assay | 48 h | IC50 = 0.08 μM | 28262526 | |
MRC5 | Cytotoxicity assay | 72 h | IC50 = 0.00052 μM | 28282127 | |
A549 | Antiproliferative activity assay | 72 h | IC50 = 0.0062 μM | 28290698 | |
KB | Antiproliferative activity assay | 72 h | IC50 = 0.0063 μM | 28290698 | |
MDA-MB-231 | Antiproliferative activity assay | 72 h | IC50 = 0.0088 μM | 28290698 | |
MCF7 | Antiproliferative activity assay | 72 h | IC50 = 0.0104 μM | 28290698 | |
KBVIN | Antiproliferative activity assay | 72 h | IC50 = 1.926 μM | 28290698 | |
PC3 | Antiproliferative activity assay | 72 h | IC50 = 0.004 μM | 28335606 | |
UACC62 | Antiproliferative activity assay | 72 h | IC50 = 0.006 μM | 28335606 | |
M14 | Antiproliferative activity assay | 72 h | IC50 = 0.007 μM | 28335606 | |
SK-MEL-2 | Antiproliferative activity assay | 72 h | IC50 = 0.009 μM | 28335606 | |
NCI-H460 | Antiproliferative activity assay | 72 h | IC50 = 0.01 μM | 28335606 | |
A375 | Antiproliferative activity assay | 72 h | IC50 = 0.01 μM | 28335606 | |
SF295 | Antiproliferative activity assay | 72 h | IC50 = 0.056 μM | 28335606 | |
ACHN | Antiproliferative activity assay | 72 h | IC50 = 0.066 μM | 28335606 | |
HeLa | Cytotoxicity assay | 48 h | IC50 = 0.00821 μM | 28340411 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.00952 μM | 28340411 | |
A549/TR | Cytotoxicity assay | 48 h | IC50 = 1.51 μM | 28340411 | |
HeLa/TR | Cytotoxicity assay | 48 h | IC50 = 1.53 μM | 28340411 | |
LO2 | Cytotoxicity assay | 72 h | IC50 = 0.002 μM | 28395199 | |
A549 | Antiproliferative activity assay | 72 h | IC50 = 0.023 μM | 28395199 | |
HT-29 | Antiproliferative activity assay | 72 h | IC50 = 0.025 μM | 28395199 | |
NCI-H596 | Antiproliferative activity assay | 72 h | IC50 = 0.035 μM | 28395199 | |
HT-29 | Cytotoxicity assay | 3 days | IC50 = 0.0014 μM | 28409637 | |
HeLa | Antiproliferative activity assay | 48 h | IC50 = 0.0015 μM | 28433513 | |
MDA-MB-435 | Antiproliferative activity assay | 48 h | IC50 = 0.002 μM | 28433513 | |
SKOV3 | Antiproliferative activity assay | 48 h | IC50 = 0.003 μM | 28433513 | |
SKOV3-MDR1-M6/6 | Antiproliferative activity assay | 48 h | IC50 = 2.33 μM | 28433513 | |
A2780 | Antiproliferative activity assay | 2 days | IC50 = 0.028 μM | 28463001 | |
BGC823 | Cytotoxicity assay | 96 h | IC50 = 0.0008 μM | 28530828 | |
NCI-H460 | Cytotoxicity assay | 96 h | IC50 = 0.001 μM | 28530828 | |
HepG2 | Cytotoxicity assay | 96 h | IC50 = 0.0063 μM | 28530828 | |
OVPF008 | Antiproliferative activity assay | 6 days | IC50 = 1.1 μM | 28548825 | |
OVPF038 | Antiproliferative activity assay | 6 days | IC50 = 1.4 μM | 28548825 | |
KB | Cytotoxicity assay | 72 h | IC50 = 0.0036 μM | 28590124 | |
KBv200 | Cytotoxicity assay | 72 h | IC50 = 2.117 μM | 28590124 | |
MDA-MB-435 | Cytotoxicity assay | 72 h | IC50 = 0.0005 μM | 28594169 | |
OVCAR3 | Cytotoxicity assay | 72 h | IC50 = 0.002 μM | 28594169 | |
MDA-MB-231 | Cytotoxicity assay | 72 h | IC50 = 0.009 μM | 28594169 | |
U937 | Cytotoxicity assay | 72 h | IC50 = 0.0017 μM | 28598633 | |
HL60 | Cytotoxicity assay | 72 h | IC50 = 0.002 μM | 28598633 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.0021 μM | 28598633 | |
DU145 | Cytotoxicity assay | 72 h | IC50 = 0.0023 μM | 28598633 | |
HeLa | Cytotoxicity assay | 72 h | IC50 = 0.003 μM | 28598633 | |
HT-29 | Cytotoxicity assay | 72 h | IC50 = 0.003 μM | 28598633 | |
K562 | Cytotoxicity assay | 72 h | IC50 = 0.0072 μM | 28598633 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.0073 μM | 28598633 | |
A2780 | Cytotoxicity assay | 48 h | IC50 = 0.00107 μM | 28624703 | |
HeLa | Cytotoxicity assay | 48 h | IC50 = 0.0011 μM | 28624703 | |
KB | Cytotoxicity assay | 48 h | IC50 = 0.0019 μM | 28624703 | |
Hela-beta3 | Cytotoxicity assay | 48 h | IC50 = 0.009 μM | 28624703 | |
A2780AD | Cytotoxicity assay | 48 h | IC50 = 1.282 μM | 28624703 | |
KBV1 | Cytotoxicity assay | 48 h | IC50 = 9.8 μM | 28624703 | |
BGC823 | Growth inhibition assay | 3 days | IC50 = 0.001 μM | 28625363 | |
HepG2 | Growth inhibition assay | 3 days | IC50 = 0.02 μM | 28625363 | |
HCT116 | Growth inhibition assay | 3 days | IC50 = 0.03 μM | 28625363 | |
A2780 | Growth inhibition assay | 3 days | IC50 = 0.03 μM | 28625363 | |
NCI-H1650 | Growth inhibition assay | 3 days | IC50 = 0.07 μM | 28625363 | |
A2780 | Antiproliferative activity assay | 2 days | IC50 = 0.0137 μM | 28648491 | |
KB | Cytotoxicity assay | 48 h | GI50 = 0.00512 μM | 28653846 | |
A549 | Cytotoxicity assay | 48 h | GI50 = 0.00703 μM | 28653846 | |
MDA-MB-231 | Cytotoxicity assay | 48 h | GI50 = 0.01 μM | 28653846 | |
MCF7 | Cytotoxicity assay | 48 h | GI50 = 0.0119 μM | 28653846 | |
KBVIN | Cytotoxicity assay | 48 h | GI50 = 2.716 μM | 28653846 | |
MCF7 | Antiproliferative activity assay | 48 h | IC50 = 0.008 μM | 28654256 | |
HL60 | Antiproliferative activity assay | 48 h | IC50 = 0.008 μM | 28654256 | |
SMMC7721 | Antiproliferative activity assay | 48 h | IC50 = 0.008 μM | 28654256 | |
A549 | Antiproliferative activity assay | 48 h | IC50 = 0.008 μM | 28654256 | |
SW480 | Antiproliferative activity assay | 48 h | IC50 = 0.008 μM | 28654256 | |
A375 | Antiproliferative activity assay | 48 h | IC50 = 0.7 μM | 28667872 | |
MIAPaCa2 | Antiproliferative activity assay | 48 h | IC50 = 2.5 μM | 28667872 | |
HEY | Cytotoxicity assay | 48 h | IC50 = 0.1041 μM | 28719204 | |
A2780 | Cytotoxicity assay | 48 h | IC50 = 0.1642 μM | 28719204 | |
HCT116 | Growth inhibition assay | 96 h | IC50 = 0.0002 μM | 28737396 | |
BGC823 | Growth inhibition assay | 96 h | IC50 = 0.0006 μM | 28737396 | |
HepG2 | Growth inhibition assay | 96 h | IC50 = 0.0076 μM | 28737396 | |
A2780 | Growth inhibition assay | 96 h | IC50 = 0.0204 μM | 28737396 | |
A549 | Growth inhibition assay | 4 days | GI50 = 0.0037 μM | 28740601 | |
PC3 | Growth inhibition assay | 4 days | GI50 = 0.0058 μM | 28740601 | |
NCI-H460 | Cytotoxicity assay | 72 h | IC50 = 0.006 μM | 28740613 | |
HT-29 | Cytotoxicity assay | 72 h | IC50 = 0.014 μM | 28740613 | |
A2780S | Antiproliferative activity assay | 48 h | IC50 = 0.0123 μM | 28763646 | |
HCT8 | Antiproliferative activity assay | 48 h | IC50 = 0.0174 μM | 28763646 | |
HCT8/T | Antiproliferative activity assay | 48 h | IC50 = 9.885 μM | 28763646 | |
A549 | Cytotoxicity assay | 24 h | IC50 = 0.0041 μM | 28835794 | |
LNCAP | Antiproliferative activity assay | 72 h | IC50 = 0.0019 μM | 28857558 | |
PA1 | Antiproliferative activity assay | 72 h | IC50 = 0.003 μM | 28857558 | |
HCT116 | Antiproliferative activity assay | 72 h | IC50 = 0.0041 μM | 28857558 | |
MDA-MB-468 | Antiproliferative activity assay | 72 h | IC50 = 0.0054 μM | 28857558 | |
HCT116/VP35 | Antiproliferative activity assay | 72 h | IC50 = 0.0063 μM | 28857558 | |
NCI-H520 | Antiproliferative activity assay | 72 h | IC50 = 0.0082 μM | 28857558 | |
LS174T | Antiproliferative activity assay | 72 h | IC50 = 0.0095 μM | 28857558 | |
MCF10A | Cytotoxicity assay | 72 h | IC50 = 0.0058 μM | 28926237 | |
MDA-MB-468 | Cytotoxicity assay | 72 h | IC50 = 0.0061 μM | 28926237 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.0088 μM | 28926237 | |
MDA-MB-231 | Cytotoxicity assay | 72 h | IC50 = 0.059 μM | 28926237 | |
HeLa | Cytotoxicity assay | 72 h | IC50 = 0.001 μM | 29043798 | |
A2780 | Cytotoxicity assay | 2 days | IC50 = 0.013 μM | 29048892 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.0062 μM | 29131631 | |
KB | Cytotoxicity assay | 72 h | IC50 = 0.0066 μM | 29131631 | |
MDA-MB-231 | Cytotoxicity assay | 72 h | IC50 = 0.0094 μM | 29131631 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.0114 μM | 29131631 | |
KBVIN | Cytotoxicity assay | 72 h | IC50 = 1.86 μM | 29131631 | |
A2780 | Function assay | 48 h | GI50 = 0.00753 μM | 29138028 | |
OVCAR5 | Function assay | 48 h | GI50 = 0.021 μM | 29138028 | |
HCT116 | Antiproliferative activity assay | 48 h | IC50 = 1.37 μM | 29172082 | |
PC3 | Antiproliferative activity assay | 48 h | IC50 = 4.57 μM | 29172082 | |
HeLa | Antiproliferative activity assay | 48 h | IC50 = 6.42 μM | 29172082 | |
H1299 | Antiproliferative activity assay | 48 h | IC50 = 7.83 μM | 29172082 | |
HCT116 | Antiproliferative activity assay | 48 h | IC50 = 0.014 μM | 29223717 | |
MCF7 | Antiproliferative activity assay | 48 h | IC50 = 1.428 μM | 29223717 | |
143B | Antiproliferative activity assay | 48 h | IC50 = 5.56 μM | 29223717 | |
MES-SA/Dx5 | Growth inhibition assay | 72 h | IC50 = 0.21 μM | 29251920 | |
MDA435/LCC6 | Growth inhibition assay | 72 h | IC50 = 0.346 μM | 29251920 | |
SMMC7721 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 29286250 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 29286250 | |
HL60 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 29286250 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 29286250 | |
SW480 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 29286250 | |
A2780 | Antiproliferative activity assay | 48 h | IC50 = 0.001 μM | 29306206 | |
SKOV3 | Antiproliferative activity assay | 48 h | IC50 = 0.002 μM | 29306206 | |
HeLa | Antiproliferative activity assay | 48 h | IC50 = 0.003 μM | 29306206 | |
MDA-MB-231 | Antiproliferative activity assay | 48 h | IC50 = 0.003 μM | 29306206 | |
KB | Antiproliferative activity assay | 72 h | IC50 = 0.0036 μM | 29319316 | |
A549 | Antiproliferative activity assay | 72 h | IC50 = 0.0045 μM | 29319316 | |
MDA-MB-231 | Antiproliferative activity assay | 72 h | IC50 = 0.007 μM | 29319316 | |
MCF7 | Antiproliferative activity assay | 72 h | IC50 = 0.0088 μM | 29319316 | |
KBVIN | Antiproliferative activity assay | 72 h | IC50 = 2.36 μM | 29319316 | |
HL60 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 29338226 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 29338226 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 29338226 | |
SW480 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 29338226 | |
SMMC7721 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 29338226 | |
SMMC7721 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 29338260 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 29338260 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 29338260 | |
SW480 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 29338260 | |
HL60 | Cytotoxicity assay | 48 h | IC50 = 0.008 μM | 29338260 | |
HT-29 | Cytotoxicity assay | 72 h | IC50 = 0.0008 μM | 29350920 | |
HeLa | Cytotoxicity assay | 48 h | IC50 = 0.0046 μM | 29359935 | |
A2780 | Cytotoxicity assay | 48 h | IC50 = 0.0134 μM | 29359935 | |
Hela-beta3 | Cytotoxicity assay | 48 h | IC50 = 0.041 μM | 29359935 | |
HL60 | Cytotoxicity assay | 48 h | IC50 = 0.002 μM | 29373791 | |
LS180 | Cytotoxicity assay | 48 h | IC50 = 0.0028 μM | 29373791 | |
MDA-MB-231 | Cytotoxicity assay | 48 h | IC50 = 0.003 μM | 29373791 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.0068 μM | 29373791 | |
HCT116 | Cytotoxicity assay | 24 h | IC50 = 0.02 μM | 29395979 | |
SW480 | Cytotoxicity assay | 24 h | IC50 = 0.19 μM | 29395979 | |
T98G | Cytotoxicity assay | 24 h | IC50 = 0.74 μM | 29395979 | |
U87 | Cytotoxicity assay | 24 h | IC50 = 4.67 μM | 29395979 | |
DU145 | Cytotoxicity assay | 72 h | IC50 = 0.0011 μM | 29406710 | |
PC3 | Cytotoxicity assay | 72 h | IC50 = 0.0037 μM | 29406710 | |
PC3-TxR | Cytotoxicity assay | 72 h | IC50 = 0.1107 μM | 29406710 | |
ViBo | Antiproliferative activity assay | 24 h | IC50 = 1.59 μM | 29407986 | |
CaSki | Antiproliferative activity assay | 24 h | IC50 = 2.9 μM | 29407986 | |
A549 | Growth inhibition assay | 48 h | IC50 = 0.008 μM | 29412669 | |
HL60 | Growth inhibition assay | 48 h | IC50 = 0.008 μM | 29412669 | |
MCF7 | Growth inhibition assay | 48 h | IC50 = 0.008 μM | 29412669 | |
SMMC7721 | Growth inhibition assay | 48 h | IC50 = 0.008 μM | 29412669 | |
SW480 | Growth inhibition assay | 48 h | IC50 = 0.008 μM | 29412669 | |
HCT116 | Growth inhibition assay | 72 h | IC50 = 0.0041 μM | 29439899 | |
paclitaxel-resistant MCF7 | Cytotoxicity assay | 72 h | IC50 = 2.29087 μM | 29468872 | |
HL60 | Antiproliferative activity assay | 48 h | IC50 = 0.0026 μM | 29475587 | |
HeLa | Antiproliferative activity assay | 48 h | IC50 = 0.023 μM | 29475587 | |
293T | Cytotoxicity assay | 4 days | IC50 = 0.0023 μM | 29486949 | |
HAC | Cytotoxicity assay | 4 days | IC50 = 0.0121 μM | 29486949 | |
KB-3-1 | Cytotoxicity assay | 72 h | IC50 = 0.0005 μM | 29501942 | |
SW620 | Cytotoxicity assay | 72 h | IC50 = 0.03 μM | 29501942 | |
KB-C2 | Cytotoxicity assay | 72 h | IC50 = 0.25 μM | 29501942 | |
SW620/AD300 | Cytotoxicity assay | 72 h | IC50 = 1.97 μM | 29501942 | |
A549 | Antiproliferative activity assay | 72 h | IC50 = 0.007 μM | 29501947 | |
A549/TR | Antiproliferative activity assay | 72 h | IC50 = 3.112 μM | 29501947 | |
SKOV3 | Cytotoxicity assay | 72 to 120 h | IC50 = 0.00239 μM | 29517223 | |
HEY | Cytotoxicity assay | 72 to 120 h | IC50 = 2.7 μM | 29517223 | |
SKVLB1 | Function assay | 72 to 120 h | IC50 = 3.733 μM | 29517223 | |
A2780cis | Growth inhibition assay | 72 h | IC50 = 0.003 μM | 29519737 | |
A2780 | Growth inhibition assay | 72 h | IC50 = 0.009 μM | 29519737 | |
OVCAR8 | Growth inhibition assay | 72 h | IC50 = 0.01 μM | 29519737 | |
ovarian epithelial | Growth inhibition assay | 48 h | IC50 = 0.03 μM | 29519737 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.0024 μM | 29648818 | |
PC9 | Cytotoxicity assay | 72 h | IC50 = 0.0027 μM | 29648818 | |
A549 | Cytotoxicity assay | 72 h | IC50 = 0.0032 μM | 29648818 | |
HCC2998 | Growth inhibition assay | 48 h | GI50 = 0.001 μM | 29655610 | |
NCI-H226 | Growth inhibition assay | 48 h | GI50 = 0.0039 μM | 29655610 | |
SW620 | Growth inhibition assay | 48 h | GI50 = 0.004 μM | 29655610 | |
OVCAR3 | Growth inhibition assay | 48 h | GI50 = 0.004 μM | 29655610 | |
MCF7 | Growth inhibition assay | 48 h | GI50 = 0.004 μM | 29655610 | |
HL-60(TB) | Growth inhibition assay | 48 h | GI50 = 0.004 μM | 29655610 | |
HCT116 | Growth inhibition assay | 48 h | GI50 = 0.004 μM | 29655610 | |
MDA-MB-435 | Growth inhibition assay | 48 h | GI50 = 0.004 μM | 29655610 | |
BT549 | Growth inhibition assay | 48 h | GI50 = 0.004 μM | 29655610 | |
SF539 | Growth inhibition assay | 48 h | GI50 = 0.005 μM | 29655610 | |
KM12 | Growth inhibition assay | 48 h | GI50 = 0.005 μM | 29655610 | |
UACC62 | Growth inhibition assay | 48 h | GI50 = 0.005 μM | 29655610 | |
LOXIMVI | Growth inhibition assay | 48 h | GI50 = 0.005 μM | 29655610 | |
M14 | Growth inhibition assay | 48 h | GI50 = 0.005 μM | 29655610 | |
SF268 | Growth inhibition assay | 48 h | GI50 = 0.005 μM | 29655610 | |
MOLT4 | Growth inhibition assay | 48 h | GI50 = 0.005 μM | 29655610 | |
HT-29 | Growth inhibition assay | 48 h | GI50 = 0.005 μM | 29655610 | |
Hs578T | Growth inhibition assay | 48 h | GI50 = 0.005 μM | 29655610 | |
SK-MEL-5 | Growth inhibition assay | 48 h | GI50 = 0.005 μM | 29655610 | |
CCRF-CEM | Growth inhibition assay | 48 h | GI50 = 0.005 μM | 29655610 | |
NCI-H23 | Growth inhibition assay | 48 h | GI50 = 0.0063 μM | 29655610 | |
U251 | Growth inhibition assay | 48 h | GI50 = 0.0063 μM | 29655610 | |
SN12C | Growth inhibition assay | 48 h | GI50 = 0.0063 μM | 29655610 | |
IGROV1 | Growth inhibition assay | 48 h | GI50 = 0.0063 μM | 29655610 | |
A549/ATCC | Growth inhibition assay | 48 h | GI50 = 0.0063 μM | 29655610 | |
PC3 | Growth inhibition assay | 48 h | GI50 = 0.0063 μM | 29655610 | |
DU145 | Growth inhibition assay | 48 h | GI50 = 0.0063 μM | 29655610 | |
NCI-H460 | Growth inhibition assay | 48 h | GI50 = 0.0063 μM | 29655610 | |
K562 | Growth inhibition assay | 48 h | GI50 = 0.0063 μM | 29655610 | |
SR | Growth inhibition assay | 48 h | GI50 = 0.0063 μM | 29655610 | |
SNB75 | Growth inhibition assay | 48 h | GI50 = 0.0079 μM | 29655610 | |
A498 | Growth inhibition assay | 48 h | GI50 = 0.0079 μM | 29655610 | |
COLO205 | Growth inhibition assay | 48 h | GI50 = 0.0079 μM | 29655610 | |
OVCAR5 | Growth inhibition assay | 48 h | GI50 = 0.0079 μM | 29655610 | |
OVCAR8 | Growth inhibition assay | 48 h | GI50 = 0.0079 μM | 29655610 | |
SNB19 | Growth inhibition assay | 48 h | GI50 = 0.01 μM | 29655610 | |
NCI-H322M | Growth inhibition assay | 48 h | GI50 = 0.0125 μM | 29655610 | |
MDA-MB-468 | Growth inhibition assay | 48 h | GI50 = 0.0125 μM | 29655610 | |
MDA-MB-231 | Growth inhibition assay | 48 h | GI50 = 0.0125 μM | 29655610 | |
RXF393 | Growth inhibition assay | 48 h | GI50 = 0.0158 μM | 29655610 | |
NCI-H522 | Growth inhibition assay | 48 h | GI50 = 0.0158 μM | 29655610 | |
HOP62 | Growth inhibition assay | 48 h | GI50 = 0.019 μM | 29655610 | |
TK10 | Growth inhibition assay | 48 h | GI50 = 0.0199 μM | 29655610 | |
RPMI8226 | Growth inhibition assay | 48 h | GI50 = 0.0199 μM | 29655610 | |
HOP92 | Growth inhibition assay | 48 h | GI50 = 0.025 μM | 29655610 | |
SF295 | Growth inhibition assay | 48 h | GI50 = 0.025 μM | 29655610 | |
786-0 | Growth inhibition assay | 48 h | GI50 = 0.039 μM | 29655610 | |
MALME-3M | Growth inhibition assay | 48 h | GI50 = 0.05 μM | 29655610 | |
EKVX | Growth inhibition assay | 48 h | GI50 = 0.079 μM | 29655610 | |
UO31 | Growth inhibition assay | 48 h | GI50 = 0.125 μM | 29655610 | |
HCT15 | Growth inhibition assay | 48 h | GI50 = 0.125 μM | 29655610 | |
ACHN | Growth inhibition assay | 48 h | GI50 = 0.158 μM | 29655610 | |
Caki1 | Growth inhibition assay | 48 h | GI50 = 0.158 μM | 29655610 | |
SK-MEL-28 | Growth inhibition assay | 48 h | GI50 = 0.4 μM | 29655610 | |
SK-MEL-2 | Growth inhibition assay | 48 h | GI50 = 0.4 μM | 29655610 | |
NCI/ADR-RES | Growth inhibition assay | 48 h | GI50 = 0.63 μM | 29655610 | |
OVCAR4 | Growth inhibition assay | 48 h | GI50 = 0.63 μM | 29655610 | |
SKHEP1 | Growth inhibition assay | 48 h | GI50 = 0.011 μM | 29655982 | |
PC3 | Growth inhibition assay | 48 h | GI50 = 0.013 μM | 29655982 | |
HT-29 | Cytotoxicity assay | 24 to 72 h | IC50 = 0.011 μM | 29656990 | |
OVCAR3 | Cytotoxicity assay | 24 to 72 h | IC50 = 0.011 μM | 29656990 | |
OVCAR8 | Growth inhibition assay | 96 h | IC50 = 0.004 μM | 29730191 | |
MCF7 | Growth inhibition assay | 96 h | IC50 = 0.0055 μM | 29730191 | |
HepG2 | Growth inhibition assay | 48 h | IC50 = 2.66 μM | 29730191 | |
NCI/ADR-RES | Growth inhibition assay | 96 h | IC50 = 3.1 μM | 29730191 | |
A2780 | Cytotoxicity assay | 2 days | IC50 = 0.013 μM | 29738243 | |
A2780S | Antiproliferative activity assay | 48 to 72 h | IC50 = 0.01894 μM | 29754076 | |
A549 | Antiproliferative activity assay | 48 to 72 h | IC50 = 0.02318 μM | 29754076 | |
A549/TR | Antiproliferative activity assay | 48 to 72 h | IC50 = 0.75939 μM | 29754076 | |
MCF7 | Cytotoxicity assay | 48 h | IC50 = 0.005 μM | 29759727 | |
MIAPaCa2 | Cytotoxicity assay | 48 h | IC50 = 0.006 μM | 29759727 | |
PC3 | Cytotoxicity assay | 48 h | IC50 = 0.007 μM | 29759727 | |
HeLaS3 | Antiproliferative activity assay | 72 h | IC50 = 0.013 μM | 29803003 | |
KBVIN | Antiproliferative activity assay | 72 h | IC50 = 1.01 μM | 29803003 | |
MCF7 | Cytotoxicity assay | 4 days | IC50 = 0.008 μM | 29884535 | |
HL60 | Cytotoxicity assay | 4 days | IC50 = 0.008 μM | 29884535 | |
SMMC7721 | Cytotoxicity assay | 4 days | IC50 = 0.008 μM | 29884535 | |
A549 | Cytotoxicity assay | 4 days | IC50 = 0.008 μM | 29884535 | |
SW480 | Cytotoxicity assay | 4 days | IC50 = 0.008 μM | 29884535 | |
A549 | Antiproliferative activity assay | 72 h | IC50 = 0.0063 μM | 30010341 | |
KB | Antiproliferative activity assay | 72 h | IC50 = 0.0068 μM | 30010341 | |
MDA-MB-231 | Antiproliferative activity assay | 72 h | IC50 = 0.0081 μM | 30010341 | |
MCF7 | Antiproliferative activity assay | 72 h | IC50 = 0.0112 μM | 30010341 | |
KBVIN | Antiproliferative activity assay | 72 h | IC50 = 2.786 μM | 30010341 | |
MCF7 | Cytotoxicity assay | 72 h | IC50 = 0.0096 μM | 30036834 | |
KB | Cytotoxicity assay | 72 h | IC50 = 0.0103 μM | 30036834 | |
KB/VCR | Cytotoxicity assay | 72 h | IC50 = 4 μM | 30036834 | |
HT-29 | Cytotoxicity assay | 72 h | IC50 = 0.009 μM | 30057155 | |
MDA-MB-435 | Cytotoxicity assay | 72 h | IC50 = 0.013 μM | 30057155 | |
OVCAR3 | Cytotoxicity assay | 72 h | IC50 = 0.013 μM | 30057155 | |
MDA-MB-231 | Cytotoxicity assay | 72 h | IC50 = 0.017 μM | 30057155 | |
HeLa | Antiproliferative activity assay | 72 h | IC50 = 0.0028 μM | 30098869 | |
MDA-MB-435 | Antiproliferative activity assay | 72 h | IC50 = 0.0045 μM | 30098869 | |
SKOV3 | Antiproliferative activity assay | 72 h | IC50 = 0.005 μM | 30098869 | |
wild-type Hela-beta3 | Antiproliferative activity assay | 72 h | IC50 = 0.024 μM | 30098869 | |
SKOV3-MDR1-M6/6 | Antiproliferative activity assay | 72 h | IC50 = 1.2 μM | 30098869 | |
A375 | Antiproliferative activity assay | 72 h | IC50 = 0.0478 μM | 30099258 | |
KB | Antiproliferative activity assay | 72 h | IC50 = 0.00571 μM | 30106296 | |
MCF7 | Antiproliferative activity assay | 72 h | IC50 = 0.00752 μM | 30106296 | |
MDA-MB-231 | Antiproliferative activity assay | 72 h | IC50 = 0.00851 μM | 30106296 | |
A549 | Antiproliferative activity assay | 72 h | IC50 = 0.00876 μM | 30106296 | |
KBVIN | Antiproliferative activity assay | 72 h | IC50 = 2.383 μM | 30106296 | |
PC3 | Cytotoxicity assay | 72 h | IC50 = 0.0011 μM | 30122035 | |
DU145 | Cytotoxicity assay | 72 h | IC50 = 0.0015 μM | 30122035 | |
PC3-TxR | Cytotoxicity assay | 72 h | IC50 = 0.1139 μM | 30122035 | |
KB | Antiproliferative activity assay | 72 h | IC50 = 5.9 μM | 30189396 | |
A549 | Antiproliferative activity assay | 72 h | IC50 = 6.8 μM | 30189396 | |
MDA-MB-231 | Antiproliferative activity assay | 72 h | IC50 = 9.6 μM | 30189396 | |
MDA-MB-231 | Cytotoxicity assay | 72 h | IC50 = 0.0026 μM | 30192537 | |
MDA-MB-435 | Cytotoxicity assay | 72 h | IC50 = 0.0031 μM | 30192537 | |
OVCAR3 | Cytotoxicity assay | 72 h | IC50 = 0.0075 μM | 30192537 | |
MV411 | Antiproliferative activity assay | 72 h | IC50 = 0.017 μM | 30212198 | |
HGC27 | Antiproliferative activity assay | 72 h | IC50 = 0.028 μM | 30212198 | |
HeLa | Antiproliferative activity assay | 72 h | IC50 = 0.046 μM | 30212198 | |
A549 | Antiproliferative activity assay | 72 h | IC50 = 0.051 μM | 30212198 | |
HeLa | Antiproliferative activity assay | 48 h | IC50 = 0.0028 μM | 30297118 | |
SKOV3 | Antiproliferative activity assay | 48 h | IC50 = 0.005 μM | 30297118 | |
SKOV3-MDR1-M6/6 | Antiproliferative activity assay | 48 h | IC50 = 1.2 μM | 30297118 | |
HCC1806 | Antiproliferative activity assay | 24 h | IC50 = 0.001 μM | 30392953 | |
BEAS2B | Antiproliferative activity assay | 24 h | IC50 = 0.007 μM | 30392953 | |
HT-29 | Antiproliferative activity assay | 24 h | IC50 = 0.008 μM | 30392953 | |
HepG2 | Antiproliferative activity assay | 24 h | IC50 = 0.009 μM | 30392953 | |
PANC1 | Antiproliferative activity assay | 24 h | IC50 = 0.04 μM | 30392953 | |
MDA-MB-231 | Cytotoxicity assay | 48 h | IC50 = 0.004 μM | 30433783 | |
A549 | Cytotoxicity assay | 48 h | IC50 = 0.004 μM | 30433783 | |
PANC1 | Cytotoxicity assay | 48 h | IC50 = 0.06 μM | 30433783 | |
4T1 | Cytotoxicity assay | 48 h | IC50 = 0.094 μM | 30433783 | |
A375 | Cytotoxicity assay | 48 h | IC50 = 0.1 μM | 30433783 | |
LLC | Cytotoxicity assay | 48 h | IC50 = 0.189 μM | 30433783 | |
B16F10 | Cytotoxicity assay | 48 h | IC50 = 0.53 μM | 30433783 | |
B16F10 spheroid | Cytotoxicity assay | 48 h | IC50 = 8.01 μM | 30433783 | |
Daudi | Growth Inhibition Assay | IC50 = 0.01708 μM | SANGER | ||
NCI-SNU-5 | Growth Inhibition Assay | IC50 = 0.01701 μM | SANGER | ||
LS-123 | Growth Inhibition Assay | IC50 = 0.01664 μM | SANGER | ||
MOLT-13 | Growth Inhibition Assay | IC50 = 0.01637 μM | SANGER | ||
SNB75 | Growth Inhibition Assay | IC50 = 0.0154 μM | SANGER | ||
K-562 | Growth Inhibition Assay | IC50 = 0.01516 μM | SANGER | ||
TE-5 | Growth Inhibition Assay | IC50 = 0.01496 μM | SANGER | ||
SNU-C2B | Growth Inhibition Assay | IC50 = 0.01496 μM | SANGER | ||
CTV-1 | Growth Inhibition Assay | IC50 = 0.01478 μM | SANGER | ||
GI-1 | Growth Inhibition Assay | IC50 = 0.01373 μM | SANGER | ||
L-363 | Growth Inhibition Assay | IC50 = 0.01351 μM | SANGER | ||
ES1 | Growth Inhibition Assay | IC50 = 0.01288 μM | SANGER | ||
HOP-62 | Growth Inhibition Assay | IC50 = 0.01276 μM | SANGER | ||
KARPAS-45 | Growth Inhibition Assay | IC50 = 0.0127 μM | SANGER | ||
RXF393 | Growth Inhibition Assay | IC50 = 0.01257 μM | SANGER | ||
RPMI-8402 | Growth Inhibition Assay | IC50 = 0.01256 μM | SANGER | ||
KE-37 | Growth Inhibition Assay | IC50 = 0.01234 μM | SANGER | ||
NCI-H1436 | Growth Inhibition Assay | IC50 = 0.01231 μM | SANGER | ||
NALM-6 | Growth Inhibition Assay | IC50 = 0.01214 μM | SANGER | ||
ST486 | Growth Inhibition Assay | IC50 = 0.01204 μM | SANGER | ||
SCC-3 | Growth Inhibition Assay | IC50 = 0.01204 μM | SANGER | ||
DOHH-2 | Growth Inhibition Assay | IC50 = 0.01203 μM | SANGER | ||
HD-MY-Z | Growth Inhibition Assay | IC50 = 0.01163 μM | SANGER | ||
SF268 | Growth Inhibition Assay | IC50 = 0.01151 μM | SANGER | ||
SK-PN-DW | Growth Inhibition Assay | IC50 = 0.01112 μM | SANGER | ||
RPMI-8226 | Growth Inhibition Assay | IC50 = 0.01102 μM | SANGER | ||
LB647-SCLC | Growth Inhibition Assay | IC50 = 0.01051 μM | SANGER | ||
QIMR-WIL | Growth Inhibition Assay | IC50 = 0.01033 μM | SANGER | ||
SR | Growth Inhibition Assay | IC50 = 0.01026 μM | SANGER | ||
Calu-6 | Growth Inhibition Assay | IC50 = 0.01012 μM | SANGER | ||
NCI-SNU-16 | Growth Inhibition Assay | IC50 = 0.01008 μM | SANGER | ||
COR-L279 | Growth Inhibition Assay | IC50 = 0.00999 μM | SANGER | ||
HL-60 | Growth Inhibition Assay | IC50 = 0.009656 μM | SANGER | ||
A101D | Growth Inhibition Assay | IC50 = 0.009598 μM | SANGER | ||
BL-41 | Growth Inhibition Assay | IC50 = 0.009345 μM | SANGER | ||
BL-70 | Growth Inhibition Assay | IC50 = 0.009303 μM | SANGER | ||
NCI-H1355 | Growth Inhibition Assay | IC50 = 0.009138 μM | SANGER | ||
OVCAR-4 | Growth Inhibition Assay | IC50 = 0.009041 μM | SANGER | ||
KNS-42 | Growth Inhibition Assay | IC50 = 0.008907 μM | SANGER | ||
A388 | Growth Inhibition Assay | IC50 = 0.008738 μM | SANGER | ||
CCRF-CEM | Growth Inhibition Assay | IC50 = 0.008708 μM | SANGER | ||
OCI-AML2 | Growth Inhibition Assay | IC50 = 0.008521 μM | SANGER | ||
DEL | Growth Inhibition Assay | IC50 = 0.008449 μM | SANGER | ||
RS4-11 | Growth Inhibition Assay | IC50 = 0.008357 μM | SANGER | ||
LXF-289 | Growth Inhibition Assay | IC50 = 0.008184 μM | SANGER | ||
HT-144 | Growth Inhibition Assay | IC50 = 0.008003 μM | SANGER | ||
8-MG-BA | Growth Inhibition Assay | IC50 = 0.007958 μM | SANGER | ||
LOUCY | Growth Inhibition Assay | IC50 = 0.00775 μM | SANGER | ||
HCE-4 | Growth Inhibition Assay | IC50 = 0.007671 μM | SANGER | ||
SW982 | Growth Inhibition Assay | IC50 = 0.00766 μM | SANGER | ||
TGBC24TKB | Growth Inhibition Assay | IC50 = 0.007523 μM | SANGER | ||
KURAMOCHI | Growth Inhibition Assay | IC50 = 0.007478 μM | SANGER | ||
CESS | Growth Inhibition Assay | IC50 = 0.007374 μM | SANGER | ||
HC-1 | Growth Inhibition Assay | IC50 = 0.007213 μM | SANGER | ||
Becker | Growth Inhibition Assay | IC50 = 0.0072 μM | SANGER | ||
LS-411N | Growth Inhibition Assay | IC50 = 0.007166 μM | SANGER | ||
KGN | Growth Inhibition Assay | IC50 = 0.007124 μM | SANGER | ||
EW-16 | Growth Inhibition Assay | IC50 = 0.006937 μM | SANGER | ||
NCI-H510A | Growth Inhibition Assay | IC50 = 0.006652 μM | SANGER | ||
SW962 | Growth Inhibition Assay | IC50 = 0.006623 μM | SANGER | ||
OCUB-M | Growth Inhibition Assay | IC50 = 0.006617 μM | SANGER | ||
NOS-1 | Growth Inhibition Assay | IC50 = 0.006496 μM | SANGER | ||
KM12 | Growth Inhibition Assay | IC50 = 0.006373 μM | SANGER | ||
BE-13 | Growth Inhibition Assay | IC50 = 0.006363 μM | SANGER | ||
ALL-PO | Growth Inhibition Assay | IC50 = 0.006298 μM | SANGER | ||
A4-Fuk | Growth Inhibition Assay | IC50 = 0.006109 μM | SANGER | ||
ATN-1 | Growth Inhibition Assay | IC50 = 0.00609 μM | SANGER | ||
TE-1 | Growth Inhibition Assay | IC50 = 0.006059 μM | SANGER | ||
KS-1 | Growth Inhibition Assay | IC50 = 0.005816 μM | SANGER | ||
TE-6 | Growth Inhibition Assay | IC50 = 0.005703 μM | SANGER | ||
ES8 | Growth Inhibition Assay | IC50 = 0.00538 μM | SANGER | ||
DJM-1 | Growth Inhibition Assay | IC50 = 0.005301 μM | SANGER | ||
NB13 | Growth Inhibition Assay | IC50 = 0.004912 μM | SANGER | ||
SK-UT-1 | Growth Inhibition Assay | IC50 = 0.004803 μM | SANGER | ||
MV-4-11 | Growth Inhibition Assay | IC50 = 0.004747 μM | SANGER | ||
NCI-H1648 | Growth Inhibition Assay | IC50 = 0.004687 μM | SANGER | ||
IMR-5 | Growth Inhibition Assay | IC50 = 0.004496 μM | SANGER | ||
ES4 | Growth Inhibition Assay | IC50 = 0.004494 μM | SANGER | ||
GT3TKB | Growth Inhibition Assay | IC50 = 0.004339 μM | SANGER | ||
SK-LMS-1 | Growth Inhibition Assay | IC50 = 0.004006 μM | SANGER | ||
EW-1 | Growth Inhibition Assay | IC50 = 0.003714 μM | SANGER | ||
no-10 | Growth Inhibition Assay | IC50 = 0.003618 μM | SANGER | ||
SIG-M5 | Growth Inhibition Assay | IC50 = 0.003272 μM | SANGER | ||
TE-9 | Growth Inhibition Assay | IC50 = 0.003255 μM | SANGER | ||
ACN | Growth Inhibition Assay | IC50 = 0.003157 μM | SANGER | ||
BB30-HNC | Growth Inhibition Assay | IC50 = 0.003138 μM | SANGER | ||
KALS-1 | Growth Inhibition Assay | IC50 = 0.00308 μM | SANGER | ||
VA-ES-BJ | Growth Inhibition Assay | IC50 = 0.002996 μM | SANGER | ||
MRK-nu-1 | Growth Inhibition Assay | IC50 = 0.00299 μM | SANGER | ||
RKO | Growth Inhibition Assay | IC50 = 0.002977 μM | SANGER | ||
MC116 | Growth Inhibition Assay | IC50 = 0.002888 μM | SANGER | ||
IA-LM | Growth Inhibition Assay | IC50 = 0.002802 μM | SANGER | ||
MFH-ino | Growth Inhibition Assay | IC50 = 0.00268 μM | SANGER | ||
NTERA-S-cl-D1 | Growth Inhibition Assay | IC50 = 0.002088 μM | SANGER | ||
HUTU-80 | Growth Inhibition Assay | IC50 = 0.001682 μM | SANGER | ||
TE-10 | Growth Inhibition Assay | IC50 = 0.001543 μM | SANGER | ||
ETK-1 | Growth Inhibition Assay | IC50 = 0.001521 μM | SANGER | ||
697 | Growth Inhibition Assay | IC50 = 0.001495 μM | SANGER | ||
MOLT-4 | Growth Inhibition Assay | IC50 = 0.001493 μM | SANGER | ||
PSN1 | Growth Inhibition Assay | IC50 = 0.001301 μM | SANGER | ||
TE-11 | Growth Inhibition Assay | IC50 = 0.001231 μM | SANGER | ||
SW954 | Growth Inhibition Assay | IC50 = 0.001187 μM | SANGER | ||
TE-8 | Growth Inhibition Assay | IC50 = 0.001174 μM | SANGER | ||
MZ1-PC | Growth Inhibition Assay | IC50 = 0.0007294 μM | SANGER | ||
RL95-2 | Growth Inhibition Assay | IC50 = 0.0006681 μM | SANGER | ||
LC-2-ad | Growth Inhibition Assay | IC50 = 0.0003167 μM | SANGER | ||
TE-15 | Growth Inhibition Assay | IC50 = 0.0002869 μM | SANGER | ||
A253 | Growth Inhibition Assay | IC50 = 0.01738 μM | SANGER | ||
TGBC1TKB | Growth Inhibition Assay | IC50 = 0.01752 μM | SANGER | ||
SJSA-1 | Growth Inhibition Assay | IC50 = 0.01767 μM | SANGER | ||
NCCIT | Growth Inhibition Assay | IC50 = 0.01769 μM | SANGER | ||
NCI-H69 | Growth Inhibition Assay | IC50 = 0.01778 μM | SANGER | ||
SH-4 | Growth Inhibition Assay | IC50 = 0.01895 μM | SANGER | ||
HCC1187 | Growth Inhibition Assay | IC50 = 0.01924 μM | SANGER | ||
HCC1599 | Growth Inhibition Assay | IC50 = 0.0202 μM | SANGER | ||
ONS-76 | Growth Inhibition Assay | IC50 = 0.02036 μM | SANGER | ||
KU812 | Growth Inhibition Assay | IC50 = 0.02039 μM | SANGER | ||
ML-2 | Growth Inhibition Assay | IC50 = 0.02047 μM | SANGER | ||
HCE-T | Growth Inhibition Assay | IC50 = 0.02092 μM | SANGER | ||
NCI-H446 | Growth Inhibition Assay | IC50 = 0.02112 μM | SANGER | ||
RPMI-6666 | Growth Inhibition Assay | IC50 = 0.02149 μM | SANGER | ||
MOLT-16 | Growth Inhibition Assay | IC50 = 0.02153 μM | SANGER | ||
JiyoyeP-2003 | Growth Inhibition Assay | IC50 = 0.02176 μM | SANGER | ||
MHH-PREB-1 | Growth Inhibition Assay | IC50 = 0.02191 μM | SANGER | ||
MC-CAR | Growth Inhibition Assay | IC50 = 0.02326 μM | SANGER | ||
BC-3 | Growth Inhibition Assay | IC50 = 0.02344 μM | SANGER | ||
KINGS-1 | Growth Inhibition Assay | IC50 = 0.02355 μM | SANGER | ||
PF-382 | Growth Inhibition Assay | IC50 = 0.02378 μM | SANGER | ||
J-RT3-T3-5 | Growth Inhibition Assay | IC50 = 0.02383 μM | SANGER | ||
SF539 | Growth Inhibition Assay | IC50 = 0.02401 μM | SANGER | ||
LB831-BLC | Growth Inhibition Assay | IC50 = 0.02485 μM | SANGER | ||
DMS-114 | Growth Inhibition Assay | IC50 = 0.02502 μM | SANGER | ||
LB1047-RCC | Growth Inhibition Assay | IC50 = 0.0251 μM | SANGER | ||
BB65-RCC | Growth Inhibition Assay | IC50 = 0.02534 μM | SANGER | ||
LB771-HNC | Growth Inhibition Assay | IC50 = 0.02534 μM | SANGER | ||
BV-173 | Growth Inhibition Assay | IC50 = 0.02554 μM | SANGER | ||
ARH-77 | Growth Inhibition Assay | IC50 = 0.02601 μM | SANGER | ||
IST-MEL1 | Growth Inhibition Assay | IC50 = 0.02623 μM | SANGER | ||
NB1 | Growth Inhibition Assay | IC50 = 0.02687 μM | SANGER | ||
EoL-1-cell | Growth Inhibition Assay | IC50 = 0.02688 μM | SANGER | ||
KY821 | Growth Inhibition Assay | IC50 = 0.02697 μM | SANGER | ||
CMK | Growth Inhibition Assay | IC50 = 0.02734 μM | SANGER | ||
NCI-H2126 | Growth Inhibition Assay | IC50 = 0.02768 μM | SANGER | ||
NCI-H526 | Growth Inhibition Assay | IC50 = 0.02891 μM | SANGER | ||
COLO-684 | Growth Inhibition Assay | IC50 = 0.02908 μM | SANGER | ||
NCI-H747 | Growth Inhibition Assay | IC50 = 0.02933 μM | SANGER | ||
JAR | Growth Inhibition Assay | IC50 = 0.02946 μM | SANGER | ||
MEG-01 | Growth Inhibition Assay | IC50 = 0.02978 μM | SANGER | ||
MONO-MAC-6 | Growth Inhibition Assay | IC50 = 0.03023 μM | SANGER | ||
IST-SL1 | Growth Inhibition Assay | IC50 = 0.03042 μM | SANGER | ||
CPC-N | Growth Inhibition Assay | IC50 = 0.03079 μM | SANGER | ||
NCI-H1963 | Growth Inhibition Assay | IC50 = 0.03131 μM | SANGER | ||
K052 | Growth Inhibition Assay | IC50 = 0.03247 μM | SANGER | ||
KM-H2 | Growth Inhibition Assay | IC50 = 0.03307 μM | SANGER | ||
TE-12 | Growth Inhibition Assay | IC50 = 0.03309 μM | SANGER | ||
TK10 | Growth Inhibition Assay | IC50 = 0.03356 μM | SANGER | ||
NMC-G1 | Growth Inhibition Assay | IC50 = 0.03452 μM | SANGER | ||
no-11 | Growth Inhibition Assay | IC50 = 0.03478 μM | SANGER | ||
NCI-H524 | Growth Inhibition Assay | IC50 = 0.03529 μM | SANGER | ||
MHH-CALL-2 | Growth Inhibition Assay | IC50 = 0.03562 μM | SANGER | ||
GB-1 | Growth Inhibition Assay | IC50 = 0.036 μM | SANGER | ||
OPM-2 | Growth Inhibition Assay | IC50 = 0.03673 μM | SANGER | ||
RH-1 | Growth Inhibition Assay | IC50 = 0.03819 μM | SANGER | ||
NCI-H64 | Growth Inhibition Assay | IC50 = 0.03857 μM | SANGER | ||
EVSA-T | Growth Inhibition Assay | IC50 = 0.03923 μM | SANGER | ||
KARPAS-299 | Growth Inhibition Assay | IC50 = 0.0398 μM | SANGER | ||
MZ7-mel | Growth Inhibition Assay | IC50 = 0.0404 μM | SANGER | ||
LB373-MEL-D | Growth Inhibition Assay | IC50 = 0.04105 μM | SANGER | ||
HEL | Growth Inhibition Assay | IC50 = 0.0414 μM | SANGER | ||
SW872 | Growth Inhibition Assay | IC50 = 0.0421 μM | SANGER | ||
DU-4475 | Growth Inhibition Assay | IC50 = 0.04244 μM | SANGER | ||
IST-SL2 | Growth Inhibition Assay | IC50 = 0.04275 μM | SANGER | ||
NCI-H82 | Growth Inhibition Assay | IC50 = 0.04307 μM | SANGER | ||
LC4-1 | Growth Inhibition Assay | IC50 = 0.04351 μM | SANGER | ||
HDLM-2 | Growth Inhibition Assay | IC50 = 0.04392 μM | SANGER | ||
MMAC-SF | Growth Inhibition Assay | IC50 = 0.04534 μM | SANGER | ||
L-540 | Growth Inhibition Assay | IC50 = 0.04639 μM | SANGER | ||
MZ2-MEL | Growth Inhibition Assay | IC50 = 0.04742 μM | SANGER | ||
LU-134-A | Growth Inhibition Assay | IC50 = 0.04773 μM | SANGER | ||
UACC-257 | Growth Inhibition Assay | IC50 = 0.04849 μM | SANGER | ||
NCI-H1581 | Growth Inhibition Assay | IC50 = 0.04953 μM | SANGER | ||
NB17 | Growth Inhibition Assay | IC50 = 0.04979 μM | SANGER | ||
SBC-1 | Growth Inhibition Assay | IC50 = 0.05042 μM | SANGER | ||
TALL-1 | Growth Inhibition Assay | IC50 = 0.05045 μM | SANGER | ||
NCI-H1304 | Growth Inhibition Assay | IC50 = 0.05208 μM | SANGER | ||
NEC8 | Growth Inhibition Assay | IC50 = 0.05286 μM | SANGER | ||
CAL-148 | Growth Inhibition Assay | IC50 = 0.05439 μM | SANGER | ||
CGTH-W-1 | Growth Inhibition Assay | IC50 = 0.05449 μM | SANGER | ||
NCI-H889 | Growth Inhibition Assay | IC50 = 0.05592 μM | SANGER | ||
GR-ST | Growth Inhibition Assay | IC50 = 0.05621 μM | SANGER | ||
KARPAS-422 | Growth Inhibition Assay | IC50 = 0.0565 μM | SANGER | ||
RPMI-8866 | Growth Inhibition Assay | IC50 = 0.05712 μM | SANGER | ||
SCLC-21H | Growth Inhibition Assay | IC50 = 0.05884 μM | SANGER | ||
COR-L88 | Growth Inhibition Assay | IC50 = 0.05927 μM | SANGER | ||
LU-139 | Growth Inhibition Assay | IC50 = 0.05986 μM | SANGER | ||
SF126 | Growth Inhibition Assay | IC50 = 0.06133 μM | SANGER | ||
NCI-H1882 | Growth Inhibition Assay | IC50 = 0.06424 μM | SANGER | ||
EW-24 | Growth Inhibition Assay | IC50 = 0.06483 μM | SANGER | ||
CP67-MEL | Growth Inhibition Assay | IC50 = 0.0681 μM | SANGER | ||
DG-75 | Growth Inhibition Assay | IC50 = 0.06899 μM | SANGER | ||
LOXIMVI | Growth Inhibition Assay | IC50 = 0.07028 μM | SANGER | ||
HH | Growth Inhibition Assay | IC50 = 0.07157 μM | SANGER | ||
K5 | Growth Inhibition Assay | IC50 = 0.07226 μM | SANGER | ||
EC-GI-10 | Growth Inhibition Assay | IC50 = 0.07257 μM | SANGER | ||
SK-N-DZ | Growth Inhibition Assay | IC50 = 0.07307 μM | SANGER | ||
A3-KAW | Growth Inhibition Assay | IC50 = 0.07351 μM | SANGER | ||
MLMA | Growth Inhibition Assay | IC50 = 0.07465 μM | SANGER | ||
LB996-RCC | Growth Inhibition Assay | IC50 = 0.07707 μM | SANGER | ||
OS-RC-2 | Growth Inhibition Assay | IC50 = 0.07748 μM | SANGER | ||
CTB-1 | Growth Inhibition Assay | IC50 = 0.0781 μM | SANGER | ||
IST-MES1 | Growth Inhibition Assay | IC50 = 0.07912 μM | SANGER | ||
LS-1034 | Growth Inhibition Assay | IC50 = 0.08035 μM | SANGER | ||
HT | Growth Inhibition Assay | IC50 = 0.08086 μM | SANGER | ||
NCI-H2141 | Growth Inhibition Assay | IC50 = 0.081 μM | SANGER | ||
LB2518-MEL | Growth Inhibition Assay | IC50 = 0.08141 μM | SANGER | ||
GI-ME-N | Growth Inhibition Assay | IC50 = 0.08452 μM | SANGER | ||
TGW | Growth Inhibition Assay | IC50 = 0.08607 μM | SANGER | ||
SK-NEP-1 | Growth Inhibition Assay | IC50 = 0.08641 μM | SANGER | ||
NOMO-1 | Growth Inhibition Assay | IC50 = 0.09275 μM | SANGER | ||
ES6 | Growth Inhibition Assay | IC50 = 0.09589 μM | SANGER | ||
NCI-H209 | Growth Inhibition Assay | IC50 = 0.09786 μM | SANGER | ||
GAK | Growth Inhibition Assay | IC50 = 0.1016 μM | SANGER | ||
BC-1 | Growth Inhibition Assay | IC50 = 0.10361 μM | SANGER | ||
KLE | Growth Inhibition Assay | IC50 = 0.10443 μM | SANGER | ||
EW-3 | Growth Inhibition Assay | IC50 = 0.1098 μM | SANGER | ||
NKM-1 | Growth Inhibition Assay | IC50 = 0.111 μM | SANGER | ||
D-336MG | Growth Inhibition Assay | IC50 = 0.11244 μM | SANGER | ||
NB69 | Growth Inhibition Assay | IC50 = 0.11301 μM | SANGER | ||
D-263MG | Growth Inhibition Assay | IC50 = 0.11712 μM | SANGER | ||
KP-N-YS | Growth Inhibition Assay | IC50 = 0.12291 μM | SANGER | ||
NCI-H1155 | Growth Inhibition Assay | IC50 = 0.12558 μM | SANGER | ||
BOKU | Growth Inhibition Assay | IC50 = 0.12579 μM | SANGER | ||
LAMA-84 | Growth Inhibition Assay | IC50 = 0.1299 μM | SANGER | ||
Raji | Growth Inhibition Assay | IC50 = 0.13117 μM | SANGER | ||
LU-65 | Growth Inhibition Assay | IC50 = 0.13307 μM | SANGER | ||
NCI-H187 | Growth Inhibition Assay | IC50 = 0.13924 μM | SANGER | ||
GCIY | Growth Inhibition Assay | IC50 = 0.14901 μM | SANGER | ||
NCI-H2107 | Growth Inhibition Assay | IC50 = 0.1508 μM | SANGER | ||
NCI-H1522 | Growth Inhibition Assay | IC50 = 0.15266 μM | SANGER | ||
NB6 | Growth Inhibition Assay | IC50 = 0.15623 μM | SANGER | ||
EM-2 | Growth Inhibition Assay | IC50 = 0.15706 μM | SANGER | ||
HCC2218 | Growth Inhibition Assay | IC50 = 0.1598 μM | SANGER | ||
NCI-H748 | Growth Inhibition Assay | IC50 = 0.16376 μM | SANGER | ||
MS-1 | Growth Inhibition Assay | IC50 = 0.16537 μM | SANGER | ||
NB5 | Growth Inhibition Assay | IC50 = 0.16597 μM | SANGER | ||
OMC-1 | Growth Inhibition Assay | IC50 = 0.16688 μM | SANGER | ||
NCI-H345 | Growth Inhibition Assay | IC50 = 0.16928 μM | SANGER | ||
L-428 | Growth Inhibition Assay | IC50 = 0.16945 μM | SANGER | ||
SCH | Growth Inhibition Assay | IC50 = 0.18685 μM | SANGER | ||
NCI-H1417 | Growth Inhibition Assay | IC50 = 0.19227 μM | SANGER | ||
COLO-320-HSR | Growth Inhibition Assay | IC50 = 0.19532 μM | SANGER | ||
BT-474 | Growth Inhibition Assay | IC50 = 0.20892 μM | SANGER | ||
GDM-1 | Growth Inhibition Assay | IC50 = 0.21971 μM | SANGER | ||
NCI-H2196 | Growth Inhibition Assay | IC50 = 0.22235 μM | SANGER | ||
KP-N-RT-BM-1 | Growth Inhibition Assay | IC50 = 0.22349 μM | SANGER | ||
KNS-81-FD | Growth Inhibition Assay | IC50 = 0.22958 μM | SANGER | ||
COLO-668 | Growth Inhibition Assay | IC50 = 0.23675 μM | SANGER | ||
C2BBe1 | Growth Inhibition Assay | IC50 = 0.26747 μM | SANGER | ||
Ramos-2G6-4C10 | Growth Inhibition Assay | IC50 = 0.26954 μM | SANGER | ||
CAS-1 | Growth Inhibition Assay | IC50 = 0.27096 μM | SANGER | ||
GOTO | Growth Inhibition Assay | IC50 = 0.27894 μM | SANGER | ||
LP-1 | Growth Inhibition Assay | IC50 = 0.28057 μM | SANGER | ||
NCI-SNU-1 | Growth Inhibition Assay | IC50 = 0.29422 μM | SANGER | ||
EB-3 | Growth Inhibition Assay | IC50 = 0.29979 μM | SANGER | ||
MHH-NB-11 | Growth Inhibition Assay | IC50 = 0.30402 μM | SANGER | ||
SK-N-FI | Growth Inhibition Assay | IC50 = 0.31692 μM | SANGER | ||
HCC2157 | Growth Inhibition Assay | IC50 = 0.33913 μM | SANGER | ||
SIMA | Growth Inhibition Assay | IC50 = 0.34581 μM | SANGER | ||
MDA-MB-134-VI | Growth Inhibition Assay | IC50 = 0.36928 μM | SANGER | ||
NCI-H1694 | Growth Inhibition Assay | IC50 = 0.37 μM | SANGER | ||
EHEB | Growth Inhibition Assay | IC50 = 0.39085 μM | SANGER | ||
U-266 | Growth Inhibition Assay | IC50 = 0.39846 μM | SANGER | ||
LC-1F | Growth Inhibition Assay | IC50 = 0.43765 μM | SANGER | ||
SHP-77 | Growth Inhibition Assay | IC50 = 0.47855 μM | SANGER | ||
LS-513 | Growth Inhibition Assay | IC50 = 0.49307 μM | SANGER | ||
TE-441-T | Growth Inhibition Assay | IC50 = 0.52479 μM | SANGER | ||
D-247MG | Growth Inhibition Assay | IC50 = 0.59924 μM | SANGER | ||
SNU-C1 | Growth Inhibition Assay | IC50 = 0.61887 μM | SANGER | ||
SU-DHL-1 | Growth Inhibition Assay | IC50 = 0.6289 μM | SANGER | ||
DB | Growth Inhibition Assay | IC50 = 0.82872 μM | SANGER | ||
CP66-MEL | Growth Inhibition Assay | IC50 = 0.95198 μM | SANGER | ||
NCI-H1650 | Growth Inhibition Assay | IC50 = 1.04651 μM | SANGER | ||
DMS-153 | Growth Inhibition Assay | IC50 = 1.10124 μM | SANGER | ||
A498 | Growth Inhibition Assay | IC50 = 1.21534 μM | SANGER | ||
U-698-M | Growth Inhibition Assay | IC50 = 1.22557 μM | SANGER | ||
NCI-H1092 | Growth Inhibition Assay | IC50 = 1.30719 μM | SANGER | ||
NCI-H23 | Growth Inhibition Assay | IC50 = 1.3319 μM | SANGER | ||
JVM-2 | Growth Inhibition Assay | IC50 = 1.42177 μM | SANGER | ||
MSTO-211H | Growth Inhibition Assay | IC50 = 1.43905 μM | SANGER | ||
A704 | Growth Inhibition Assay | IC50 = 1.51191 μM | SANGER | ||
ECC4 | Growth Inhibition Assay | IC50 = 1.54949 μM | SANGER | ||
NCI-H226 | Growth Inhibition Assay | IC50 = 1.71489 μM | SANGER | ||
CA46 | Growth Inhibition Assay | IC50 = 1.73216 μM | SANGER | ||
NCI-H719 | Growth Inhibition Assay | IC50 = 1.73651 μM | SANGER | ||
KMS-12-PE | Growth Inhibition Assay | IC50 = 1.90481 μM | SANGER | ||
MPP-89 | Growth Inhibition Assay | IC50 = 1.94182 μM | SANGER | ||
NCI-H2171 | Growth Inhibition Assay | IC50 = 2.20593 μM | SANGER | ||
CHP-126 | Growth Inhibition Assay | IC50 = 2.24737 μM | SANGER | ||
DMS-79 | Growth Inhibition Assay | IC50 = 2.27644 μM | SANGER | ||
SCC-15 | Growth Inhibition Assay | IC50 = 2.30678 μM | SANGER | ||
REH | Growth Inhibition Assay | IC50 = 2.31165 μM | SANGER | ||
NCI-H2081 | Growth Inhibition Assay | IC50 = 2.32315 μM | SANGER | ||
NCI-H720 | Growth Inhibition Assay | IC50 = 2.55972 μM | SANGER | ||
KMOE-2 | Growth Inhibition Assay | IC50 = 2.75712 μM | SANGER | ||
D-502MG | Growth Inhibition Assay | IC50 = 2.86805 μM | SANGER | ||
MN-60 | Growth Inhibition Assay | IC50 = 2.95245 μM | SANGER | ||
LU-165 | Growth Inhibition Assay | IC50 = 3.01956 μM | SANGER | ||
DSH1 | Growth Inhibition Assay | IC50 = 3.23442 μM | SANGER | ||
SK-MM-2 | Growth Inhibition Assay | IC50 = 3.54385 μM | SANGER | ||
LAN-6 | Growth Inhibition Assay | IC50 = 3.54788 μM | SANGER | ||
NCI-H1838 | Growth Inhibition Assay | IC50 = 4.18573 μM | SANGER | ||
U-87-MG | Growth Inhibition Assay | IC50 = 4.18673 μM | SANGER | ||
NB7 | Growth Inhibition Assay | IC50 = 4.40376 μM | SANGER | ||
BB49-HNC | Growth Inhibition Assay | IC50 = 4.94617 μM | SANGER | ||
NCI-H1395 | Growth Inhibition Assay | IC50 = 5.00345 μM | SANGER | ||
RCC10RGB | Growth Inhibition Assay | IC50 = 5.06271 μM | SANGER | ||
COLO-824 | Growth Inhibition Assay | IC50 = 5.08313 μM | SANGER | ||
NCI-H322M | Growth Inhibition Assay | IC50 = 5.186 μM | SANGER | ||
SW684 | Growth Inhibition Assay | IC50 = 5.23288 μM | SANGER | ||
P30-OHK | Growth Inhibition Assay | IC50 = 5.35052 μM | SANGER | ||
COLO-829 | Growth Inhibition Assay | IC50 = 5.49884 μM | SANGER | ||
HAL-01 | Growth Inhibition Assay | IC50 = 5.73185 μM | SANGER | ||
LNCaP-Clone-FGC | Growth Inhibition Assay | IC50 = 6.34489 μM | SANGER | ||
SK-MEL-1 | Growth Inhibition Assay | IC50 = 6.70896 μM | SANGER | ||
THP-1 | Growth Inhibition Assay | IC50 = 6.72583 μM | SANGER | ||
EW-18 | Growth Inhibition Assay | IC50 = 7.03675 μM | SANGER | ||
EKVX | Growth Inhibition Assay | IC50 = 7.16865 μM | SANGER | ||
NB14 | Growth Inhibition Assay | IC50 = 7.8139 μM | SANGER | ||
ES5 | Growth Inhibition Assay | IC50 = 7.86662 μM | SANGER | ||
SK-MEL-2 | Growth Inhibition Assay | IC50 = 8.45976 μM | SANGER | ||
COLO-800 | Growth Inhibition Assay | IC50 = 8.4787 μM | SANGER | ||
EB2 | Growth Inhibition Assay | IC50 = 9.19835 μM | SANGER | ||
ES3 | Growth Inhibition Assay | IC50 = 9.30665 μM | SANGER | ||
SKM-1 | Growth Inhibition Assay | IC50 = 9.39459 μM | SANGER | ||
MFM-223 | Growth Inhibition Assay | IC50 = 9.50127 μM | SANGER | ||
LB2241-RCC | Growth Inhibition Assay | IC50 = 10.0386 μM | SANGER | ||
EW-13 | Growth Inhibition Assay | IC50 = 10.3333 μM | SANGER | ||
D-283MED | Growth Inhibition Assay | IC50 = 10.4959 μM | SANGER | ||
EW-11 | Growth Inhibition Assay | IC50 = 11.6694 μM | SANGER | ||
NCI-H128 | Growth Inhibition Assay | IC50 = 12.1334 μM | SANGER | ||
ES7 | Growth Inhibition Assay | IC50 = 15.2494 μM | SANGER | ||
AM-38 | Growth Inhibition Assay | IC50 = 15.4166 μM | SANGER | ||
NCI-H716 | Growth Inhibition Assay | IC50 = 17.9299 μM | SANGER | ||
NCI-H1770 | Growth Inhibition Assay | IC50 = 18.3851 μM | SANGER | ||
JVM-3 | Growth Inhibition Assay | IC50 = 20.8985 μM | SANGER | ||
CW-2 | Growth Inhibition Assay | IC50 = 21.1349 μM | SANGER | ||
YT | Growth Inhibition Assay | IC50 = 21.4691 μM | SANGER | ||
C8166 | Growth Inhibition Assay | IC50 = 22.2746 μM | SANGER | ||
SUP-T1 | Growth Inhibition Assay | IC50 = 23.2512 μM | SANGER | ||
KASUMI-1 | Growth Inhibition Assay | IC50 = 23.5119 μM | SANGER | ||
IM-9 | Growth Inhibition Assay | IC50 = 23.6979 μM | SANGER | ||
NH-12 | Growth Inhibition Assay | IC50 = 24.1654 μM | SANGER | ||
WSU-NHL | Growth Inhibition Assay | IC50 = 25.7261 μM | SANGER | ||
TUR | Growth Inhibition Assay | IC50 = 26.6533 μM | SANGER | ||
RL | Growth Inhibition Assay | IC50 = 27.2242 μM | SANGER | ||
EW-12 | Growth Inhibition Assay | IC50 = 28.0702 μM | SANGER | ||
KG-1 | Growth Inhibition Assay | IC50 = 28.2865 μM | SANGER | ||
P31-FUJ | Growth Inhibition Assay | IC50 = 29.0489 μM | SANGER | ||
NB10 | Growth Inhibition Assay | IC50 = 31.509 μM | SANGER | ||
COLO205 | Cytotoxicity assay | GI50 = 0.00176 μM | 7908950 | ||
SF539 | Cytotoxicity assay | GI50 = 0.00366 μM | 7908950 | ||
SNB75 | Cytotoxicity assay | GI50 = 0.00808 μM | 7908950 | ||
DMS114 | Cytotoxicity assay | GI50 = 0.0123 μM | 7908950 | ||
OVCAR-3 | Cytotoxicity assay | GI50 = 0.0197 μM | 7908950 | ||
NCI-H460 | Cytotoxicity assay | GI50 = 0.0219 μM | 7908950 | ||
HOP62 | Cytotoxicity assay | GI50 = 0.0671 μM | 7908950 | ||
mammary carcinoma | Cytotoxicity assay | IC50 = 0.299 μM | 8182698 | ||
NCI60 | Cytotoxicity assay | GI50 = 0.00065 μM | 9461653 | ||
MCF-7 | Growth inhibition assay | GI50 = 0.0011 μM | 9873597 | ||
murine leukemic P388 | Growth inhibition assay | GI50 = 0.016 μM | 9873597 | ||
KB | Cytotoxicity assay | IC50 = 0.006 μM | 10978200 | ||
MCF-7 | Cytotoxicity assay | ED50 = 0.004 μM | 11334567 | ||
uterine sarcoma (MES-SA) | Cytotoxicity assay | IC50 = 0.00004 μM | 11728191 | ||
nonsmall cell lung carcinoma (NCI-H460) | Cytotoxicity assay | IC50 = 0.00014 μM | 11728191 | ||
colon adenocarcinoma (HT-29) | Cytotoxicity assay | IC50 = 0.00016 μM | 11728191 | ||
prostate carcinoma (DU-145) | Cytotoxicity assay | IC50 = 0.00489 μM | 11728191 | ||
L2987 | Cytotoxicity assay | IC50 = 0.2 μM | 12443783 | ||
colon adenocarcinoma RKO | Cytotoxicity assay | IC50 = 0.01 μM | 12852768 | ||
KB | Cytotoxicity assay | ED50 = 0.0004 μM | 15043407 | ||
Lu1 | Cytotoxicity assay | ED50 = 0.002 μM | 15043407 | ||
LNCAP | Cytotoxicity assay | ED50 = 0.005 μM | 15043407 | ||
RPE1 | Cytotoxicity assay | ED50 = 0.023 μM | 15043407 | ||
Col2 | Cytotoxicity assay | ED50 = 0.046 μM | 15043407 | ||
A431 | Cell cycle arrest assay | EC50 = 0.009 μM | 16377187 | ||
Aro | Cytotoxicity assay | IC50 = 0.0002 μM | 16539377 | ||
PT45 | Cytotoxicity assay | IC50 = 0.005 μM | 16539377 | ||
A549 | Cytotoxicity assay | IC50 = 0.006 μM | 16539377 | ||
MCF7 | Cytotoxicity assay | IC50 = 0.007 μM | 16539377 | ||
HeLa | Cytotoxicity assay | IC50 = 0.008 μM | 16539377 | ||
Ovcar3 | Cytotoxicity assay | IC50 = 0.01 μM | 16539377 | ||
HT29 | Cytotoxicity assay | IC50 = 0.05 μM | 16539377 | ||
H295R | Cytotoxicity assay | IC50 = 0.08 μM | 16539377 | ||
BNL | Cytotoxicity assay | IC50 = 0.2 μM | 16539377 | ||
4T1 | Cytotoxicity assay | IC50 = 0.2 μM | 16539377 | ||
HepG2 | Cytotoxicity assay | IC50 = 0.3 μM | 16539377 | ||
VA13 | Cytotoxicity assay | IC50 = 0.0059 μM | 16724842 | ||
WI38 | Cytotoxicity assay | IC50 = 0.0468 μM | 16724842 | ||
HepG2 | Cytotoxicity assay | IC50 = 9.49 μM | 16724842 | ||
HT29 | Cytotoxicity assay | EC50 = 0.006 μM | 16870428 | ||
K562 | Cytotoxicity assay | EC50 = 0.014 μM | 16870428 | ||
MCF7 | Cytotoxicity assay | EC50 = 0.036 μM | 16870428 | ||
VA-13 | Cytotoxicity assay | IC50 = 0.005 μM | 16933868 | ||
WI38 | Cytotoxicity assay | IC50 = 0.04 μM | 16933868 | ||
VA13 | Cytotoxicity assay | IC50 = 0.005 μM | 17067155 | ||
WI38 | Cytotoxicity assay | IC50 = 0.04 μM | 17067155 | ||
Hep G2 | Cytotoxicity assay | IC50 = 8.1 μM | 17067155 | ||
TW01 | Cytotoxicity assay | IC50 = 0.0003 μM | 17113288 | ||
MCF7 | Cytotoxicity assay | IC50 = 0.0005 μM | 17113288 | ||
MKN45 | Cytotoxicity assay | IC50 = 0.0005 μM | 17113288 | ||
MES-SA | Cytotoxicity assay | IC50 = 0.0005 μM | 17113288 | ||
HCT116 | Cytotoxicity assay | IC50 = 0.0006 μM | 17113288 | ||
RPTEC | Cytotoxicity assay | IC50 = 0.0009 μM | 17113288 | ||
Hep3B | Cytotoxicity assay | IC50 = 0.0054 μM | 17113288 | ||
NCI-H226 | Cytotoxicity assay | IC50 = 0.0068 μM | 17113288 | ||
A498 | Cytotoxicity assay | IC50 = 0.061 μM | 17113288 | ||
MDA435/LCC6 | Antiproliferative activity assay | IC50 = 0.0029 μM | 17154505 | ||
multidrug resistant MDA435/LCC6 | Antiproliferative activity assay | IC50 = 0.0048 μM | 17154505 | ||
P388 | Antiproliferative activity assay | IC50 = 0.022 μM | 17154505 | ||
adriamycin resistant P388 | Antiproliferative activity assay | IC50 = 0.03 μM | 17154505 | ||
A2780 | Cytotoxicity assay | IC50 = 0.001 μM | 17206139 | ||
A2780-1A9 | Cytotoxicity assay | IC50 = 0.0011 μM | 17206139 | ||
A549 | Cytotoxicity assay | IC50 = 0.0036 μM | 17206139 | ||
1A9PTX22 | Cytotoxicity assay | IC50 = 0.019 μM | 17206139 | ||
1A9PTX10 | Cytotoxicity assay | IC50 = 0.03 μM | 17206139 | ||
A2780AD | Cytotoxicity assay | IC50 = 0.9 μM | 17206139 | ||
KB | Antiproliferative activity assay | IC50 = 0.00245 μM | 17228873 | ||
COLO205 | Cytotoxicity assay | IC50 = 0.0033 μM | 17228873 | ||
KB8.5 | Antiproliferative activity assay | IC50 = 0.026 μM | 17228873 | ||
KBV1 | Antiproliferative activity assay | IC50 = 2.013 μM | 17228873 | ||
A2780 | Cytotoxicity assay | IC50 = 0.0007 μM | 17239597 | ||
2780AD | Cytotoxicity assay | IC50 = 0.535 μM | 17239597 | ||
1A9 | Cytotoxicity assay | ED50 = 0.001 μM | 17350834 | ||
MCF7 | Cytotoxicity assay | ED50 = 0.0011 μM | 17350834 | ||
DU145 | Cytotoxicity assay | ED50 = 0.0013 μM | 17350834 | ||
KB | Cytotoxicity assay | ED50 = 0.0018 μM | 17350834 | ||
A549 | Cytotoxicity assay | ED50 = 0.0023 μM | 17350834 | ||
LNCAP | Cytotoxicity assay | ED50 = 0.0026 μM | 17350834 | ||
PC3 | Cytotoxicity assay | ED50 = 0.0555 μM | 17350834 | ||
KBVIN | Cytotoxicity assay | ED50 = 0.311 μM | 17350834 | ||
A2780 | Cytotoxicity assay | IC50 = 0.0016 μM | 17395465 | ||
A2780/AD | Cytotoxicity assay | IC50 = 0.92 μM | 17395465 | ||
KB | Antiproliferative activity assay | IC50 = 0.00245 μM | 17416524 | ||
COLO205 | Cytotoxicity assay | IC50 = 0.0033 μM | 17416524 | ||
KB8.5 | Antiproliferative activity assay | IC50 = 0.026 μM | 17416524 | ||
KBV1 | Antiproliferative activity assay | IC50 = 2.013 μM | 17416524 | ||
neural precursor | Antiproliferative activity assay | EC50 = 0.01 μM | 17417631 | ||
OVCAR-3 | Cytotoxicity assay | IC50 = 0.0002 μM | 17419065 | ||
MDA-MB-231 | Cytotoxicity assay | IC50 = 0.0045 μM | 17419065 | ||
MCF7 | Cytotoxicity assay | IC50 = 0.0049 μM | 17419065 | ||
A2780 | Cytotoxicity assay | IC50 = 0.025 μM | 17419065 | ||
PC3 | Cytotoxicity assay | IC50 = 0.077 μM | 17419065 | ||
LoVo | Cytotoxicity assay | IC50 = 0.09 μM | 17419065 | ||
L2987 | Cytotoxicity assay | IC50 = 0.2 μM | 17419065 | ||
cells | Cytotoxicity assay | IC50 = 0.0059 μM | 17442577 | ||
cells | Cytotoxicity assay | IC50 = 0.01 μM | 17485207 | ||
A2780 | Growth inhibition assay | IC50 = 0.0028 μM | 17490878 | ||
VA13 | Growth inhibition assay | IC50 = 0.005 μM | 17490878 | ||
WI38 | Growth inhibition assay | IC50 = 0.04 μM | 17490878 | ||
2780AD | Growth inhibition assay | IC50 = 0.183 μM | 17490878 | ||
HepG2 | Growth inhibition assay | IC50 = 8.1 μM | 17490878 | ||
cells expressing MRP1 | Growth inhibition assay | IC50 = 0.0025 μM | 17567121 | ||
cells expressing Pgp/MRP1 | Growth inhibition assay | IC50 = 2.7 μM | 17567121 | ||
VA13 | Growth inhibition assay | IC50 = 5 μM | 17595134 | ||
MCF7 | Function assay | IC50 = 0.0018 μM | 17601739 | ||
adriamycin-resistant MCF7 | Function assay | IC50 = 8.2 μM | 17601739 | ||
RPMI8226 | Cytotoxicity assay | GI50 = 0.002 μM | 17696332 | ||
HT29 | Cytotoxicity assay | GI50 = 0.002 μM | 17696332 | ||
COLO205 | Cytotoxicity assay | GI50 = 0.003 μM | 17696332 | ||
HCC2998 | Cytotoxicity assay | GI50 = 0.003 μM | 17696332 | ||
HS578T | Cytotoxicity assay | GI50 = 0.003 μM | 17696332 | ||
PC3 | Cytotoxicity assay | GI50 = 0.004 μM | 17696332 | ||
SNB75 | Cytotoxicity assay | GI50 = 0.004 μM | 17696332 | ||
A549 | Cytotoxicity assay | GI50 = 0.004 μM | 17696332 | ||
KM12 | Cytotoxicity assay | GI50 = 0.004 μM | 17696332 | ||
DU145 | Cytotoxicity assay | GI50 = 0.005 μM | 17696332 | ||
SK-OV3 | Cytotoxicity assay | GI50 = 0.008 μM | 17696332 | ||
NCI-H322M | Cytotoxicity assay | GI50 = 0.013 μM | 17696332 | ||
UACC257 | Cytotoxicity assay | GI50 = 0.04 μM | 17696332 | ||
HCT15 | Cytotoxicity assay | GI50 = 0.158 μM | 17696332 | ||
ACHN | Cytotoxicity assay | GI50 = 0.398 μM | 17696332 | ||
HeLa | Cytotoxicity assay | IC50 = 0.0056 μM | 17764148 | ||
MCF7 | Cytotoxicity assay | IC50 = 0.0124 μM | 17764148 | ||
A549 | Cytotoxicity assay | IC50 = 0.0126 μM | 17764148 | ||
HGC27 | Cytotoxicity assay | IC50 = 0.7778 μM | 17764148 | ||
HeLa | Cytotoxicity assay | IC50 = 0.02 μM | 17911017 | ||
HepG2 | Cytotoxicity assay | IC50 = 0.82 μM | 17911017 | ||
BGC823 | Cytotoxicity assay | IC50 = 1.15 μM | 17911017 | ||
cells assessed as accumulation at G2/M phase after 24 hrs by flow cytometric analysis | Cell cycle arrest assay | EC50 = 0.049 μM | 17973361 | ||
cells after 48 hrs by XTT assay | Antiproliferative activity assay | IC50 = 0.4 μM | 17973361 | ||
A2780 | Cytotoxicity assay | IC50 = 0.0063 μM | 18001087 | ||
BGC823 | Cytotoxicity assay | IC50 = 0.007 μM | 18001087 | ||
A549 | Cytotoxicity assay | IC50 = 0.019 μM | 18001087 | ||
HCT8 | Cytotoxicity assay | IC50 = 0.037 μM | 18001087 | ||
Bel7402 | Cytotoxicity assay | IC50 = 0.1 μM | 18001087 | ||
cells by alamar blue assay | Function assay | IC50 = 0.04 μM | 18070965 | ||
HT29 | Antiproliferative activity assay | GI50 = 0.015 μM | 18502639 | ||
M21 | Antiproliferative activity assay | GI50 = 0.037 μM | 18502639 | ||
MCF7 | Antiproliferative activity assay | GI50 = 0.054 μM | 18502639 | ||
HCT116 | Cytotoxicity assay | IC50 = 0.0136 μM | 18606540 | ||
SF268 | Cytotoxicity assay | IC50 = 0.0153 μM | 18606540 | ||
A549 | Cytotoxicity assay | IC50 = 0.0231 μM | 18606540 | ||
MDA-MB-231 | Cytotoxicity assay | IC50 = 0.0405 μM | 18606540 | ||
SF295 | Cytotoxicity assay | IC50 = 0.29 μM | 18606540 | ||
SKOV3 | Cytotoxicity assay | IC50 = 2.43 μM | 18701281 | ||
KB | Cytotoxicity assay | IC50 = 2.54 μM | 18701281 | ||
Eca109 | Cytotoxicity assay | IC50 = 2.73 μM | 18701281 | ||
PC3 | Cytotoxicity assay | IC50 = 2.85 μM | 18701281 | ||
SMMC7721 | Cytotoxicity assay | IC50 = 2.86 μM | 18701281 | ||
MCF7 | Cytotoxicity assay | IC50 = 2.98 μM | 18701281 | ||
HeLa | Cytotoxicity assay | IC50 = 3.11 μM | 18701281 | ||
HCT8 | Cytotoxicity assay | IC50 = 3.29 μM | 18701281 | ||
K562 | Cytotoxicity assay | IC50 = 3.65 μM | 18701281 | ||
A549 | Cytotoxicity assay | IC50 = 0.002 μM | 18715782 | ||
MCF7 | Cytotoxicity assay | ED50 = 0.0032 μM | 18926701 | ||
NCI/ADR-RES | Cytotoxicity assay | ED50 = 1.5 μM | 18926701 | ||
MCF7 | Cytotoxicity assay | ED50 = 0.0021 μM | 18977659 | ||
NCI/ADR-RES | Cytotoxicity assay | ED50 = 2 μM | 18977659 | ||
cells after 72 hrs by MTT assay | Cytotoxicity assay | IC50 = 5.14 μM | 19053781 | ||
KB | Growth inhibition assay | ED50 = 0.023 μM | 19161316 | ||
HepG2 | Cytotoxicity assay | GI50 = 0.001 μM | 19195901 | ||
WI38 | Cytotoxicity assay | GI50 = 0.0137 μM | 19195901 | ||
RKO | Antiproliferative activity assay | IC50 = 0.02 μM | 19220018 | ||
KB/HeLa | Antiproliferative activity assay | IC50 = 0.03 μM | 19220018 | ||
SKOV3 | Antiproliferative activity assay | IC50 = 0.05 μM | 19220018 | ||
SF268 | Antiproliferative activity assay | IC50 = 0.05 μM | 19220018 | ||
NCI-H460 | Antiproliferative activity assay | IC50 = 0.07 μM | 19220018 | ||
A2780 | Function assay | IC50 = 0.386 μM | 19239240 | ||
A2780 | Cytotoxicity assay | IC50 = 0.014 μM | 19282186 | ||
A431 | Antiproliferative activity assay | GI50 = 0.00001 μM | 19394218 | ||
MESSA | Antiproliferative activity assay | GI50 = 0.00001 μM | 19394218 | ||
HCT15 | Antiproliferative activity assay | GI50 = 0.011 μM | 19394218 | ||
MES-SA/Dx5 | Antiproliferative activity assay | GI50 = 0.16 μM | 19394218 | ||
HCT15/CLO2 | Antiproliferative activity assay | GI50 = 0.83 μM | 19394218 | ||
paclitaxel-resistant A2780TC1 | Function assay | IC50 = 5.898 μM | 19423340 | ||
HepG2 | Cytotoxicity assay | GI50 = 0.059 μM | 19476336 | ||
PtK2 | Growth inhibition assay | IC50 = 0.021 μM | 19601594 | ||
rat A10 | Growth inhibition assay | IC50 = 0.038 μM | 19601594 | ||
MES-SA/Dx5 | Cytotoxicity assay | IC50 = 7.538 μM | 19679475 | ||
A549 | Cytotoxicity assay | IC50 = 0.0023 μM | 19708679 | ||
BGC823 | Cytotoxicity assay | IC50 = 0.0033 μM | 19708679 | ||
HCT8 | Cytotoxicity assay | IC50 = 0.0036 μM | 19708679 | ||
A2780 | Cytotoxicity assay | IC50 = 0.0079 μM | 19708679 | ||
Bel7404 | Cytotoxicity assay | IC50 = 0.0123 μM | 19708679 | ||
A2780 | Cytotoxicity assay | IC50 = 0.0028 μM | 19877653 | ||
A2780AD | Cytotoxicity assay | IC50 = 0.415 μM | 19877653 | ||
KBVIN | Cytotoxicity assay | IC50 = 0.00109 μM | 20036537 | ||
KB | Cytotoxicity assay | IC50 = 0.00155 μM | 20036537 | ||
A549 | Cytotoxicity assay | IC50 = 0.00193 μM | 20036537 | ||
DU145 | Cytotoxicity assay | IC50 = 0.00235 μM | 20036537 | ||
KB | Cytotoxicity assay | IC50 = 0.08 μM | 20122764 | ||
786-0 | Cytotoxicity assay | IC50 = 0.08 μM | 20122764 | ||
A375 | Cytotoxicity assay | IC50 = 0.81 μM | 20122764 | ||
BGC | Cytotoxicity assay | IC50 = 1.5 μM | 20122764 | ||
769-P | Cytotoxicity assay | IC50 = 7.1 μM | 20122764 | ||
HT-29 | Cytotoxicity assay | IC50 = 0.0014 μM | 20553003 | ||
HCT116 | Cytotoxicity assay | IC50 = 0.00321 μM | 20553003 | ||
KB | Cytotoxicity assay | IC50 = 0.08 μM | 20627721 | ||
786-0 | Cytotoxicity assay | IC50 = 0.08 μM | 20627721 | ||
HepG2 | Cytotoxicity assay | IC50 = 0.08 μM | 20627721 | ||
OS-RC2 | Cytotoxicity assay | IC50 = 0.08 μM | 20627721 | ||
22Rv1 | Cytotoxicity assay | IC50 = 0.08 μM | 20627721 | ||
HT-29 | Cytotoxicity assay | IC50 = 0.38 μM | 20627721 | ||
A375 | Cytotoxicity assay | IC50 = 0.81 μM | 20627721 | ||
MCF7 | Cytotoxicity assay | IC50 = 1.3 μM | 20627721 | ||
BCG823 | Cytotoxicity assay | IC50 = 1.5 μM | 20627721 | ||
769-P | Cytotoxicity assay | IC50 = 7.1 μM | 20627721 | ||
KB | Cytotoxicity assay | IC50 = 0.08 μM | 20716468 | ||
786-0 | Cytotoxicity assay | IC50 = 0.08 μM | 20716468 | ||
OS-RC2 | Cytotoxicity assay | IC50 = 0.08 μM | 20716468 | ||
22Rv1 | Cytotoxicity assay | IC50 = 0.08 μM | 20716468 | ||
HepG2 | Cytotoxicity assay | IC50 = 0.08 μM | 20716468 | ||
HT-29 | Cytotoxicity assay | IC50 = 0.38 μM | 20716468 | ||
A375 | Cytotoxicity assay | IC50 = 0.81 μM | 20716468 | ||
MCF7 | Cytotoxicity assay | IC50 = 1.3 μM | 20716468 | ||
BGC823 | Cytotoxicity assay | IC50 = 1.5 μM | 20716468 | ||
769-P | Cytotoxicity assay | IC50 = 7.1 μM | 20716468 | ||
DU145 | Cytotoxicity assay | ED50 = 0.003 μM | 20738103 | ||
KB | Cytotoxicity assay | ED50 = 0.007 μM | 20738103 | ||
A549 | Cytotoxicity assay | ED50 = 0.008 μM | 20738103 | ||
multidrug-resistant MDA-MB-435/LCCMDR1 | Function assay | IC50 = 0.0693 μM | 20919720 | ||
LNCAP | Cytotoxicity assay | IC50 = 0.0223 μM | 20936874 | ||
HeLa | Antiproliferative activity assay | IC50 = 0.0016 μM | 20973488 | ||
SKOV3 | Antiproliferative activity assay | IC50 = 0.003 μM | 20973488 | ||
HT-29 | Anticancer assay | ED50 = 0.0001 μM | 21067206 | ||
MES-SA | Antiproliferative activity assay | IC50 = 0.00296 μM | 21324686 | ||
MES-SA | Antiproliferative activity assay | IC50 = 0.00296 μM | 21324687 | ||
SF295 | Antiproliferative activity assay | IC50 = 0.02455 μM | 21324687 | ||
MES-SA | Cytotoxicity assay | IC50 = 0.00296 μM | 21324692 | ||
KB | Cell cycle arrest assay | EC50 = 0.002 μM | 21480626 | ||
786-0 | Antiproliferative activity assay | IC50 = 0.004 μM | 21774499 | ||
PC3 | Antiproliferative activity assay | IC50 = 0.00043 μM | 21775150 | ||
DU145 | Antiproliferative activity assay | IC50 = 0.0023 μM | 21775150 | ||
MDA-MB-435 | Antiproliferative activity assay | IC50 = 0.016 μM | 21775150 | ||
KB | Cytotoxicity assay | IC50 = 6.684 μM | 21784631 | ||
DU145 | Cytotoxicity assay | IC50 = 8.626 μM | 21784631 | ||
A549 | Cytotoxicity assay | IC50 = 9.265 μM | 21784631 | ||
HeLa | Antiproliferative activity assay | IC50 = 0.00138 μM | 21786793 | ||
SKOV3 | Antiproliferative activity assay | IC50 = 0.00295 μM | 21786793 | ||
HT-29 | Cytotoxicity assay | GI50 = 0.002 μM | 21839640 | ||
RPMI8226 | Cytotoxicity assay | GI50 = 0.002 μM | 21839640 | ||
HCC2998 | Cytotoxicity assay | GI50 = 0.003 μM | 21839640 | ||
Hs578T | Cytotoxicity assay | GI50 = 0.003 μM | 21839640 | ||
COLO205 | Cytotoxicity assay | GI50 = 0.003 μM | 21839640 | ||
PC3 | Cytotoxicity assay | GI50 = 0.004 μM | 21839640 | ||
A549 | Cytotoxicity assay | GI50 = 0.004 μM | 21839640 | ||
SNB75 | Cytotoxicity assay | GI50 = 0.004 μM | 21839640 | ||
KM12 | Cytotoxicity assay | GI50 = 0.004 μM | 21839640 | ||
DU145 | Cytotoxicity assay | GI50 = 0.005 μM | 21839640 | ||
SKOV3 | Cytotoxicity assay | GI50 = 0.008 μM | 21839640 | ||
NCI-H322M | Cytotoxicity assay | GI50 = 0.013 μM | 21839640 | ||
UACC257 | Cytotoxicity assay | GI50 = 0.04 μM | 21839640 | ||
HCT15 | Cytotoxicity assay | GI50 = 0.158 μM | 21839640 | ||
ACHN | Cytotoxicity assay | GI50 = 0.398 μM | 21839640 | ||
KB | Cytotoxicity assay | IC50 = 0.08 μM | 21875764 | ||
786-0 | Cytotoxicity assay | IC50 = 0.08 μM | 21875764 | ||
OS-RC2 | Cytotoxicity assay | IC50 = 0.08 μM | 21875764 | ||
22Rv1 | Cytotoxicity assay | IC50 = 0.08 μM | 21875764 | ||
HepG2 | Cytotoxicity assay | IC50 = 0.08 μM | 21875764 | ||
HT-29 | Cytotoxicity assay | IC50 = 0.38 μM | 21875764 | ||
A375 | Cytotoxicity assay | IC50 = 0.81 μM | 21875764 | ||
MCF7 | Cytotoxicity assay | IC50 = 1.3 μM | 21875764 | ||
BGC823 | Cytotoxicity assay | IC50 = 1.5 μM | 21875764 | ||
769-P | Cytotoxicity assay | IC50 = 7.1 μM | 21875764 | ||
BGC823 | Cytotoxicity assay | IC50 = 0.00329 μM | 21928797 | ||
HT-29 | Cytotoxicity assay | IC50 = 0.00394 μM | 21928797 | ||
HepG2 | Cytotoxicity assay | IC50 = 0.0044 μM | 21928797 | ||
A375 | Cytotoxicity assay | IC50 = 0.0049 μM | 21928797 | ||
A549 | Cytotoxicity assay | IC50 = 0.0449 μM | 21928797 | ||
NCI-H460 | Cytotoxicity assay | IC50 = 8 μM | 21942765 | ||
HBL100 | Growth inhibition assay | GI50 = 0.000017 μM | 21986585 | ||
HeLa | Growth inhibition assay | GI50 = 0.000033 μM | 21986585 | ||
T47D | Growth inhibition assay | GI50 = 0.00015 μM | 21986585 | ||
WiDr | Growth inhibition assay | GI50 = 0.00022 μM | 21986585 | ||
A2780 | Growth inhibition assay | GI50 = 0.00027 μM | 21986585 | ||
SW1573 | Growth inhibition assay | GI50 = 0.005 μM | 21986585 | ||
A2780 | Antiproliferative activity assay | IC50 = 0.017 μM | 21995542 | ||
DU145 | Cytotoxicity assay | EC50 = 0.0059 μM | 22142543 | ||
KB | Cytotoxicity assay | EC50 = 0.006 μM | 22142543 | ||
A549 | Cytotoxicity assay | EC50 = 0.0064 μM | 22142543 | ||
SKOV3 | Cytotoxicity assay | IC50 = 0.0001 μM | 22506620 | ||
BGC823 | Cytotoxicity assay | IC50 = 0.0033 μM | 22506620 | ||
HepG2 | Cytotoxicity assay | IC50 = 0.0044 μM | 22506620 | ||
A549 | Cytotoxicity assay | IC50 = 0.016 μM | 22506620 | ||
HCT8 | Cytotoxicity assay | IC50 = 0.051 μM | 22506620 | ||
HCT116 | Cytotoxicity assay | IC50 = 0.05 μM | 22691179 | ||
SKBR3 | Cytotoxicity assay | IC50 = 0.11 μM | 22691179 | ||
SK-MEL-5 | Cytotoxicity assay | IC50 = 0.15 μM | 22691179 | ||
SKOV3 | Cytotoxicity assay | IC50 = 0.4 μM | 22691179 | ||
MCF7 | Cytotoxicity assay | IC50 = 0.9 μM | 22691179 | ||
HeLa | Cytotoxicity assay | IC50 = 1 μM | 23103097 | ||
A2780 | Cytotoxicity assay | IC50 = 1.1 μM | 23103097 | ||
MES-SA | Cytotoxicity assay | IC50 = 0.003 μM | 23141916 | ||
NUGC3 | Growth inhibition assay | GI50 = 0.02 μM | 23167614 | ||
HONE1 | Growth inhibition assay | GI50 = 0.02 μM | 23167614 | ||
NCI-H460 | Growth inhibition assay | GI50 = 0.03 μM | 23167614 | ||
MCF7 | Growth inhibition assay | GI50 = 0.03 μM | 23167614 | ||
A549 | Growth inhibition assay | GI50 = 0.06 μM | 23167614 | ||
HepG2 | Growth inhibition assay | GI50 = 0.18 μM | 23167614 | ||
OVCAR8 | Cytotoxicity assay | IC50 = 0.005 μM | 23214452 | ||
NCI/ADR-RES | Cytotoxicity assay | IC50 = 3.3 μM | 23214452 | ||
DU145 | Growth inhibition assay | GI50 = 0.0065 μM | 23274123 | ||
KB | Growth inhibition assay | GI50 = 0.00777 μM | 23274123 | ||
A549 | Growth inhibition assay | GI50 = 0.00818 μM | 23274123 | ||
KBVIN | Growth inhibition assay | GI50 = 1.803 μM | 23274123 | ||
K562 | Antiproliferative activity assay | IC50 = 0.41 μM | 23274570 | ||
CaEs17 | Antiproliferative activity assay | IC50 = 0.43 μM | 23274570 | ||
MGC803 | Antiproliferative activity assay | IC50 = 0.85 μM | 23274570 | ||
Bel7402 | Antiproliferative activity assay | IC50 = 1.89 μM | 23274570 | ||
HT-29 | Cytotoxicity assay | ED50 = 0.001 μM | 23301897 | ||
NCI-H358 | Cytotoxicity assay | IC50 = 0.01 μM | 23425970 | ||
A2780S | Cytotoxicity assay | IC50 = 0.02 μM | 23425970 | ||
DU145 | Cytotoxicity assay | IC50 = 0.03 μM | 23425970 | ||
SKOV3 | Cytotoxicity assay | IC50 = 0.1 μM | 23425970 | ||
ES2 | Cytotoxicity assay | IC50 = 0.1 μM | 23425970 | ||
HCT15 | Cytotoxicity assay | IC50 = 0.12 μM | 23425970 | ||
PC3 | Cytotoxicity assay | IC50 = 0.14 μM | 23425970 | ||
SKHEP1 | Cytotoxicity assay | IC50 = 0.24 μM | 23425970 | ||
HT-29 | Cytotoxicity assay | IC50 = 0.45 μM | 23425970 | ||
MCF7 | Cytotoxicity assay | IC50 = 0.66 μM | 23425970 | ||
C26 | Cytotoxicity assay | IC50 = 1.05 μM | 23425970 | ||
SPC-A1 | Cytotoxicity assay | IC50 = 5.3 μM | 23425970 | ||
A2780 | Cytotoxicity assay | IC50 = 8.25 μM | 23425970 | ||
A2780 | Cytotoxicity assay | IC50 = 0.001 μM | 23547884 | ||
BGC823 | Cytotoxicity assay | IC50 = 0.001 μM | 23547884 | ||
Bel7402 | Cytotoxicity assay | IC50 = 0.006 μM | 23547884 | ||
A549 | Cytotoxicity assay | IC50 = 0.016 μM | 23547884 | ||
HCT8 | Cytotoxicity assay | IC50 = 0.051 μM | 23547884 | ||
A2780 | Cytotoxicity assay | IC50 = 0.028 μM | 23659371 | ||
HCT116 | Cytotoxicity assay | GI50 = 0.01 μM | 23725535 | ||
T47D | Cytotoxicity assay | GI50 = 0.01 μM | 23725535 | ||
LOXIMVI | Cytotoxicity assay | GI50 = 0.016 μM | 23725535 | ||
OVCAR3 | Cytotoxicity assay | GI50 = 0.02 μM | 23725535 | ||
DU145 | Cytotoxicity assay | GI50 = 0.032 μM | 23725535 | ||
MOLT4 | Cytotoxicity assay | GI50 = 0.032 μM | 23725535 | ||
SNB19 | Cytotoxicity assay | GI50 = 0.04 μM | 23725535 | ||
NCI-H322M | Cytotoxicity assay | GI50 = 0.05 μM | 23725535 | ||
RXF393 | Cytotoxicity assay | GI50 = 0.05 μM | 23725535 | ||
2008 | Growth inhibition assay | GI50 = 0.003 μM | 23750455 | ||
MES-SA | Growth inhibition assay | GI50 = 0.004 μM | 23750455 | ||
MES-SA/Dx5 | Growth inhibition assay | GI50 = 0.75 μM | 23750455 | ||
2008/17/4 | Growth inhibition assay | GI50 = 2 μM | 23750455 | ||
MOLT4 | Cytotoxicity assay | IC50 = 0.0018 μM | 23806112 | ||
U937 | Cytotoxicity assay | IC50 = 0.0019 μM | 23806112 | ||
BGC823 | Cytotoxicity assay | IC50 = 0.0035 μM | 23806112 | ||
A549 | Cytotoxicity assay | IC50 = 0.0036 μM | 23806112 | ||
K562 | Cytotoxicity assay | IC50 = 0.0049 μM | 23806112 | ||
MCF7 | Cytotoxicity assay | IC50 = 0.005 μM | 23806112 | ||
DU145 | Cytotoxicity assay | GI50 = 0.006 μM | 23867604 | ||
KB | Cytotoxicity assay | GI50 = 0.0064 μM | 23867604 | ||
A549 | Cytotoxicity assay | GI50 = 0.0076 μM | 23867604 | ||
KBVIN | Cytotoxicity assay | GI50 = 1.21 μM | 23867604 | ||
HL60 | Cytotoxicity assay | IC50 = 0.002 μM | 23937981 | ||
DU145 | Cytotoxicity assay | IC50 = 0.005 μM | 23937981 | ||
MES-SA | Cytotoxicity assay | IC50 = 0.005 μM | 23937981 | ||
MDA435 | Cytotoxicity assay | IC50 = 0.005 μM | 23937981 | ||
Bowes | Cytotoxicity assay | IC50 = 0.005 μM | 23937981 | ||
A549 | Cytotoxicity assay | IC50 = 0.01 μM | 23937981 | ||
Clone A | Cytotoxicity assay | IC50 = 0.5 μM | 23937981 | ||
MIP101 | Cytotoxicity assay | IC50 = 1.1 μM | 23937981 | ||
PBMC | Cytotoxicity assay | IC50 = 5 μM | 23937981 | ||
39SK | Cytotoxicity assay | IC50 = 5 μM | 23937981 | ||
MCF7 | Cytotoxicity assay | IC50 = 3.1 μM | 24195466 | ||
DU145 | Cytotoxicity assay | GI50 = 0.006 μM | 24315191 | ||
A549 | Cytotoxicity assay | GI50 = 0.0076 μM | 24315191 | ||
KB | Cytotoxicity assay | GI50 = 0.008 μM | 24315191 | ||
KBVIN | Cytotoxicity assay | GI50 = 1.8 μM | 24315191 | ||
MCF7 | Growth inhibition assay | GI50 = 0.00129 μM | 24405702 | ||
Bel7402 | Growth inhibition assay | GI50 = 0.001792 μM | 24405702 | ||
MOLT4 | Growth inhibition assay | GI50 = 0.002232 μM | 24405702 | ||
A431 | Growth inhibition assay | GI50 = 0.002355 μM | 24405702 | ||
U937 | Growth inhibition assay | GI50 = 0.002392 μM | 24405702 | ||
PANC1 | Growth inhibition assay | GI50 = 0.002409 μM | 24405702 | ||
SGC7901 | Growth inhibition assay | GI50 = 0.003088 μM | 24405702 | ||
HeLa | Growth inhibition assay | GI50 = 0.003206 μM | 24405702 | ||
BGC823 | Growth inhibition assay | GI50 = 0.003605 μM | 24405702 | ||
HT1080 | Growth inhibition assay | GI50 = 0.003889 μM | 24405702 | ||
DU145 | Growth inhibition assay | GI50 = 0.005568 μM | 24405702 | ||
K562 | Growth inhibition assay | GI50 = 0.007014 μM | 24405702 | ||
A549 | Growth inhibition assay | GI50 = 0.01873 μM | 24405702 | ||
HuH7 | Growth inhibition assay | GI50 = 0.2067 μM | 24405702 | ||
HeLa | Cytotoxicity assay | IC50 = 0.0025 μM | 24422592 | ||
DU145 | Cytotoxicity assay | GI50 = 0.006 μM | 24502232 | ||
KB | Cytotoxicity assay | GI50 = 0.0064 μM | 24502232 | ||
A549 | Cytotoxicity assay | GI50 = 0.0076 μM | 24502232 | ||
KBVIN | Cytotoxicity assay | GI50 = 1.21 μM | 24502232 | ||
A2780 | Cytotoxicity assay | IC50 = 0.00138 μM | 24680057 | ||
1A9PTX22 | Cytotoxicity assay | IC50 = 0.1607 μM | 24680057 | ||
1A9PTX10 | Cytotoxicity assay | IC50 = 0.53295 μM | 24680057 | ||
BCG823 | Cytotoxicity assay | IC50 = 0.0028 μM | 24684840 | ||
HepG2 | Cytotoxicity assay | IC50 = 0.0064 μM | 24684840 | ||
HL-7702 | Cytotoxicity assay | IC50 = 0.0518 μM | 24684840 | ||
NCI-ADR-RES | Cytotoxicity assay | EC50 = 0.013 μM | 24801610 | ||
OVCAR8 | Cytotoxicity assay | EC50 = 0.018 μM | 24801610 | ||
HeLa | Antiproliferative activity assay | IC50 = 0.00121 μM | 24890652 | ||
MDA-MB-435 | Antiproliferative activity assay | IC50 = 0.00193 μM | 24890652 | ||
SKOV3 | Antiproliferative activity assay | IC50 = 0.003 μM | 24890652 | ||
SKOV3 | Cytotoxicity assay | GI50 = 0.0047 μM | 24893224 | ||
P-gp expressing SKOV3-M6/6 | Cytotoxicity assay | GI50 = 0.6 μM | 24893224 | ||
HT-29 | Cytotoxicity assay | IC50 = 0.001 μM | 24937209 | ||
MCF7 | Cytotoxicity assay | IC50 = 0.0015 μM | 24960143 | ||
HepG2 | Cytotoxicity assay | IC50 = 0.0046 μM | 24960143 | ||
MDA-MB-231 | Cytotoxicity assay | IC50 = 0.0082 μM | 24960143 | ||
HL7702 | Cytotoxicity assay | IC50 = 1.1 μM | 24960143 | ||
A2780 | Cytotoxicity assay | IC50 = 0.0004 μM | 25047938 | ||
HeLa | Cytotoxicity assay | IC50 = 0.0007 μM | 25047938 | ||
MCF7 | Cytotoxicity assay | IC50 = 0.0017 μM | 25047938 | ||
1A9 | Cytotoxicity assay | IC50 = 0.0039 μM | 25047938 | ||
1A9/A8 | Cytotoxicity assay | IC50 = 0.0042 μM | 25047938 | ||
1A9PTX22 | Cytotoxicity assay | IC50 = 0.0328 μM | 25047938 | ||
1A9PTX10 | Cytotoxicity assay | IC50 = 0.0814 μM | 25047938 | ||
MCF7/R | Cytotoxicity assay | IC50 = 0.299 μM | 25047938 | ||
A2780AD | Cytotoxicity assay | IC50 = 1.244 μM | 25047938 | ||
KB | Antiproliferative activity assay | IC50 = 0.0033 μM | 25059503 | ||
KB-7d | Antiproliferative activity assay | IC50 = 0.0079 μM | 25059503 | ||
KB-S15 | Antiproliferative activity assay | IC50 = 0.273 μM | 25059503 | ||
COLO205 | Cytotoxicity assay | IC50 = 0.003 μM | 25091926 | ||
NCI-H460 | Cytotoxicity assay | IC50 = 0.01 μM | 25091926 | ||
DU145 | Cytotoxicity assay | IC50 = 1.5 μM | 25105722 | ||
MCF7 | Cytotoxicity assay | IC50 = 1.8 μM | 25105722 | ||
HeLa | Cytotoxicity assay | IC50 = 5 μM | 25105722 | ||
PANC1 | Cytotoxicity assay | IC50 = 1.18 μM | 25466201 | ||
HeLa | Cytotoxicity assay | IC50 = 1.3 μM | 25466201 | ||
Calu1 | Cytotoxicity assay | IC50 = 1.33 μM | 25466201 | ||
H460 | Cytotoxicity assay | IC50 = 1.43 μM | 25466201 | ||
HCT116 | Cytotoxicity assay | IC50 = 1.55 μM | 25466201 | ||
ACHN | Cytotoxicity assay | IC50 = 2.33 μM | 25466201 | ||
HeLa | Growth inhibition assay | IC50 = 0.0035 μM | 25685941 | ||
DU145 | Growth inhibition assay | IC50 = 0.004 μM | 25685941 | ||
PC3 | Growth inhibition assay | IC50 = 0.04 μM | 25685941 | ||
SKOV3 | Growth inhibition assay | IC50 = 6.2 μM | 25685941 | ||
Hep3B2 | Cytotoxicity assay | IC50 = 0.000016 μM | 25760674 | ||
PANC1 | Cytotoxicity assay | IC50 = 0.0011 μM | 25760674 | ||
CNE1-LMP1 | Cytotoxicity assay | IC50 = 0.0042 μM | 25760674 | ||
MGC | Cytotoxicity assay | IC50 = 0.0064 μM | 25760674 | ||
A375 | Cytotoxicity assay | IC50 = 0.0089 μM | 25760674 | ||
MCF7 | Cytotoxicity assay | IC50 = 0.014 μM | 25760674 | ||
HaCaT | Cytotoxicity assay | IC50 = 0.024 μM | 25760674 | ||
A549 | Cytotoxicity assay | IC50 = 0.03 μM | 25760674 | ||
EC109 | Cytotoxicity assay | IC50 = 0.14 μM | 25760674 | ||
NIH/3T3 | Cytotoxicity assay | IC50 = 4.2 μM | 25760674 | ||
DU145 | Antiproliferative activity assay | GI50 = 0.0057 μM | 25770782 | ||
KB | Antiproliferative activity assay | GI50 = 0.0064 μM | 25770782 | ||
A549 | Antiproliferative activity assay | GI50 = 0.0071 μM | 25770782 | ||
KBVIN | Antiproliferative activity assay | GI50 = 0.95 μM | 25770782 | ||
DU145 | Antiproliferative activity assay | GI50 = 0.006 μM | 26242242 | ||
KB | Antiproliferative activity assay | GI50 = 0.0064 μM | 26242242 | ||
A549 | Antiproliferative activity assay | GI50 = 0.0076 μM | 26242242 | ||
vincristine-resistant KBVIN | Antiproliferative activity assay | GI50 = 1.21 μM | 26242242 | ||
K562 | Cytotoxicity assay | IC50 = 0.9 μM | 26287401 | ||
A549 | Cytotoxicity assay | IC50 = 0.0063 μM | 26448037 | ||
cells after 48 hrs by SRB assay | Cytotoxicity assay | GI50 = 0.00148 μM | 26462052 | ||
cells assessed as cell growth inhibition after 48 hrs by MTT assay | Cytotoxicity assay | IC50 = 0.65 μM | 26638041 | ||
MCF7 | Cytotoxicity assay | IC50 = 0.0006 μM | 27441892 | ||
HCT116 | Cytotoxicity assay | IC50 = 0.0009 μM | 27441892 | ||
BGC823 | Cytotoxicity assay | IC50 = 0.0033 μM | 27441892 | ||
HepG2 | Cytotoxicity assay | IC50 = 0.012 μM | 27441892 | ||
Capan2 | Cytotoxicity assay | IC50 = 0.017 μM | 27441892 | ||
A375 | Cytotoxicity assay | IC50 = 0.022 μM | 27441892 | ||
A549 | Cytotoxicity assay | IC50 = 0.023 μM | 27441892 | ||
A2780 | Cytotoxicity assay | IC50 = 0.038 μM | 27441892 | ||
NCI-H1650 | Cytotoxicity assay | IC50 = 0.068 μM | 27441892 | ||
MDA-MB-435 | Antiproliferative activity assay | GI50 = 0.001 μM | 28112516 | ||
HepG2 | Cytotoxicity assay | IC50 = 0.3 μM | 28262527 | ||
Hep3B | Cytotoxicity assay | IC50 = 0.73 μM | 28262527 | ||
KB | Antiproliferative activity assay | IC50 = 0.0059 μM | 28457756 | ||
A549 | Antiproliferative activity assay | IC50 = 0.00685 μM | 28457756 | ||
MDA-MB-231 | Antiproliferative activity assay | IC50 = 0.00963 μM | 28457756 | ||
MCF7 | Antiproliferative activity assay | IC50 = 0.01146 μM | 28457756 | ||
KBVIN | Antiproliferative activity assay | IC50 = 2.035 μM | 28457756 | ||
1A9 | Cytotoxicity assay | IC50 = 0.00371 μM | 28850227 | ||
A549 | Growth inhibition assay | IC50 = 0.0071 μM | 29439899 | ||
A549-T24 | Growth inhibition assay | IC50 = 0.07 μM | 29439899 | ||
HCT116 | Cytotoxicity assay | IC50 = 0.0338 μM | 29468872 | ||
HeLa | Antiproliferative activity assay | IC50 = 0.0016 μM | 29655610 | ||
SKOV3 | Antiproliferative activity assay | IC50 = 0.003 μM | 29655610 | ||
SKOV3-MDR1-M6/6 | Antiproliferative activity assay | IC50 = 2.6 μM | 29655610 | ||
點擊查看更多細胞系數(shù)據(jù) |
產(chǎn)品描述 | Paclitaxel是一種microtubule聚合物穩(wěn)定劑,在人內(nèi)皮細胞中IC50為0.1 pM。Paclitaxel可引起有絲分裂停滯和細胞凋亡。 Paclitaxel還會誘導自噬。 | ||
---|---|---|---|
特性 | Paclitaxel 是有絲分裂抑制劑。 | ||
靶點 |
|
體外研究(In Vitro) | ||||
體外研究活性 | Paclitaxel在104到 105倍更高濃度時,抑制非內(nèi)皮性人類細胞,IC50 為1 nM -10 nM。Paclitaxel選擇性抑制細胞增殖,具有種屬特異性,在Paclitaxel極低濃度時,小鼠內(nèi)皮細胞對 Paclitaxel不敏感。 極低濃度Paclitaxel抑制 人類內(nèi)皮細胞,但是不影響細胞微管結構,且處理的細胞在 G2/M 期沒有出現(xiàn)細胞周期停滯和凋亡,說明這是一種新型尚未查明的作用機制。在體外血管生成實驗中,在三維纖維蛋白基質(zhì)中,極低濃度Paclitaxel阻斷人類內(nèi)皮細胞形成芽管。[1] 在SMF存在時, Paclitaxel 作用于 K562 細胞的有效濃度從50 ng/ml降低到 10 ng/ml。在有或無SMF時,Paclitaxel 使K562 細胞周期停滯與DNA損傷相關。[2] Paclitaxel單獨處理四種細胞系,包括A549 細胞,H358, H1395 細胞和H1666 細胞,抑制CDK1,這種作用存在時間依賴性。[3] |
|||
---|---|---|---|---|
細胞實驗 | 細胞系 | 細胞,包括人類新生兒皮膚微血管內(nèi)皮細胞(HMVECs), 人臍靜脈內(nèi)皮細胞(HUVECs), 人臍動脈內(nèi)皮細胞 (HUAVECs), 正常人類星形膠質(zhì)細胞(NHAs), 正常人體皮膚成纖維細胞(NHDFs), 正常人表皮角質(zhì)形成細胞(NHEKs), 人類乳腺上皮細胞(HMEpCs), 人前列腺上皮細胞(PrEpCs) 和人臍動脈平滑肌細胞(UASMCs) | ||
濃度 | 0.1 pM-100 pM | |||
孵育時間 | 72 小時 | |||
方法 | 培養(yǎng)細胞,包括人類新生兒皮膚微血管內(nèi)皮細胞(HMVECs), 人臍靜脈內(nèi)皮細胞(HUVECs), 人臍動脈內(nèi)皮細胞 (HUAVECs), 正常人類星形膠質(zhì)細胞(NHAs), 正常人體皮膚成纖維細胞(NHDFs), 正常人表皮角質(zhì)形成細胞(NHEKs), 人類乳腺上皮細胞(HMEpCs), 人前列腺上皮細胞(PrEpCs) 和人臍動脈平滑肌細胞(UASMCs)。在96孔板中使用6和12通道的細胞進行增殖。細胞按每孔3000–5000個細胞接種,然后粘附4小時。Paclitaxel在培養(yǎng)基中稀釋,然后按一式四份加到孔中,細胞溫育3天,然后加入MTS 試劑,然后定量測量每孔中的活細胞。 |
|||
實驗圖片 | 檢測方法 | 檢測指標 | 實驗圖片 | PMID |
Western blot | p-ERK / ERK MARCKS (pSer159/163) Src (pTyr416) p-JAK2 / p-STAT3 / p-AKT / p-MAPK / Bcl-xl / MCL-1 Id1 MARCKS | 20068074 | ||
Growth inhibition assay | Cell viability | 28823711 | ||
Immunofluorescence | α-tubulin Rab11a/BV9 | 22904633 |
體內(nèi)研究(In Vivo) | ||
體內(nèi)研究活性 | Paclitaxel單獨處理 BC-V 和 BC-ER腫瘤的抑制定額分別為49.78 和 51.23%。20 mg/kg Paclitaxel處理6個周期,顯著降低Ki-67陽性細胞百分比,BC-V腫瘤中降到20.4%,BC-ER 腫瘤中降到25.1%。[4] |
---|
|
|||||
NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
---|---|---|---|---|---|
NCT05312372 | Withdrawn | Esophageal Squamous Cell Carcinoma |
Institut de Recherches Internationales Servier|ADIR a Servier Group company|Servier |
May 2025 | Phase 1|Phase 2 |
NCT04715542 | Not yet recruiting | Chemotherapy Induced Peripheral Neuropathy (CIPN) |
University of Bern|Insel Gruppe AG University Hospital Bern|Hospital of Thun|Tumor- und Brustzentrum ZeTuP St.Gallen|Gesundheitszentrum Fricktal AG|Kantonsspital Winterthur KSW|Kantonsspital Graubünden|Kantonsspital Aarau |
August 2024 | Phase 3 |
NCT06387901 | Not yet recruiting | Breast Cancer|Paclitaxel Adverse Reaction|Chemotherapeutic Toxicity|Chemotherapeutic Agent Toxicity|Body Weight|Physical Inactivity |
Universitair Ziekenhuis Brussel|Vrije Universiteit Brussel|University Ghent |
May 6 2024 | -- |
NCT05826015 | Not yet recruiting | Recurrent High Grade Uterine Cancer |
Washington University School of Medicine|National Cancer Institute (NCI)|Aravive Inc. |
May 31 2024 | Phase 1 |
NCT05695313 | Recruiting | Breast Cancer |
Centre Georges Francois Leclerc |
April 12 2024 | Phase 2 |
分子量 | 853.91 | 分子式 | C47H51NO14 |
CAS號 | 33069-62-4 | SDF | Download Paclitaxel SDF |
Smiles | CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C | ||
儲存條件(自收到貨起) | |||
體外溶解度 |
DMSO : 100 mg/mL ( (117.1 mM) ;DMSO吸濕會降低化合物溶解度,請使用新開封DMSO) Ethanol : 23 mg/mL (26.93 mM) Water : Insoluble |
|
體內(nèi)溶解度 現(xiàn)配現(xiàn)用,請按從左到右的順序依次添加,澄清后再加入下一溶劑 |
|
第一步:請輸入基本實驗信息(考慮到實驗過程中的損耗,建議多配一只動物的藥量)
第二步:請輸入動物體內(nèi)配方組成(配方適用于不溶于水的藥物;不同批次藥物配方比例不同,請聯(lián)系Selleck為您提供正確的澄清溶液配方)
計算結果:
工作液濃度: mg/ml;
DMSO母液配制方法: mg 藥物溶于μL DMSO溶液(母液濃度mg/mL,注:如該濃度超過該批次藥物DMSO溶解度,請先聯(lián)系Selleck);
體內(nèi)配方配制方法:取μL DMSO母液,加入μL PEG300,混勻澄清后加入μL Tween 80,混勻澄清后加入μL ddH2O,混勻澄清。
體內(nèi)配方配制方法:取μL DMSO母液,加入μL Corn oil,混勻澄清。
注意:1. 首先保證母液是澄清的;
2.一定要按照順序依次將溶劑加入,進行下一步操作之前必須保證上一步操作得到的是澄清的溶液,可采用渦旋、超聲或水浴加熱等物理方法助溶。
在訂購、運輸、儲存和使用我們的產(chǎn)品的任何階段,您遇到的任何問題,均可以通過撥打我們的熱線電話400-668-6834,或者技術支持郵箱tech@selleck.cn,直接聯(lián)系到我們。我們會在24小時內(nèi)盡快聯(lián)系您。
如果有其他問題,請給我們留言。
* 必填項
問題 1:
I am interested in the product S1150 for in vivo studies, could you please give some suggestions for the formulation?
回答:
S1150 in 1% DMSO+30% polyethylene glycol+1% Tween 80 at 30mg/ml is a suspension. If the you want to inject it, there is another vehicle, 5% DMSO+5% Tween 80+ddH2O. S1150 can dissolve in it at 2.5mg/ml as a clear solution. It is a common formulation we used, but is not cited from reference.
問題 2:
the compound was dissolved into 1ml DMSO and diluted with 1x PBS or water (500ul + 9.5 ml PBS or water). I found the white precipitation goes out. How to figure it out?
回答:
Paclitaxel has very low solubility in water based solution and that's why it precipitated out once you dilute the stock with water. The vehicle we suggest is: 1% DMSO+30% polyethylene glycol+1% Tween 80.